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Abstract 
The first main objective of this project was to isolate cellular 
fibronectin from cultures of skin fibroblasts derived from tuberous sclerosis 
(TS) patients and normals and to compare their structures, paying particular 
attention to the content and pattern of carbohydrate (glycosylation). The 
second main objective of this project was to establish the expression and 
localisation of glycoproteins fibronectin, laminin and tenascin of the 
extracellular matrix (ECM) in cultures of skin fibroblasts derived from 
patients with TS and normal individuals. In order to achieve these 
objectives, fibroblasts were established from primary cultures of skin 
explants of patients with TS. Control cells were cultured from skin explants 
donated by people not known to be suffering from any disorder. The 
purification of cellular fibronectin was achieved from conditioned medium of 
skin fibroblasts of TS patients and control fibroblasts using Prosep-gelatin 
affinity chromatography and gel filtration chromatography techniques. 
Analysis of purified cellular fibronectin by high pH anion-exchange 
chromatography with pulsed amperometric detection (HPAEC-PAD) 
revealed that the carbohydrate portion of the fibronectin molecule was made 
up of galactose, mannose, glucosamine, galactosamine, sialic acid and fucose. 
An increased concentration of sialic acid, galactosamine, glucosamine, 
galactose and mannose was observed in purified fibronectin derived from 
neck and ungual fibromas of patients with TS. To provide a total increase of 
carbohydrates more than two fold in comparison to normal fibroblasts- 
derived fibronectin. Purified cellular fibronectin from conditioned medium of 
fibroblasts grown from skin lesions of different TS patients and from normal 
skin fibroblasts did not express HNK-1 (anti-leu 7) carbohydrate epitope. 
Normal skin fibroblasts showed an altered morphology and less confluence 
when grown on cell culture plates coated with cellular fibronectin derived 
from TS fibroblasts compared with control fibronectin. This may be a 
consequence of an altered glycosylation of this protein. The amino acid 
composition of the purified fibronectin from TS fibroblasts was very similar 
to that purified fibronectins from normal fibroblasts and to standard 
commercial plasma and cellular fibronectins. 
Laminin and tenascin were partially purified from conditioned cell culture 
medium demonstrating their synthesis and secretion into the cell culture 
ix 
medium by dermal skin fibroblasts. Expression and distribution of 
fibronectin, tenascin and laminin by established TS and normal skin 
fibroblasts using immunofluorescence, ELISA, and flow cytometry 
techniques were analysed and presented qualitative and quantitatively in 
this thesis. Increased expression and altered distribution of fibronectin and 
tenascin were observed in the fibroblasts derived from ungual fibroma lesion 
of a TS patient, but not in fibroblasts of neck fibroma, forehead plaque lesion 
or unaffacted skin of TS patients in comparison to control fibroblasts. 
However, increased expression and altered distribution of laminin were 
observed in neck fibroma-derived fibroblasts in contrast to fibronectin and 
tenascin. Laminin expression was not changed in ungual fibroma and 
forehead plaque lesion-derived fibroblasts in comparison to control 
fibroblasts. Altered distribution of fibronectin was well observed by 
immunofluorescence particularly in large cells of ungual fibroma. Similar 
differences were observed with laminin of cells from neck fibroma of TS 
patients. 
These results suggest the abnormal assembly of ECM in different TS skin 
lesions. Abnormal migration of cells during early embryonic development 
and the hardening of tissues associated with TS may result from abnormal 
assembly of the ECM. Alterations in distribution and structure of these 
adhesive glycoproteins may cause functional disruption in their binding and 
interactions with cells and ECM macromolecules. Studies of these changes 
in the ECM components may contribute to the understanding of the 
mechanisms involved in the aetiology of hardened tissues of TS. 
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Chapter 1 
Chapter 1 
Introduction 
This chapter will review some of the general aspects of tuberous sclerosis, and also 
structure function relationships of the major adhesive glycoproteins fibronectin, 
laminin and tenascin of the extracellular matrix synthesised in cultures of human skin 
fibroblasts. 
1.1 What is Tuberous Sclerosis ? 
Tuberous sclerosis (TS) is a genetic disorder that causes a variety of 
neurological and physical symptoms including seizures, mental retardation, 
tumours and skin lesions. The name derives from a description of its cerebral 
lesions by the French neurologist Bourneville in 1880. The brain, skin, 
heart, eyes, lungs and kidneys are the most frequently affected organs. 
Therefore, the disease is often referred to as tuberous sclerosis complex 
(TSC), emphasising the multiplicity of organs involved. In 1890, Pringle 
succeeded in bringing about the first explanation of the significance of the 
neurocutaneous relationship of adenoma sebaceum, epilepsy and mental 
retardation. Berg reported the first hereditary nature of TS in 1913 (Gomez, 
1979). Recently, linkage studies have established locus heterogeneity with 
disease-determining genes on chromosomes 9 (Fryer et al., 1987) and more 
recently 16 ( Kandt et al., 1992; Nellist et al., 1993). It has been shown 
histopathologically that TSC is a disorder of cellular migration, proliferation 
and differentiation (Johnson and Gomez, 1991). Recent data suggest that TS 
has a birth incidence of up to one in 5800 (Osborne et al., 1991). 
1.1.1 Clinical Signs of Tuberous Sclerosis 
The complete syndrome of TS exhibits a wide range of clinical symptoms 
with degrees of severity. Gomez (1988) suggested that the clinical features 
of TS may be classified according to their diagnostic importance as 
pathognomonic (definitively diagnostic), or presumptive (provisionally 
diagnostic). 
(i) Definitive Diagnosis o TS 
The following symptoms are considered pathognomonic: 
a) Cortical tubers, which can be recognised by direct inspection, 
histopathological examination or computed tomography (CT) scan 
and magnetic resonance (MR). 
b) Subependymal glial nodules, which are demonstrated by pathologic 
examination or neuroimaging (Cl' or MR). 
c) A lesion in the retina with the typical appearance of a hamartoma. 
d) Skin lesions such as facial angiofibroma, periungual or subungual 
fibromas and scalp/ forehead fibrous plaques. 
e) Multiple renal angiomyolipomas (unilateral or bilateral) as 
demonstrated by renal imaging methods (Cr, MR or ultrasound). 
(ii) Presumptive Diagnosis of TS 
The common diagnostic features of TS include: 
a) infantile spasms. 
b) seizures. 
c) hypomelanotic macules. 
d) shagreen patches. 
e) gingival fibromas. 
f) multiple renal tumours. 
g) renal cysts. 
h) cardiac rhabdomyoma. 
i) pulmonary lymphangiomyomatosis. 
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j) dental enamel pits. 
k) immediate relative with TSC. 
The diagnosis of TS should be suspected if only one feature is present, or 
considered presumptive if two or more features are present. These 
diagnostic features imply that what constitutes TS is not a particular 
symptom or sign but specific lesions in certain organs (Gomez, 1988). In one 
study involving 160 patients (88 male, 72 female), the most common 
presenting symptom (88% of the cases) was seizures. However, this 
symptom was less frequent than the most common abnormal finding on 
examination, namely the skin lesions observed in 91 % of the patients. 
Mental retardation (60%) and retinal hamartoma (50%) were the third and 
fourth most common clinical features of TS (Gomez, 1979). 
1.1.1.1 Dermatologic Manifestations 
As the most common abnormal finding, dermatologic manifestations are 
critical to the diagnosis of TS. The typical skin lesions of TS are described 
briefly below. 
The most characteristic of the skin lesions are facial angiofibromas 
(improperly called adenoma sebaceum) which occur in pink red papules or 
nodules with a smooth shiny surface. These pink or flesh coloured papules 
occur in nasolabial folds and on the cheeks (see Fig. 1.1-a). Facial lesions 
start to appear in the first year of life and fully developed angiofibromas 
occur by the age of 5 years. When the patient reaches puberty the lesions 
may become more various and prominent, and can require repeated dermal 
abrasion or other procedures for cosmesis (Gomez, 1988; Kwiatkowski and 
Short, 1994). 
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(a) Angiofibroma (b) Ungual fibroma 
Figure 1.1 Skin lesions of tuberous sclerosis (Photographs kindly provided 
by TS association of Great Britain). 
The main findings in facial lesions, dermal fibrosis and vasodilatation, make 
the term "angiofibroma". Elastic tissue is absent from these lesions. 
Irregularly, large stellate fibroblasts give the tissue a "glial appearance" 
(Gomez, 1988). Angiofibromas also develop under and around the nails 
(ungual fibromas) as seen in Figure 1.1-b. 
Multiple ungual fibromas are diagnostic of TS and usually appear late in life, 
age 15 through 60 years (Kwiatkowski and Short, 1994). The ungual 
fibromas are flesh or red coloured papules or nodules appearing on the toes, 
but can sometimes occur on fingers. Histopathologically, ungual fibromas 
are similar to facial angiofibromas or forehead plaques. The older lesions of 
ungual fibromas may also accommodate large stellate fibroblasts with a "glial 
appearance". 
Shagreen patch (skin with the appearance of untanned leather) is a 
connective tissue hamartoma. Such patches are usually organised in the 
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lumbosacral area. The size of a shagreen patch may change from a few 
millimetres to 10 or more centimetres. They are slightly raised above the 
surrounding skin surface with a pink or yellowish-brown colour and the 
appearance of pig skin. These shagreen patches are not absolutely 
pathognomonic signs but still a very helpful finding in the diagnosis of TS 
(Gomez, 1988). 
1.1.2 Pathogenesis 
The name tuberous sclerosis (TS) is derived from the descriptive designation 
originally based on the particular anatomic abnormalities in the brain that are 
distinctive for the disease. For instance, tubers (cerebral hamartias) and 
subependymal nodules or subependymal giant cell astrocytomas are the 
characteristic features of central nervous system in this disease (Edward and 
Richardson, 1991; Kwiatkowski and Short, 1994). The other organs most 
frequently involved in TS are the retina, skin, kidneys, heart and lungs. 
Many speculations have been made concerning the pathogenesis of TS. 
Bournville and Brissaud (1881) postulated an inflammatory aetiology (fetal 
encephalitis) in one of the first papers on this disease. Hartdegen proposed a 
neoplastic aetiology for TS in 1881. Others supported this idea based on the 
presence of "monster cells, benign astrocytic nodules and occasional 
malignant tumours in the brain of patients with TS, all indicating a neoplastic 
tendency" (Ferraro and Doolittle, 1936). Moolten (1942) reported the 
hamartomatous nature of the tumours in the brain and other organs 
emphasising their lack of malignant characteristics such as mitotic cells or 
metastatic spread. 
Inglis (1950) indicated initially that an intrinsic neural factor influenced cells 
in various organs at an early multipotential stage of organogenesis, causing 
them to develop along the lines of immature nerve sheath cells. He also 
observed that the renal lesions contain elongated cells that are histologically 
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more similar to immature nerve sheath cells than to smooth muscle fibres. He 
proposed that the same neuronal intrinsic factor underlies the angiomatous 
and lipomatous elements of extracerebral TS tumours. 
Rundle et al. (1975) searched serum levels of four main immunoglobulins, 
IgA, IgM, IgG and IgD, in 54 patients with TS. They found normal levels of 
IgA and IgD in the TS patients, but increased levels of IgM, and a significant 
decrease in IgG levels. 
Fabing (1934) studied TS in twins, identical in appearance and both with 
mental dullness, seizures, and adenoma sebaceum. He suggested that the 
mirror-image nature of their central nervous system and skin lesions revealed 
the defect had developed early in embryogenesis. His cases, however, 
lacked pathological demonstration of the cerebral involvement and the 
mirror-image skin lesions were not those of TS. Recently Gomez et al. 
(1982) declared two sets of monozygous twins who were discordant in 
seizures and intelligence. The mentally normal twin of each set had few or 
no seizures whereas the mentally abnormal twins had been subjected to 
frequent infantile spasms or seizures. 
It has been reported that TS is a disorder of collagen metabolism, which 
results in the absence of elastic tissue from the lesions of adenoma sebaceum. 
As the angiofibromas mature, the collagen becomes sclerotic and layered. 
Occasionally, large stellate fibroblasts occur with a "glial appearance". 
Histologically, the forehead and scalp plaques are fibromata without the 
vascular components. Hyalinisation and sclerosis of tissue due to changes in 
the collagen fibres are common findings in older adenoma sebaceum lesions 
(Gomez, 1988). 
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1.1.3 Genetics 
Tuberous sclerosis (TS) is a multisystem disorder that is inherited as an 
autosomal dominant trait. The hereditary nature of TS was first recognised 
by Berg in 1913 (Wiederhalt et al., 1985). Furthermore, Gunther and Penrose 
(1935), and Nevin and Pearce (1935) explained the dominant inheritance of 
TS and its high mutation rate. 
Recognition of genetic heterogeneity is essential in trying to locate a 
disease gene and also for prenatal and presymptomatic diagnosis. It has been 
demonstrated that locus heterogeneity, in which the same phenotype can 
result from genes at two or more loci, occurs in tuberous sclerosis (Conneally, 
1991). Linkage studies have confirmed locus heterogeneity for TS with 
disease-determining genes on chromosomes 9 (Fryer et at., 1987) and 16 
(Kandt et at., 1992). Recent studies have suggested that the gene for TS is 
linked to the loci for the ABO blood group, which are also on the long arm 
of chromosome 9 (q34). More recently, a TS gene on chromosome 16 has 
been identified and characterised as a result of the co-operation between 
three different research groups collectively known as the European 
Chromosome 16 Tuberous Sclerosis Consortium (Nellist et at., 1993) 
1.1.4 Biochemistry 
There is no basic defect described in TS or any known specific biochemical 
marker for the disease in spite of previous intensive studies. Biochemical 
investigators, however, continue to search for a clue to identify the main 
defect of TS. 
Collagen synthesis, measured by the activities of prolylhydroxylase, was 
clearly increased in angiofibromas of three patients and in one soft tumour of 
the face, but it was unchanged in shagreen patches (Oikarinen et al., 1982). 
Tanaka et al., (1983) found increased levels of free serum proline in TS 
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patients. Rundle (1976) found quantitative differences in haptoglobulin a-1 
acid glycoprotein, ceruloplasmin, ß-1 E-globulin and transferrin in 
comparison with TS. According to this study, there were no changes in a 1- 
antitripsin and fibrinogen levels. Ceruloplasmin, al-acid glycoprotein and 
PI-globulin levels were increased in affected subjects. Transferrin and 
haptoglobulin showed decreased concentration in affected subjects. 
Subsequently, none of these protein markers have proven to be consistently 
different in patients with IS. Fischer et al., (1977) previously reported that 
amino acid analyses on the acid hydrolysates of an angiofibroma and skin 
established that the former tissue contained less collagen than skin based on 
the reduced content of glycine, proline, alanine and hydroxyproline in the 
tumour. Lysosomal enzyme measurements have shown that the specific 
activities of the hexosaminidases, ß-galactosidase and ß-glucuronidase were 
raised. It was also demonstrated, by uronic acid and hexosamine 
measurements, that the tumour contained more glycosaminoglycan than 
skin. The most outstanding finding of their study was the seven fold 
increase in the total carbohydrate in the glycosaminoglycan fraction of the 
tumour. The sulphate content was higher in tumour tissue than foetal skin. 
Henderson (1991) studied the glycosaminoglycan composition of the 
fibroblasts, and showed that there was no change in the glycosaminoglycan 
composition of TS and normal cells. Fibroblasts produced heparan sulphate 
with markedly less N-sulphation than did normal fibroblasts. Previous 
metabolic studies of Ellis and Hemming (1990) at the University of 
Nottingham revealed that fibroblasts from skin lesions of TS patients 
contained higher levels of carbohydrates associated with glycoproteins. The 
most important increases were observed in glycoproteins with molecular 
masses in the region of 200-240,135-160 and 80-90 kDa. These were 
further investigated using antibody raised against human fibronectin. TS 
and normal fibroblasts cell extracts were applied to SDS/PAGE followed by 
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blotting on to nitrocellulose. Treatment of the "blot" with rabbit anti- 
fibronectin and peroxidase confirmed that the 220 kDa protein was 
fibronectin. Their work also showed an elevated production of fibronectin 
synthesized from fibroblasts of TS patients. One of the aims of this thesis is 
to extend this preliminary work of Ellis and Hemming in this laboratory. 
1.1.5 Biology of the Cell 
Histopathologically, TS is a disorder of cellular migration, proliferation and 
differentiation. Large, slowly dividing dendritic cells in cultures of skin 
lesions have been described by Johnson et al. (1991). The large slowly 
dividing dendritic cells in cultures of TS lesions are referred to as N-cells. 
These N-cells could represent a normal cell type in an unexpected location or 
a pathologic cell in TS lesions. N-cells differ from astrocytes because they 
stain negatively for glial fibrillary acidic protein (GFAP). GFAP occurs in 
astrocytes, some ependymal cells, and tumours of these cells (Johnson et al., 
1991). 
However, Ishibashi et al. (1990) reported that fibroblasts of adenoma 
sebacea in patients with TS synthesized a GFAP in addition to tubulin, actin, 
fibronectin and vimentin. Lallier (1991) proposed a model for TS mutation 
effects on neural crest cell migration. In early embryonic development, 
normal neural crest cells may migrate through a series of extracellular matrix 
molecules, causing them to differentiate into a specific cell type. TS mutant 
cells may lack the ability to interact properly with the matrix molecules they 
encounter, leading to misplaced cells or cells that differentiate into abnormal 
cell types as seen in Figure 1.2. 
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Figure 1.2. A model for tuberous sclerosis mutation effects on neural crest cell 
migration (After Lallier, 1991). 
1.1.6 Prevalence and Treatment of the Disease 
The prevalence rate of tuberous sclerosis at birth is now estimated to be 
perhaps as high as 1 person in 5800 (Osborne et al., 1991). The disorder 
affects both sexes and all races. Unfortunately there is no cure for TS, but 
there is treatment available for its symptoms. For instance, anticonvulsant 
drugs (Nitrazepam and Clonazepam) have been used to control seizures 
more effectively. Children with learning disabilities and speech and 
language difficulties are being helped through more sophisticated 
educational techniques. Orthopaedists, neurologists, physical therapists and 
other professionals help handicapped patients learn daily living skills and 
ways to improve mobility. 
Argon laser treatment is quite effective in removing facial angiofibromas. 
Fibromas of nails can also be treated with lasers, and can be removed by 
surgery. Renal disease is most troublesome when angiomyolipomas bleed. 
Angiomyolipomas and renal cysts are the most characteristic renal 
abnormalities of TS. In patients with severe bleeding, the only life-saving 
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procedure may be the removal of the whole kidney. A person can live with 
only one healthy kidney, but in patients with tuberous sclerosis both 
kidneys are already affected by angiomyolipomas, and the removal of one 
kidney may leave one that is already impaired. For this reason, in cases of 
emergency operations partial removal of the kidney or removal of the 
bleeding angiomyolipoma will be preferable, leaving the functioning part of 
the kidney (Gomez, 1983). 
1.2 Extracellular Matrix (ECM) and Tuberous Sclerosis 
The extracellular matrix, the substratum that cells adhere to in vivo, consists 
of glycoproteins and proteoglycans that are secreted by cells. The 
extracellular matrix contains several adhesive glycoproteins that bind to 
both cells and other matrix macromolecules. Connective tissue cells, such as 
dermal fibroblasts and chondrocytes, are completely surrounded by their 
extracellular matrix. Matrix constituents can modulate the shape of the cell 
in culture. Fibronectin promotes spreading of many cell types such as 
fibroblasts. Laminin promotes attachment of cells. Both fibronectin and 
laminin promote adhesion of cells to collagen (Watt, 1986). Fibronectin, 
laminin, tenascin, vitronectin, the collagens, von Willebrand factor and 
thrombospondin are examples of adhesive ECM glycoproteins. Fibronectin 
is widely distributed in connective tissues, whereas laminin is found mainly 
in basal laminae. Several ECM proteins such as tenascin, laminin and 
thrombospondin contain domains with homology to epidermal growth factor 
(EGF), providing growth-promoting activity. As a result, they play an 
important role in the development and maintenance of cellular organisation 
and in tissue repair (Engel, 1989). Many of the adhesive glycoproteins 
contain the common tripeptide sequence (RGD) which is recognised by the 
cell surface integrins and helps bind cells to the ECM (see Fig. 1.3). 
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Figure 1.3. Representation of several cell interactions with ECM glycoproteins via 
specific recognition sequences (After Yamada, 1991). 
Cells can use integrin receptors, for example (X5(31 to bind fibronectin, and 
a6(31 to bind laminin. These receptors can participate in a number of 
biological processes, including adhesion, migration and assembly of a matrix. 
Fibroblasts are a class of cells that adhere, migrate and grow readily in tissue 
culture, adopting a flattened and/or elongated morphology. They are 
responsible for the production and maintenance of the connective tissue 
matrix. Fibroblasts in culture produce fibronectin. The fibronectin 
synthesised by fibroblasts has two fates; it can be incorporated into fibrillary 
matrices at the cell surface or it can be secreted to the culture medium 
(Hynes, 1990). 
Fibroblasts also produce thrombospondin (Jaffe et al., 1983) and tenascin 
(Erickson and Taylor, 1987 ) into the ECM but usually fail to synthesize 
significant amounts of laminin (Timpl et al., 1982). As indicated previously, 
components of ECM such as fibronectin play an important role in the 
migration of cells during early embryonic development. 
One of the various features of tuberous sclerosis (TS) is the hardening of 
affected tissue. The interrelations between cells and the surrounding 
extracellular matrix is an important parameter in the degree of hardening 
(Ellis et al., 1991). Alterations in the structure and distribution of these 
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glycoproteins may change their binding and interactions with cells and 
ECM macromolecules. Studies of these changes could contribute to the 
understanding of the mechanisms involved in the aetiology of hardened 
tissues of TS. 
1.3 Structure and Biosynthesis of Glycoproteins 
Glycoproteins are defined as proteins which contain glycan chains linked 
glycosidically to selected amino acid residues. Glycosylation is an example 
of the post-translational modification of proteins. Monosaccharides 
commonly found in the glycans of the glycoproteins include mannose, 
galactose, glucose, fucose, xylose, N-acetylglucosamine, N- 
acetylgalactosamine, glucuronic acid, iduronic acid and N-acetylneuraminic 
acid (Hemming, 1991). 
1.3.1 Carbohydrate-Protein Linkages 
The oligosaccharide chains are attached to the polypeptide backbone of 
glycoproteins at one of five amino acid residues: asparagine (Asn), serine 
(Ser), threonine (Thr), hydroxylysine (Hyl) or hydroxyproline (Hyp). 
Oligosaccharides are covalently linked to the side chains of these amino 
acids along the polypeptide backbone by glycosidic links. The 
carbohydrate chains are classified according to the linkage between sugar 
and amino acid. Carbohydrates are attached to proteins at different positions 
by either an N-linkage, an O-linkage, or both, or a phosphoethanolamine- 
linkage (via glycosyl-phosphatidylinositol, GPI, anchor) (Lis and Sharon, 
1993). Many glycoproteins such as human fibronectin, plasminogen, and 
calf fetuin contain both N- and 0- linked glycans on the same polypeptide 
chain (Schachter and Brockhausen, 1992). 
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i) N-glycosidic link: 
The most common type of linkage occurs between the anomeric carbon of 
N-acetylglucosamine monosaccharide and the nitrogen of the amide group 
of asparagine within the polypeptide chain (see Fig. 1.4-b). 
H 
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Figure 1.4. Two ways to link oligosaccharide chains to proteins (a) An 0- 
glycosidic linkage, (b) An N-glycosidic linkage (Lehninger et. al., 1993). 
The many N-linked glycans of known structure can be categorised in terms 
of three basic oligosaccharide structures: high mannose, complex and hybrid 
as summarised in Figure 1.5. All of the known N-linked oligosaccharides 
have a common core pentasaccharide structure: Man a 1-3(Man o d-6) 
Manß 1-4G1cNAcß 1-4GlcNAc-Asp (the boxed areas in Fig. 1.5). 
a) High Mannose (simple): 
High-mannose oligosaccharides typically have 2-6 additional mannose 
residues linked to the pentasaccharide core. 
b) Complex (lactosaminyl): 
Glycoproteins of complex type generally contain branches of a terminal 
sialic acid residue and underlying galactose and N-acetylglucosamine, the 
last two sugars often constituting the disaccharide N- acetyllactosamine 
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linked to the branched mannose residues of the core. The oligosaccharide 
branches are commonly referred to as antennae, so that bi-, tri-, tetra-, and 
penta-antennary structures may all be found. These structures sometimes 
contain a further N-acetylglucosamine linked to the ß-mannose of the core. 
Some also contain fucose linked to the first N-acetylglucosamine of the core. 
c) Hybrid (mixed): 
This form is the result of a combination of the above two cases. 
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Figure 1.5. Major types of asparagine-linked oligosaccharide structures. The boxed 
area represents the pentasaccharide core common to all N-linked structures (from 
Kornfeld and Kornfeld, 1985). 
All of the asparagine-linked oligosaccharide structures have the common 
pentasaccharide core structure (Fig. 1.5), because they all arise from the 
same biosynthetic precursor lipid-linked oligosaccharide. This is transferred 
to nascent peptide chains and then processed to form these various 
structures (Kornfeld and Kornfeld, 1985). Lis and Sharon (1993) reviewed 
the more recent advances on the structure and function of glycoproteins. 
Figure 1.6 illustrates the protein-carbohydrate linkages known in 1982 and 
in 1992. Several new asparagine-linked monosaccharides have been 
discovered during the last decade. These include glucose (both in a- and 0- 
linkages), ß-N-acetylgalactosamine and L-rhamnose (in bacterial 
glycoproteins). More recently, a novel N-glycosylation (laminin contains the 
linkage unit ß-glucosylasparagine) has also been reported in eukaryotes 
(Schrainer et al., 1994). 
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Figure 1.6. Protein-carbohydrate linkages known in 1982 and in 1992 (Lis and 
Sharon, 1993). 
ii) The O-glycosidic link: 
Many glycoproteins contain oligosaccharides linked through an 0- 
glycosidic bond to the hydroxyl groups of serine, threonine, hydroxylysine 
or hydroxyproline amino acid residues. The most common 0-glycosidic 
linkage found is that between N-acetylgalactosamine and serine or threonine 
(Fig. 1.4-a). This protein-carbohydrate linkage is usually referred to as the 
"mucin" type of linkage. O-glycosidic linkages may also occur between 
xylose and serine. Glycosaminoglycans (GAGs) are attached to proteins via 
this type of linkage. An O-glycosidic linkage is also found between 
galactose and hydroxylysine in collagen. The novel O-glycosidic linkages 
can be seen in Figure 1.6. Tyrosine has been added to the list of O-linked 
amino acids with the presence of Glca-Tyr in glycogenin (Lis and Sharon, 
1993). Figure 1.7 shows some of the peripheral sugar sequences that may 
occur in glycoproteins. 
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Ser/Thr-GaINAc NANA 
Gal NANA 
Ser/Thr-GaINAc 
NANA 
GaINAc 
Gal GlcNAc-Gal-GlcNAc 
-Gal J Ser/Thr-GaINAc Fuc GIcNAc GaI-Fuc 
I Ser/Thr-GaINAc-GIcNAc Gal-Fuc 
GIcNAc Gal 
I Ser/Thr-GaINAc Gal-NANA GIcNAc ýFuc 
Figure 1.7. O-linked oligosaccharide sequences. Examples of peripheral sequences 
that may be linked to one of five core structures. Ser, serine; Thr, threonine; Gal, 
galactose; GIcNAc, N-acetylglucosamine; GaINAc, N-acetylgalactosamine; Fuc, 
fucose; NANA, N-acetylneuraminic acid (sialic acid). The core oligosaccharide is 
boxed (From Graham, 1992). 
1.3.2 Synthesis of Oligosaccharides 
The understanding of the N-glycosylation of proteins is well developed, 
unlike O-glycosylation or GPI assembly. Particular attention is therefore 
given to N-glycosylation here. As indicated in Figure 1.8, the endoplasmic 
reticulum (ER) and Golgi apparatus are the major sites involved in 
glycosylation processes. The oligosaccharide portion of glycoproteins is 
assembled in the endoplasmic reticulum on the lipid carrier dolichol 
phosphate (reviewed in Kornfeld and Kornfeld, 1985). The sugars are added 
by stepwise donation, with the first seven sugars (two G1cNAc and five 
Man) derived from the nucleotide sugars, UDP-GlcNAc and GDP-Man. The 
next seven sugars (four Man and three Glc residues) are derived from the 
lipid intermediates, Dol-P-Man and Dol-P-Glc residues. These initial stages of 
N-linked oligosaccharide synthesis result in formation of the precursor 
oligosaccharide Glc3Man9GlcNAc2 on a pyrophosphoryl-dolichol 
backbone. This oligosaccharide is then transferred en block to a suitable 
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peptide asparagine residue. While the nucleotide sugar substrates are 
cytoplasmic, newly glycosylated proteins are found in the lumen of the 
rough endoplasmic reticulum. Moreover, dolichol (polyisoprenoid 
compound) is present mainly in endoplasmic reticulum membranes. 
After the precursor Glc3Man9GlcNAc2 is first transferred to the polypeptide 
chain (step 1, Fig. 1.8), processing is initiated by the removal of the terminal 
glucose residue from oligosaccharide by a-glucosidase-I (step 2). The two 
inner glucose residues are then removed by a-glucosidase-II (step 3). A 
specific a mannosidase which catalyzes the removal of at least one a 1,2- 
linked mannose residue (step 4), acts next. The non-lysosomal glycoproteins 
(lysosomal glycoproteins undergo phosphorylation in the Golgi) can be 
further trimmed by the Golgi al, 2 mannosidase (Golgi Mannosidase 1) to 
yield a Man5GlcNAc2 structure (step 5). 
In medial cisternae of the Golgi, a N-acetylglucosamine residue is added 
catalyzed by N-acetylglucosaminyl transferase 1, to become complex type 
structures (step 6). This is followed by the removal of two mannose residues 
by Golgi a-mannosidase II (step 7) and subsequent addition of another outer 
chain N-acetylglucosamine residue catalyzed by N-acetylglucosaminyl 
transferase II (step 8). At this stage, the addition of fucose to the asparagine- 
linked N-acetylglucosamine is catalyzed by fucosyltransferase (step 9). 
In the final steps of the complex oligosaccharide synthesis, the galactosyl 
and sialyl transferase enzymes that then transfer galactose and sialic acid, 
respectively, to the glycoprotein are located mainly in the trans region of the 
Golgi apparatus (steps 10 and 11). The completed glycoproteins then exit 
Golgi and are transported to their final destinations. The final stage of 
biosynthesis in the Golgi apparatus is called "terminal glycosylation" to 
distinguish it from "core glycosylation", which takes place in the ER. More 
detailed description can be found in Kornfeld and Kornfeld (1985), and 
Hirschberg and Snider (1987). 
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Figure I. S. Schematic pathway of oligosaccharide processing on newly synthesized 
glycoproteins (from Kornfeld and Kornfeld, 1985) 
19 
Glycoproteins in the secretory pathway receive GaINAc in O-glycosydic 
linkage from-UDP-GaINAc via a transferase that acts directly on serine or 
threonine residues of proteins. No dolichol-linked intermediates are 
involved. Such O-linked glycosylation occurs only after the protein has 
been transported to the Golgi apparatus. The sugars of the oligosaccharide 
chains of the O-glycosidic type of glycoprotein are built up by the stepwise 
donation of sugars from nucleotide sugars (such as UDP-GaINAc, UDP-Gal, 
and CMP-NeuAc) catalyzed by membrane-bound specific 
gl ycosyltransferases. 
1.4 Adhesive Glycoproteins of ECM Synthesized in 
Cultures of Human Skin Fibroblasts 
1.4.1 Fibronectins 
Fibronectins (FNs) are a group of large, dimeric adhesive glycoproteins 
possesing two subunits of 220-250 kDa which are joined by disulphide 
bonds. Fibronectin is the "grandfather" of extracellular matrix proteins and 
is currently one of the most widely studied and best known matrix proteins, 
although much still remains to be learned about its structure and function. 
Fibronectins are adhesive glycoproteins present on cell surfaces and in 
extracellular matrices, as well as in blood, amniotic fluid, and cerebrospinal 
fluid. All fibronectins contain approximately 4-8% carbohydrate and have 
an acidic p1(5.5-6.3) (Hynes, 1990). 
1.4.1.1 Synthesis 
There are at least two major classes of fibronectins which are termed "cellular 
fibronectin" (cFN) and "plasma fibronectin" (pFN). Fibronectin is found in 
blood as a soluble plasma glycoprotein at around 0.3 g/litre; the form found 
in plasma is termed "plasma fibronectin" (Hay, 1991). Tamkun and Hynes 
(1983) demonstrated that the liver is the major source of pFN which is 
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secreted by hepatocytes. Cellular FNs are produced by many different cell 
types which secrete them and often organize them into extensive 
extracellular matrices. Cellular FN was first detected on fibroblasts using 
both in vivo and in vitro techniques. The fibronectin synthesised by 
fibroblasts has two destinations; it can be incorporated into fibrillar matrices 
at the cell surface or it can be secreted to the culture medium (Hynes, 1990). 
1.4.1.2 Structure of Fibronectins 
Fibronectin (FN) polypeptide is composed of three types of homologous 
repeating units, termed types I, II, and III. The general structure of 
fibronectin polypeptide is shown in Figure 1.9 (Potts and Campbell, 1994). 
Twelve type I repeats are about 45 amino acid residues long and make up 
the NH2 and COOH-terminal ends of the polypeptide. Two type Il repeats 
(each 60 amino acids long) interrupt a row of nine type I repeats at the N142- 
terminus. Moreover, 15-17 type III repeats, each about 90 amino acids long, 
make up the middle of the polypeptide. The FN molecule is composed of 
two polypeptides that associate through two disulfide bonds near the 
COOH- terminus to form a dimer. 
At a genetic level the beginning and end of most of the repeat sequences 
coincides with intron and exon boundaries within the single FN gene. This 
suggests that the FN gene has evolved by acquiring pre-existing domain 
motifs from other genes by "exon shuffling" and subsequent duplications of 
such domains (Ruoslahti, 1988). Hence, domains homologous to the type I 
repeats in fibronectin are present also in blood clotting factor XII and tissue 
plasminogen activator. Type II homologies are also found in factor XII as 
well as in prothrombin, plasminogen and urokinase (Patel et al., 1987). Like 
the type I and II repeats of FN, type III repeats are also present in other 
proteins. Tenascin (TN), another extracellular matrix protein, contains 11 
type III repeats of FN (Jones et al., 1988). A neuronal cell-cell adhesion 
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molecule (LI) also contains three type III repeats of FN (Moos et al., 1988), 
whereas the other neuronal cell surface protein, contactin, contains two type 
III repeats of FN (Ranscht, 1988) and N-CAM contains one type III repeat of 
FN (Cunningham et al., 1987). 
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Figure 1.9. The general structure of the Fibronectin polypeptide showing repeating 
homologous units. The positions of the EDA, EDB and IIICS alternatively spliced 
regions are shown. FN3 contains the Arg-Gly-Asp (RGD) sequence involved in 
integrin binding (After Potts and Campbell, 1994). 
The differences in FNs from different tissue sources of the same species are 
due to post-translational modifications and alternative splicing mRNA 
transcript which give rise to variations in the mature protein. Comparison of 
FNs from different sources reveals slight differences in the molecular weights 
of the FN polypeptides when studied by SDS-PAGE. Fibronectin isolated 
from plasma is smaller in molecular weight than that produced by most types 
of cultured cells, such as fibroblast cell cultures, and also runs a doublet 
unlike the other types (Hynes, 1990). 
Three potential sites of alternative splicing have been demonstrated in FN 
polypeptide as shown in Figure 1.9. Two of these involve the addition or 
deletion of complete type III repeats, ED-A and ED-B. The third one, 
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IIICS=V (the variable region), is more complex. This IIICS (V) region of FN is 
a 120-amino acid stretch of polypeptide that can either be included 
completely or partially in the polypeptide, or completely left out. The 
patterns of alternative splicing of FN can produce the insertion or deletion of 
cell-type specific adhesion sites. The different isoforms of FN result from 
alternative splicing of the EDA and EDB modules and of the type III 
connecting segment, IIICS (Pott and Campbell, 1994). Although 
alternatively spliced sequences (ED-A, ED-B, and IIICS) tend to be retained 
in "cellular" fibronectins, especially by certain embryonic and malignant 
cells, plasma FN produced by liver generally lacks ED-A and ED-B 
sequences. It can contain 50% (or less) of the IIICS type of alternatively 
spliced region of FN. Thus, inclusion of ED-A and/or ED-B is characteristic 
of cFN and is a major distinction between cFN and pFN. cFN and pFN differ 
in solubility when isolated. In vivo, pFN is a soluble plasma protein whereas 
the characteristic form of cFN is a fibrillar matrix around cells. Earlier reports 
indicated that cFN is more effective in restoring normal morphology to 
transformed cells and is a better hemagglutinin than pFN (Yamada et al, 
1975; Yamada and Kennedy, 1979). The apparent binding of cFN to 
hyaluronic acid is known to be due to a contaminating proteoglycan in the 
hyaluronic acid preparation. Apart from these studies, few researchers have 
analyzed the functions of cFN because it is more difficult to obtain in 
quantity than is pFN. Therefore, there are no differences between cFN and 
pFN that have been well defined, although they probably exist (Hynes, 
1990). 
The functions of the variable regions (IIICS=V) within FN and the two 
distinct forms (cellular and plasma) are not clear. However, using fragments 
isolated from intact human pFN and synthetic peptides based on the V 
region sequence, Humphries et al. (1986 and 1987) showed clearly that the 
V region can act as cell adhesion sites for B16 melanoma cells. Moreover, 
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the V region of rat (Schwarzbauer et al., 1983) and bovine pFN 
(Skorstengaard et al., 1986) contains an RGDV sequence which promote 
cell adhesion. Furthermore, the HICS region possesses a cell-attachment site 
that interacts with the a 433 integrin and is distinct from the major tripeptide 
(Arg-Gly-Asp; RGD) cell-binding site recognized by a5(31 integrin (Hughes, 
1992). 
There is no definitive evidence on the potential roles of ED-A and ED-B, the 
two segments that show most distinction between cFN and pFN. But they 
seem to be more readily expressed in embryonic tissues compared to adult 
tissues (Norton and Hynes, 1987). Wounding of rat skin can induce the re- 
expression of these domains in localized areas (Ffrench-Constant et al., 
1989). Other studies have shown that the expression of ED-A and ED-B 
increase on oncogenic transformation (Borsi et al., 1987, Zardi et al., 1987). 
1.4.1.3 The Binding Domains of Fibronectin 
Fibronectin (FN) polypeptide is extremely sensitive to proteolysis. Each FN 
polypeptide chain consists of a series of structural and functional domains. 
These domains have been defined by proteolytic fragmentation studies to 
locate interchain disulphide bonds, sulfhydryl groups, and carbohydrate 
residues. The study of proteolytic fragments using biochemical methods, 
immunological methods (using antibodies), biological assays (cell adhesion 
and migration) and affinity chromatography has led to a reasonably 
complete picture of the structure of FN. Many of these proteolytic 
fragments are globular, relatively resistant to further proteolysis and retain 
their functional and binding properties (Hynes, 1990). 
1.4.1.3.1 The N-terminal domain of Fibronectin 
The N-terminal domain of FN (domain a, Fig. 1.10) can be isolated as a 24-32 
kDa fragment using proteases (Site 1, Fig. 1.10) such as trypsin, thrombin, 
plasmin, and thermolysin on intact FN (Kurkinen et al., 1980; Sekiguchi and 
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Hakomori, 1983). This domain is basic with a pI of 8.2-8.6 (Mosher and 
Proctor, 1980) and contain no carbohydrate (Wagner and Hynes, 1979). 
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Figure 1.10. Domain model of fibronectin subunit. 
Lower case letters (a to f) identify discrete domains proceeding from amino- to carboxy 
terminal. Ligand affinities are listed beneath each domain. The open and solid circles 
indicate the approximate location of the Arg- Gly-Asp (RGD) cell-binding sequence. 
The cross-hatched region indicates a potential area of sequence variability due to 
insertion of a domain via differential mRNA splicing. IIICS (arrowhead) is a 
differentially spliced region connecting domains d and e. S is the location of the 
interchain disulfide link. Arrows indicate protease-sensitive sites (Ito 4) where limited 
proteolysis results in the release of major domains (From Carsons, 1989). 
It also contains a five-fold repeat of disulfide-bonded type I homologies and 
comprises various binding sites. Cathepsin D digestion gives a 70kDa 
fragment which includes N-terminal and gelatin-binding domains. This 
70kDa fragment of FN can be further cleaved with chymotrypsin, plasmin or 
thrombin to separate these two domains (Balian et al., 1979; Hormann and 
Seidl, 1980). 
The N-terminal domain of FN binds to: 
(i) heparin (HEP I) (Sekiguchi and Hakomori, 1980), 
(ü) fibrin (Hormann and Seidl, 1980) 
(üi) Staphylococcus aureus (Mosher and Proctor, 1980) 
(iv) gangliosides (Thompson et al., 1986). 
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(v) a self association site in the C-terminal region of FN (Homandberg 
and Erickson, 1986). 
(vi) thrombospondin (Homandberg and Kramer-Bjerke, 1987). 
The N-terminal domains of FN also comprises a glutamine residue reactive 
with factor XIIIa transglutaminase (Mosher and Proctor, 1980). It is also able 
to participate in matrix assembly (Quade and McDonald, 1988). This domain 
may bind to other glycosaminoglycans (GAGs) at low salt concentration 
(50mM). However at physiological salt concentrations it is specific to 
heparin. In addition, it also participates in folding of FN, in fibrillogenesis 
and in the binding of fibrin to macrophages (Hynes, 1990). 
1.4.1.3.2 The Gelatin-Binding Domain of Fibronectin 
The gelatin-binding domain of FN (domain b, Fig. 1.10) is adjacent to the N- 
terminal domain. Various proteases, including thermolysin and chymotrypsin 
(site 2, Fig. 1.10) cleave FN so as to produce gelatin binding fragments 
ranging in size from 40-60 kDa (Sekiguchi and Hakomori, 1983). Cathepsin 
D treatment results in the generation of a slightly larger 70 kDa collagen- 
binding domain joined to the 
-30 kDa N-terminal domain (domains a and b, 
Fig. 1.9) (Richter et al., 1981). The gelatin-binding domain identified on FN 
as the first functional domain binds to collagen. The gelatin-binding domain 
includes a single type I repeat, followed by two type II repeats and then 
three more type I homologies of FN polypeptide as seen in Figure 1.9. This 
domain is quite resistant to proteolysis due to intrachain disulfide bonding 
and attached carbohydrates. Many carbohydrate side chains are attached to 
the gelatin-binding domain and they may cause small differences in the size 
of this domain in pFN, cFN, and aFN (Balian et al., 1979). Olden et al. (1978, 
1979) reported that FN synthesized in the presence of tunicamycin lacks the 
carbohydrates and is much more sensitive to proteolysis. 
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The central region of the FN following the gelatin-binding site comprises 
type III repeating units towards the C-terminal, and the first three of these 
are labile to proteolysis. The next three type III repeats (4-6) can be isolated 
as a 30 kDa DNA binding domain and a heparin binding domain (HEPIII) 
(Skorstengaard et al., 1986a). 
1.4.1.3.3 The Cell-Binding Domain 
Most cells such as fibroblasts can adhere to fibronectin by binding to the 
centrally located cell-binding domain (domain c, Fig. 1.10). The large central 
domain of fibronectin is composed of type III repeating units, each 90 amino 
acids long. The active cell attachment peptide is located on the tenth type 
III segment (Kornblihtt et al., 1985). Three important variable areas have 
been identified in the cell-binding domain. One type of variation occurs as a 
result of the insertion or deletion of an entire type III repeat following the 
seventh and/or the eleventh type III repeat (Kornblihtt et al., 1984). As 
mentioned before, the presence of these "extra domains" referred to as ED(A- 
B) is a feature of cellular fibronectins whereas plasma lack the ED segments 
(Fig. 1.9). 
A significant sequence in the cell-binding domain is Arginine-Glycine- 
Aspartic acid (abbreviated RGD using the single-letter amino acid code). 
Many other adhesive proteins present in extracellular matrices and in the 
blood also contain the tripeptide RGD as their cell recognition site. In 
addition to FN these include vitronectin, osteopontin, collagens, 
thrombospondin, fibrinogen, and von Willebrand factor, tenascin, laminin 
and entactin/ nidogen (Ruoslahti and Pierschbacher, 1987; Yamada and 
Kleinman, 1992). The RGD sequences of each of the adhesive proteins are 
recognised by integrins. 
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1.4.1.3.4 The High-Affinity Heparin-Binding Domain 
There are at least three heparin-binding sites on each monomer subunit of 
fibronectin. One heparin-binding site is located in the amino terminal 29- or 
30-kDa domain of the molecule (domain a, Fig. 1.10) and this binding is 
inhibited by 0.25 M salt or divalent cations. Fibronectin contains a second 
and stronger heparin-binding site (domain d, Fig. 1.10) that is located near 
the carboxyl-terminus and is unaffected by divalent cations. Higher salt 
concentrations (0.5 M NaCI) are necessary to disrupt binding of the 
carboxyl terminal domains to heparin than to distrupt binding of the amino 
terminal domain. A third heparin-binding site (domain c, Fig. 1.10) with 
lower affinity is located in the region between the gelatin- and cell-binding 
domains. Fibronectin interacts with cell surface heparan sulfate 
proteoglycans and mediates cell adhesion in this way (Hynes, 1990). 
1.4.1.3.5 The C-Terminal Fibrin Binding Domain 
The C-Terminal fragment (21-37 kDa) binds to fibrin but is different from the 
N-terminal (25-30 kDa) fragment, which also binds to fibrin. This fibrin 
binding domain (domain e, Fig. 1.10) is relatively sensitive to proteases and 
does not bind to gelatin or heparin or act as a substrate for factor XIIIa 
(Sekiguchi et al., 1981). It has an acidic pI (5.1-5.8) (Richter and Horman, 
1982) whereas the N-terminal domain is basic. The complete amino acid 
sequence of this domain consists of three type I repeats. There are no 
carbohydrates in this C-terminal fibrin binding domain. 
1.4.1.3.6 The C-Terminal Interchain Disulfide Bonds 
A small (3-6 kDa) domain located at the carboxyterminal (domain f, Fig 1.10) 
has been found to contain the interchain disulfide bond that joins the 
subunits of the fibronectin dimer (Hayashi and Yamada, 1983). Both pFN 
and cFN are disulfide-bonded dimers. The region containing these 
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interchain bonds has been sequenced and shown, by digestion with plasmin, 
to contain the interchain disulfide bonds in the last 20 residues 
(Skorstengaard et al., 1982) and cathepsin D (Richter and Hormann, 1982). 
1.4.1.4 Glycosylation of Fibronectin 
Fibronectins are glycoproteins that contain 4-9% sugar, depending on the 
tissue or cell origin (Petersen et al., 1989). Most of the carbohydrate is 
present in complex-type asparagine-linked oligosaccharide chains (Fisher 
and Laine, 1979; Fucuda, Levery and Hakomori, 1982). The presence of 0- 
glycosidically linked carbohydrate on fibronectin has also been described 
(Krusius, Fukuda, Dell, and Ruoslahti, 1985). Fibronectin from tumour cells 
has a higher content than that from adult human skin fibroblasts (Ruoslahti, 
1988). As the bovine sequence has been determined on the protein level, 
the putative attachment sites of the carbohydrate groups are known for this 
species (Skorstengaard et al., 1986b). In fact, each polypeptide chain 
contains seven glycans N-linked to asparagines at positions 399,497,511, 
846,976,1213, and 2168. The IIICS (alternatively spliced) region carries 
one or two groups which are O-linked to threonines at positions 2124 and/or 
2125 (Fig. 1.11). 
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Figure 1.11. Domain structure and potential sites of N-linked carbohydrate addition 
for fibronectin. Various potential N-glycosylation sites are marked as lollipops and 
the numbers above them indicate the amino acid position for each site (From Tanzer et 
al., 1993). The basic fibronectin structure was derived from the longest polypeptide 
chain of human plasma fibronectin (Skorstengaard et al., 1986b). 
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The major type of side chain is the biantennary complex asparagine-linked 
type. Consistent differences in the sialylation pattern of plasma and cellular 
fibronectins have been reported. Cellular fibronectins contain less sialic acid, 
which is linked to a 2-3 galactose in contrast to the a 2-6 linkage found in 
plasma fibronectin. Cellular fibronectin also contains fucose linked to the 
proximal N-acetylglucosamine units. Fucose is not detected in plasma 
fibronectin (Fukuda and Hakomori, 1979; Fukuda et al., 1982). Human 
plasma fibronectin contains mainly biantennary complex types, whereas 
amniotic fluid fibronectin contains triantennary groups with fucose linked to 
the innermost N-acetylglucosamine residue. Human placenta fibronectin 
contains highly branched carbohydrates with a large percentage of 
polylactosamine (Petersen et al., 1989). 
1.4.1.4.1 Functions of Fibronectin Glycosylation 
Although the physiological functions of the carbohydrates of fibronectin are 
unresolved, given the organization of functional domains on the fibronectin 
molecule, modification of glycan structure at critical locations is likely to 
result in functional alterations. Various oligosaccharide-dependent 
functional alterations have been described. A significant function of the 
carbohydrate moiety of a glycoprotein is protection of the protein from 
proteolytic attack. It has been demonstrated that the heavily glycosylated 
collagen-binding domain of chicken embryo fibroblast fibronectin was 
selectively resistant to a broad variety of proteases. When N-linked 
glycosylation was inhibited by tunicamycin treatment, the collagen domain 
became increasingly susceptible to proteolysis (Bernard et al., 1982). Zhu et 
al. (1984) demonstrated that the gelatin-binding domain from placental 
(embryonal) fibronectin was more resistant to proteolysis than the 
corresponding domain from plasma fibronectin. Although attention has 
focused on the role of the RGD sequence in fibronectin-mediated cell 
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adhesion, Jones et al. (1986) have presented data that suggest that the 
oligosaccharides of fibronectin may also be important, acting as modulators 
of fibroblast adhesion and spreading. Zhu and Laine (1985,1987) have 
reported that fibronectin-carrying polylactosamine (PLA) type chains show 
weaker binding to denatured collagen than plasma fibronectin. This 
suggests that PLA or possibly increased branching may modulate 
fibronectin-mediated adhesions of cells to collagen subtrate. Interestingly, 
glycosylation of amniotic fluid and placental fibronectin appears to vary 
during gestation and the appearance of PLA in amniotic and placental 
fibronectins may have biological significance (Hughes, 1992). 
1.4.1.5 The HNK-1 (Leu-7) Carbohydrate Epitope 
Significant advances in understanding of the functional roles of 
oligosaccharides have been made using carbohydrate-specific monoclonal 
antibodies. The neural cell adhesion molecules such as L1 and N-CAM share 
a common carbohydrate epitope that is recognised by monoclonal 
antibodies L2 and HNK-1. The L2/HNK-1 carbohydrate epitope is also 
present on tenascin, myelin-associated glycoprotein (MAG) and the 
intercellular cell adhesion molecule (I-CAM) (Schachner, 1989). This epitope 
has been identified as a 3'-S04-glucuronic acid that is found on glycolipids 
(Chou et al., 1986), proteoglycans (Gowda et al., 1989) and glycoproteins 
(Kruse et al., 1985). Harper et al. (1990) previously reported that human 
tumours of neuroectodermal origin secrete fibronectin that contains the 
HNK-1 carbohydrate epitope. Thus, fibronectin joined the growing the list 
of RGD-containing extracellular matrix glycoproteins that possess the HNK- 
1 epitope, strengthening the correlation between these two structures. 
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1.4.2 Tenascin-C 
The tenascins are a family of structurally related, large oligomeric 
glycoproteins of extracellular matrix. The first member of the family to be 
discovered, previously known by the names tenascin, hexabrachion protein, 
myotendinous antigen, glioma mesenchymal extracellular matrix (GMEM) 
protein, cytotactin, and J1-200-220, is now referred to as tenascin-C (TN-C) 
(Erickson and Bourdon, 1989; Erickson, 1993). The original version of 
tenascin is denoted by TN-C, where the "C" represents cytotactin. The TN-C 
of human, pig, mouse, chicken and newt show a high degree of homology 
(75-90 %) at the domain level of structure. The more recent members of the 
tenascin family are tenascin-R (TN-R) and tenascin-X (TN-X). TN-R was 
originally found as restrictin in chicken (Norenberg et al., 1992) and J1-160- 
180 in rats (Fuss et al., 1993). These proteins are as closely related to each 
other as are the TN-Cs from chicken and rat, but more distantly related to all 
species of TN-C. Tenascin-X (human) was originally reported as a sequence 
encoded by gene X. TN-X is structurally most different than the others 
(Bristow et al., 1993). Tenascin C was the first discovered glycoprotein of 
the tenascin family and therefore its structure and expression are better 
established than those of TN-R and TN-X. In this research, TN-C expression 
has also been investigated in cultured fibroblasts derived from skin tissues of 
tuberous sclerosis patients. Hence, the expression and structure of TN-C are 
briefly described below. For simplicity the name tenascin, without a letter, 
will be used for TN-C in this thesis. 
1.4.2.1 Structure 
The native tenascin molecule exists as a six armed, star-shaped structure 
consisting of similar subunits linked by interchain disulfide bonds. The 
amino terminal region possesses oligomerization sites where the subunits are 
joined to form hexamers. The known tenascin family members share a very 
32 
distinctive pattern of three types of domains: epidermal growth factor (EGF) 
domains, fibronectin (FN) III domains and fibrinogen-like domains (F) (Fig. 
1.12) (Hay, 1991). 
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Figure 1.12. The domain structure of tenascin (After Hay, 1991). 
Tenascin contains a single cystein amino-terminal to the trimer-forming 
segment, which is able to connect two trimers into the characteristic 
hexabrachion structure. The next segment consists of EGF-like domains, 
each 31 amino acids long. The next segment comprises a series of FN-III 
domains, each about 91 amino acids long. Approximately two-thirds of 
potential N-linked glycosylation sites in tenascin are found within type III 
repeats. FN-III repeats of the tenascin arms promote cell adhesion via RGD- 
integrin receptor interaction (Bourdon and Ruoslahti, 1989), whereas the 
fragments containing the cysteine-rich EGF-like repeats are anti-adhesive 
(Spring et al., 1989). The alternatively spliced domains are also present 
within the fibronectin type III repeats (Jones et al., 1989). At the COOH 
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terminus a fibrinogen-like sequence is found, and is abbreviated in Figure 
1.12 as F. 
1.4.2.2 Expression of Tenascin 
Tenascin is secreted by fibroblasts, myoblasts, and glial cells in tissue culture, 
and can be purified from spent medium of tissue culture. The human glioma 
cell line (U-251 MG) is the champion producer of tenascin (5-10 ug/mI). 
Chicken embryo fibroblasts are also a good source of tenascin (2-5 ug/ml) 
while human foreskin fibroblasts produce tenascin in smaller amounts (0.2- 
0.5 µg/ml) (Erickson and Lightner, 1988). Bourdon et al. (1983) reported 
that tumours of glial cells (glioblastomas) produce large quantities of 
tenascin. They suggested that tenascin may be a useful marker of 
glioblastomas in vivo and in vitro. Tenascin synthesis can be stimulated in 
fibroblasts by serum and transforming growth factor ß (Pearson et al., 1988). 
In contrast to most other major proteins of the extracellular matrix, tenascin 
expression is confined to a few tissues and often occurs only in a transient 
manner. During embryogenesis, tenascin is transiently expressed in 
mammary gland, tooth, or kidney. It is present in embryonic cartillage and 
bone. In the adult, tenascin becomes confined to the perichondrium and 
periosteum, ligaments, tendons, and myotendinous junctions. Smooth muscle 
also contains tenascin, whereas many other organs or tissues, such as the 
heart, skeletal muscle and epithelial organs, contain little or no tenascin. 
Transient expression of tenascin is also reported in healing wounds 
(Chiquet-Ehrismann, 1990). In normal human skin, tenascin is detected in a 
zone beneath the dermal-epidermal junction (Lightner et al., 1990). 
Expression of tenascin in a wide variety of tumours was one of the most 
remarkable early findings. Tenascin expressed abundantly in malignant 
breast carcinomas (Koukoulis et al., 1991). In general it appears that 
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tenascin expression is often low in adult tissues and is drastically increased 
during many pathological conditions. 
1.4.2.3 Biological Functions of Tenascin 
Culture studies have shown that tenascin has multiple functions including 
cell attachment and detachment, promotion and inhibition of neural crest cell 
migration, cell growth stimulation and hemagglutination (Sakakura and 
Kusano, 1991). In contrast to fibronectin, tenascin was found to be a very 
poor adhesion molecule and the addition of tenascin to the cell culture 
medium inhibited fibroblast adhesion to fibronectin (Chiquet-Ehrismann et 
al., 1988). Although cells were able to adhere to tenascin at 4°C, this 
adhesion became weaker at 370C (Lotz et al., 1989). Because of these 
studies tenascin has been classified as an antiadhesive or adhesion- 
modulating extracellular matrix protein (Chiquet-Ehrismann, 1991; Sage and 
Bornstein, 1991). EGF-like repeats are adjacent to the amino-terminal 
globular domain and are involved in the anti-adhesive activity of tenascin. 
Major cell-binding sites of tenascin are present in the tenth and eleventh 
fibronectin type III repeating units toward the carboxyl-terminus of the 
protein (Spring et al., 1989). Tenascin binds heparin by its fibronectin type 
III domain five (Weber et al., 1995). Tenascin also binds to chondroitin 
sulfate proteoglycan. It binds weakly to fibronectin, but it does not bind to 
laminin (Hay, 1991). Crossin (1991) reported that tenascin inhibited cell 
growth. In contrast to this report, tenascin stimulates cell growth by acting 
as a mitogen. This mitogenic activity, however, appears to be associated 
with the region in the fibronectin type III domains (End et al., 1992). 
Tenascin has contrary effects, stimulation or inhibition, on neurite outgrowth 
(Lochter et al., 1991). All these observed functions support the idea that 
tenascin is a multifunctional extracellular matrix molecule. A summary of 
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proposed functions for tenascin based on experimental data (Chiquet- 
Ehrismann, 1990) is presented in Table 1.1. 
Table 1.1 A summary of proposed activities for tenascin. 
* Hemagglutination (Erickson and Iglesias, 1984) 
* Neuron-glia adhesion (Kruse et al., 1985) 
* Growth promotion (Chiquet-Ehrismann et al., 1986) 
* Inhibition of cell attachment/ spreading on fibronection (Chiquet-Ehrismann et al., 
1988) 
* Promotion of chondrogenesis (Mackie et al., 1987) 
* Necessary for cerebellar granule cell migration (Chuong et al., 1987) 
* Guidance of neural crest cell migration (Chiquet, 1989) 
* Promotion of neurite outgrowth (Chiquet, 1989) 
* Inhibition of epithelial cell-cell contacts (Chiquet-Ehrismann et al., 1989) 
* Promotion of cell attachment, not spreading (Spring et al., 1989; Chiquet 
Ehrismann et al., 1988). 
* Anti-adhesive activity (Lotz et al., 1989; Spring et al., 1989) 
* Immunosuppression of T cells (Ruegg, et a!., 1989) 
1.4.3 Laminin 
Laminin is a large extracellular glycoprotein found in the matrix, known as 
the basement membranes to which epithelial tissues, muscle, nerves and fat 
cells are bound. Laminin can serve various biological activities, including 
promotion of cell adhesion, growth, migration, differentiation, neurite 
outgrowth and tumour metastases. It can also take part in the structural 
assembly of basement membranes. Many of these properties are related to 
specific interactions of laminin with connective tissue components and cell 
surface receptors. For example, laminin binds to itself and other components 
in the matrix such as type 4 collagen, heparan sulfate proteoglycan and 
entactin to create an integrated structure within the basement membrane 
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(Kleinman and Weeks, 1989). This introduction will focus on the structure, 
occurrence, sources, active sites and biological activities of this molecule. 
1.4.3.1 Occurrence and sources of laminin 
Most of what is known about the biosynthesis of laminin is derived from 
studies using tumour-derived cell lines. Laminin was originally purified in a 
native form from the Englebreth-Hol m-Swarm (EHS) tumour of a mouse 
(Timpl et al., 1979). Engel (1993) indicated that the- preparation of laminin 
from nontumor sources is generally difficult and usually only small amounts 
can be obtained for analytical characterizations. Paulsson and Saladin 
(1989) reported a successful isolation of native laminin in small quantities 
from heart muscle tissues using the EDTA extraction method. It has been 
reported earlier that a variety of cultured cells including various epithelial 
cells, smooth muscle cells, schwann cells, endodermal and several tumour cell 
lines were found to produce and secrete laminin (Timpl et al., 1982; Martin 
and Timpl, 1987). Fibroblasts from human skin were found not to produce 
significant laminin (Foidart et al., 1980; Timpl et al., 1979,1982). 
1.4.3.2 Structure 
Since laminin was first identified as a large glycoprotein from a mouse EHS 
tumour, most biochemical and structural work has been performed with the 
EHS laminin. In electron microscopy it is visualised as a cross-shaped 
structure with three short arms and one long arm. Laminin consists of three 
polypeptide chains, a 400-kDa heavy (A) chain and two light (B) chains of 
about 200-kDa as shown in Figure 1.13. The A chain has three globular 
domains separated by three epidermal growth factor (EGF)-like repeats at 
the amino terminus. The B chains (B 1 and B2) are structurally similar but 
contain only two amino terminal globules (in the short arm) and EGF-like 
repeats and no globule at the carboxyl end (in the long arm). Laminin has 
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multiple structures in tissues due to variations in the number and type of 
chains. Mouse and human laminin have approximately 90% sequence 
homology, whereas Drosophila is only about 45% homologous to mouse 
protein (Kleinman and Weeks, 1989). 
Laminin was originally thought to be a single protein; however, 
investigations have shown that there are different forms of laminin that are 
separate gene products. Merosin is one member of the laminin gene family. 
The deduced amino acid sequence of merosin (380 kDa) is present in 
placenta, striated muscle, and peripheral nerve. Merosin is homologous to 
the carboxy-terminal part of the laminin A chain. It is associated with 
laminin B1 and B2 chains (Ehrig et al., 1990). S-laminin, another form of 
laminin, is homologous to the B1 chain of traditional laminin and is found in 
synaptic basement membranes, as well as in glomeruli and blood vessels 
(Hunter et al., 1990). The existence of different forms and tissue 
distributions of laminin implies that there may be different specific functions 
for each type of laminin. 
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Figure 1.13. Schematic model of laminin showing approximate locations of 
biologically active sites (After Kleinman and Weeks, 1989). 
1.4.3.3 Active sites and biological activities of laminin 
Numerous studies indicate that laminin possesses diverse biological activities 
which include promotion of cell adhesion, migration, differentation, growth, 
neurite outgrowth, collagenase IV activity, tyrosine hydroxylase activity and 
tumor metastases (Yamada and Kleinman, 1992; Engel, 1993). Laminin can 
interact with cells via a variety of adhesive recognition sequences and 
receptors. According to Kleinman and Weeks (1989), the center of the cross 
region was found to have cell adhesion activity while the end of long arm 
had both cell attachment and neurite outgrowth activity. Growth-promoting 
functions have been reported for laminin and some other ECM proteins 
containing EGF-like domains (Engel, 1989). A unique sequence of five 
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YIGSR 
Cell attachment 
amino acids, Tyr-Ile-Gly-Ser-Arg (YIGSR), from one of the EGF-like repeats 
is located in the B1 chain of laminin (Fig. 1.13). YIGSR peptide was 
identified as promoting cell adhesion and migration (Graf et al., 1987). 
Likewise YIGSR, PDSGR and F9 (RYVVLPR) are located on the B1 chain 
and inhibit tumour metastases (Yamada, 1991; Iwamoto et al., 1987; Murata 
et al., 1989; Skubitz et al., 1990). In contrast, IKVAV containing peptide 
increases tumor metastases, growth, angiogenesis, plasminogen activation 
and collagenase IV activity (Kanemoto et al., 1990; Stack et al., 1990; 
Kubota et al., 1992). The YIGSR peptide has also been reported to interact 
with normal cells and to influence cell differentiation. From these data, it is 
clear that YIGSR is one of the major functional sites in laminin (Yamada and 
Kleinman, 1992). 
Sasaki et al. (1988) reported that there is an Arg-Gly-Asp (RGD) sequence in 
one of the cystein-rich domains of the A chain. They indicated that this 
potential cell binding sequence could be active as another adhesion signal, 
in addition to the previously identified cell binding sequence YIGSR of the 
B1 chain. Several receptors proposed for laminin on mammalian cells have 
been reviewed by Mecham (1991) and Engel (1992). At least 8 members of 
the integrin family have been reported to bind to EHS laminin: a1ß1, a2ß1, 
a3ß1, a6ß1, a7ß1, avß3, a6ß4 and aIIß3. Among these receptors, a6ß1 is 
considered a specific laminin receptor as EHS laminin is its only known 
ligand (Tryggvason, 1993). 
Laminin is a heavily glycosylated molecule. In addition to earlier studies that 
reported 12-15% (w/w) glycosylation (Arumughan et al., 1986 ; Fujiwara et 
al., 1988), a value of 25-30% (w/w) glycosylation has also recently been 
reported (Chandrasekaran et al., 1991). A functional role of glycosylation of 
laminin was indicated for tumor cell adhesion, cell spreading and neurite 
outgrowth by Dean et al. (1990). 
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1.5 Aims of the project 
The principal aims of this study are outlined below: 
(i) To characterise the amino acid composition and compare the 
glycosylation of purified cellular fibronectin from the conditioned medium of 
cultured skin fibroblasts derived from patients with TS and from normal 
individuals. Preliminary work by Ellis and Hemming (1990), involving 
metabolic studies of such cells, showed a general increase in glycosylation 
and secretion of proteins, in particular fibronectin, in the TS fibroblasts 
compared to normal cells. Detailed in this thesis is a comparative study of 
purified fibronectin from TS and normal skin fibroblasts to ascertain 
variations in the structure of the protein in the diseased state. 
(ii) To establish the expression, distribution, and localisation of 
extracellular matrix (ECM) glycoproteins fibronectin, laminin and tenascin in 
cultures of skin fibroblasts derived from patients with tuberous sclerosis (TS) 
and normal individuals. 
Fibronectin, laminin and tenascin play an important role in the migration of 
cells during early embryonic development, and are involved in the assembly 
of the ECM. These glycoproteins have also been noted to affect the cell 
morphology, differentiation, proliferation, and attachment of the cells during 
embryonic development. Alterations in distribution and structure of these 
glycoproteins may cause functional disruption in their binding and 
interactions with cells and ECM macromolecules. This may result in 
abnormal assembly of the ECM, a consequence of which could be the 
hardening of tissues associated with TS. Variation in the assembly of the 
ECM may cause an abnormal migration of cells during early embryonic 
development. Therefore, studies of these changes may contribute to the 
understanding of the mechanisms involved in the aetiology of the hardened 
tissues of TS. 
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Chapter 2 
Chapter 2 
Materials and Methods 
2.1 Introduction 
The process of analysing carbohydrates of purified fibronectin and looking 
at the expression of major extracellular matrix glycoproteins of skin 
fibroblasts from patients with tuberous sclerosis and normal persons requires 
extensive equipment and numerous materials. The following is a list of the 
equipment and materials. Details of their use in the project can be found in 
the next sections. 
2.2 Materials and Equipment 
The plate reader was a Dynatech MR 5000 (Dynatech Laboratories inc. ). 
The electrophoresis unit (SE-250) was purchased from Hoeffer Scientific 
Instruments, San Francisco, CA. The BIO-RAD Western-blotting equipment 
was driven by a LKB power supply unit. Nitrocellulose membrane 
(Hybond-C or Hybond-C super) was purchased from Amersham. PVDF 
membranes were obtained from Millipore. The DIG glycan differentiation kit 
and DIG glycan detection kit were purchased from Boehringer Manheim 
Biochemica. 0.22µm filters were from Millipore. 
2.2.1 Buffers and Reagents 
All chemicals used for the work presented in this thesis were analytical grade 
and obtained from the following companies: 
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Sigma Chemical Company. Poole. Dorset. UK : 
bovine serum albumin (BSA), 2,2'-azino-bis-3-ethyl benzthiazoline-6- 
sulphonic acid (ABTS), polyoxyethylene-sorbitan monolaurate (Tween 20), 
gelatin-agarose, mercaptoethanol, silver nitrate, Coomassie Brilliant Blue R- 
250, sodium dodecyl sulphate (SDS), Folin's and Ciocalteu's phenol reagent, 
diaminobenzidine tetra-hydrochloride (DAB), sodium citrate, phenylmethyl- 
sulphonyl fluoride (PMSF). 
Fisons Scientific Apparatus Ltd.. Loughborough. Leicester. UK.: 
hydrogen peroxide, copper sulphate, sodium potassium tartrate, 
formaldehyde, acetone, methanol, magnesium chloride, potassium chloride, 
disodium hydrogen orthophosphate, urea, bromophenol blue, ammonium 
sulphate, calcium chloride, diaminoethanetetraacetic-acid (EDTA). 
BDH Chemicals Ltd.. Poole. Dorset UK: 
acrylamide-bisacrylamide, potassium dihydrogen orthophosphate, N, N, N', N'- 
tetramethylethylene-diamine (TEMED), tris (hydroxymethyl) methylamine 
(Tris), sodium carbonate (anhydrous). 
FSH Laboratory Supplies: 
methanol, ammonium persulphate. 
2.2.2 Cell Culture Materials 
Dulbecco's Modification Eagle's Medium (DMEM), trypsin and L-glutamine 
were purchased from Gibco BRL, Paisley, Scotland. Foetal calf serum (FCS) 
was from Advanced Protein Products (APP). 100mm cell culture dishes, 6 
and 96 well plates were obtained from Costar (Northumbria Biologicals Ltd., 
Cranlington, Northumberland, UK. ). Kanamycin was purchased from Sigma. 
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2.2.3 Chromatography equipment 
Prosep-gelatin was purchased from Bioprocessing Ltd., Medomsley Road 
Consett, CoDurham. The HPAEC-PAD chromatography system was 
supplied by Dionex (UK) Ltd., Camberly, Surrey. The Superose-12 column, 
Mono Q HR 5/5 column, and fast protein liquid chromatography system 
(FPLC) was from Pharmacia. 
2.2.4 Enzymes 
Pepsin was purchased from Sigma. Chymotrypsin was obtained from 
Calbiochem. 
2.2.5 Antibodies 
HNK-1 (anti-Leu-7) monoclonal antibody was obtained from Becton 
Dickinson. Horse radish peroxidase conjugated swine-derived antisera 
against rabbit antibodies was purchased from Dako. Rabbit-derived 
polyclonal antisera against human fibronectin, human laminin, and human 
tenascin were puchased from Telios Company, USA. 
2.3 Methods 
2.3.1 Cell Culture 
2.3.1.1 Primary Culture : Growing Fibroblasts from Skin Explants 
In this study, skin samples were obtained from patients undergoing surgery. 
The following cell lines, established from primary cultures of skin samples, 
were available for our experimental studies : 
TSJH : Skin tissue was obtained from a forehead plaque (lesion) of a 14 year 
old female tuberous sclerosis (TS) patient. 
TSHS : Skin tissue was obtained from an ungual fibroma of a 31 year old 
female TS patient. 
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TSFC : Skin sample was obtained by biopsy from the upper forearm of the 
left second phalanx of a 10 year old male. 
TSFM : Skin tissue was derived from an ungual fibroma of the second 
phalanx of a 10 year old male. 
TSFL : Skin tissue was obtained from a neck fibroma of a 13 year old male 
TS patient. 
TSSC : Skin tissue was from a toe lesion (ungual fibroma) of a 43 year old 
female TS patient. 
TSAH : Unaffacted skin was obtained from the lumbo-sacral area of a 65 
year old male TS patient. 
NSFS : Normal (control) skin tissue was obtained during operation on a 
congenital hair lip malformation of a4 month old male infant. 
DAKO (12 year old female), JPA (8 year old male), and RICA (6 year old 
female) control fibroblast cell lines were kindly provided by Dr Bruce 
Middleton of Nottingham University. 
The primary cell culture work mentioned above was performed in a laminar 
flow cabinet to avoid contamination of the samples. Fibroblast cultures were 
established from the above mentioned skin explants as described below. 
The method used was a modified version of that of Sly and Grubb (1979). 
The Establishment of Fibroblast Cultures from Skin Tissue : 
The subcutaneous fat was scraped carefully from the skin samples with a 
sterile scalpel in 100mm plates. The tissue was then cut into approximately 
1 mm2 pieces in the presence of saline and Dulbecco's Modification Eagle's 
Medium (DMEM) to prevent the tissue from drying. Following this, tissue 
pieces (6-10) were placed with the dermal side in contact with the surface of 
the sterile 60mm tissue culture dishes. Tissue pieces were fixed to the petri 
dishes in the incubator (5-6 minutes) using a serum clot on each explant. 
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When the explants settled on the cell culture dishes, 5ml of DMEM 
containing 15% foetal calf serum and kanamycin (100ug/ml) was added 
gently to avoid any disturbance. The culture dishes were incubated at 370C 
in a humidified incubator with 5% C02 in air, without moving for at least 10 
days. After 10 days the dishes were examined with a light microscope. 
2.3.1.2 Maintenance of Cultured Skin Fibroblasts 
When enough fibroblasts had grown from the explant, the explant was 
removed from the plates. The plates were rinsed with phosphate buffered 
saline (PBS) and enough trypsin (1X, Gibco) was added to cover the surface 
of the dishes before being incubated at 370C for 10-15 minutes. At this 
stage medium (8ml) containing 10% foetal calf serum (FCS) was added. The 
trypsin was quenched by the presence of natural protease inhibitors in the 
serum. The procedure for the preparation of the single cell suspension was 
as follows. The cells were sedimented in a sterile universal tube by 
centrifuging at 185g, and the medium was aspirated from the tubes. The cells 
were then resuspended in 10ml fresh medium (DMEM) containing 10% FCS, 
2mM L-glutamine and kanamycin (50µg/ml). Finally, the cells were 
transferred to 100mm cell culture dishes, and incubated at 370C in a 
humidified incubator with 5% C02 in air. The cells were fed by replacing 
the used medium by fresh 10% FCS in DMEM (10ml) every 3 days. 
2.3.1.3 Subculture of Fibroblast Cells and Collection of the Spent 
Medium 
When cell culture dishes were confluent, the conditioned medium was 
removed by aspiration and the cell layer washed twice with PBS. The cell 
layer was covered with trypsin solution and incubated at 370C for 10-15 
minutes. The activity of the trypsin was stopped by the addition of medium 
containing 10% foetal calf serum (FCS). The cell suspension was transferred 
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to a sterile universal tube and centrifuged at 185g for 7-8 minutes in a bench 
centrifuge (Sartorius). The supernatant was removed by aspiration, and the 
cell pellet resuspended in 10% FCS and 2mM L-glutamine. Resuspended 
cells from each 100mm dish were distributed into four 100mm dishes and 
incubated at 370C in humidified incubator with 5% C02 in air until they 
reached confluence. At confluence, the standard medium was replaced by 
fi bronecti n 
-depleted medium to avoid any plasma fibronectin contamination 
with cellular fibronectin which is synthesised by fibroblasts. After 2-3 days, 
the conditioned (spent) medium was harvested from the cell culture dishes in 
the presence of protease inhibitors (2mM PMSF, 5mM EDTA). Harvested 
medium of TS and normal fibroblasts was stored at 
-800C until sufficient 
medium was available for fibronectin purification. 
2.3.1.4 Freezing and Storage of Cells in Liquid Nitrogen 
For long term storage, cells were harvested when the plates were nearly 
confluent and then frozen. For this purpose, cells were washed twice with 
PBS, and trypsin was added before being kept at 37°C for 10-15 minutes as 
described above. Trypsin activity was stopped by the addition of growth 
medium containing foetal calf serum (FCS). The cell suspension was 
centrifuged and the supernatant removed as before. The cell pellet was 
resuspended in 1 ml of growth medium containing 20% (v/v) FCS and 10% 
(v/v) dimethyl sulphoxide (DMSO), and then transferred to Costar 2ml 
freezing vials. Finally, the vials were frozen at 
-80°C overnight before 
being 
stored at 
-196 °C under liquid nitrogen. 
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2.3.1.5 Cell Defrosting 
The vials containing cells were removed from liquid nitrogen storage when 
required. Firstly, they were warmed to 370C to defrost completely. 5ml of 
medium was then added and the cells were immediately centrifuged at 185g 
for 5 minutes, after which the supernatant was removed by aspiration. This 
process was repeated to remove any remaining DMSO. The cells were 
resuspended in DMEM containing 15% (v/v) FCS, then plated out and 
grown in small 60mm cell culture dishes initially. All pipettes, flasks and 
media used in the above procedures were either purchased sterile or 
sterilised by autoclaving or filtering through 0.22 µm filter. 
2.3.1.6 Cell Quantification and Cell Viability 
The cell viability and counting was achieved on a haemocytometer by the 
trypan blue exclusion method. The dye exclusion test is based on the 
concept that viable cells do not take up certain dyes, whereas dead cells are 
permeable to these dyes (Freshney, 1992). The cell viability and counting 
was performed as follows ; 700 µl of phophate buffered saline (pH 7.4) and 
200 µl of 0.8% Trypan blue (w/v) were added to 100 µl of cell suspension. 
The suspension was mixed and cell numbers determined by using an 
improved haemocytometer (Neubauer) on a light microscope at 100x 
magnification. The haemocytometer plate contains 16 equal large squares 
each subdivided into 25 equal small squares. The average number of cells in 
each large square was determined (all 16 squares were counted). The total 
cells per ml were calculated by multiplying this number of cells by 10 (the 
dilution factor) and then by 104. Trypan blue stains the the dead cells dark 
blue, whilst healthy cells remain clear. 
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2.3.2 Fibronectin Purification Methods 
In this work, fibronectin was purified from culture medium of fibroblasts 
derived from the skin of tuberous sclerosis patients and normal individuals. 
Serum previously depleted of fibronectin was used in preparation of the 
medium to ensure that the product was pure cellular fibronectin of the 
fibroblasts. Optimised purification of fibronectin was achieved by gelatin- 
affinity and size column chromatography (gel filtration) techniques. 
2.3.2.1 Gelatin-affinity Gel Chromatography 
The affinity of fibronectin (FN) for gelatin is used routinely for 
chromatographic purification of fibronectin. The use of gelatin columns for 
this purpose was initially developed and popularised by Engvall and 
Ruoslahti (1977). A Prosep-gelatin column purchased from Bioprocessing 
Ltd was used for FN purification in this study. First step purification of 
fibronectin is described below. 
Puri ication of Cellular Fibronectin using Prosep-Gelatin : 
1) When the fibroblasts reached confluence, cell culture medium was 
removed, cells were rinsed three times with PBS, and fresh culture 
medium lacking plasma FN (plasma FN was depleted from foetal calf 
serum by prosep-gelatin) was added into each cell culture dishes. 
2) Fibroblasts isolated from TS patients and normal individuals were 
cultured for 3-4 days. 
3) The medium of the cells was harvested and filtered with Whatman 
No. 50 filter paper to remove debris. 
4) PMSF (2mM) and EDTA (10mM) were added into the medium, 
which was stored at 
-80 OC in plastic roller bottles. 
5) 500-1000 ml medium was added to Prosep-Gelatin prewashed with 
PBS containing 2mM EDTA and 2mM PMSF. 
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6) The mixture was shaken for 2 hr at room temperature in I liter plastic 
roller bottles. 
7) Prosep-Gelatin was removed, and transferred into a polypropylene 
econopac column. 
8) Culture medium once again was passed through the Prosep Gelatin. 
9) The prosep column was washed with 10 column volumes of PBS 
containing 2mM PMFS and 2mM EDTA. 
10) The column was washed with IM NaCl and IM urea in PBS to 
remove other contaminants of FN. 
11) Bound fibronectin was eluted from Prosep Gelatin with 4M urea in 
20 mM CAPS, pH 11, containing 0.15 NaCI, 2mM PMFS and 2mM 
EDTA. 
12) Eluted fibronectin solution was dialysed, freeze dried and 
concentrated in vacuum dryer. 
13) The pellet was redissolved in 20mM CAPS, pH 11, and stored at 
-80 
OC until further purification on Superose 12 (size column) by FPLC 
was performed. 
2.3.2.2 Final Purification of Fibronectin By Gel-filtration Column by 
Fast Performance Liquid Chromatography (FPLC) System 
An FPLC system was used in conjuction with a gel filtration column 
(Superose 12) for the second step of fibronectin purification 
. 
All column 
buffers were made with nanopure water and filtered through 0.2214m 
micropore filters prior to use. Partially-pure fibronectin of Prosep-Gelatin 
column was applied onto the size column using 200µl loop. 
The superose 12 column (24 ml bed volume) was first equilibrated with 
20mM CAPS buffer, pH 11.5 bed volumes of buffer was enough to 
equlibrate the column. When a flat baseline occurred on the chart recorder, 
20Oµ1 of fibronectin solution was injected into the column and fractions 
were collected either manually or using a fraction collector at constant flow 
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rate (0.2m1/minute). Thirty two lml fractions were collected from the column. 
An ELISA assay was performed on these collected fractions to determine 
fibronectin positive fractions. ELISA positive fractions were selected and 
analysed by polyacrylamide gel electrophoresis (PAGE). 
2.3.3 Optimisation of Ammonium Sulphate Concentration 
For Precipitation of Laminin (LM) and Tenascin (TN) 
As a first stage of the purification procedure in the initial experiments of this 
research, ammonium sulphate precipitation was carried out to achieve a 
partial fractionation of the two proteins (LM, TN) from spent medium of cell 
culture. The first strategy was to attempt to optimise the ammonium sulphate 
concentration for precipitation of the proteins. Hence, eight aliquots 
containing 3ml of conditioned medium were taken into universal tubes and 
pre-chilled to 4°C. Suitable quantities of ammonium sulphate required to 
give 20,30,40,50,60,70, and 80% saturation were added (Harlow and 
Lane, 1988) to each aliquot while slowly stirring. Each aliquot was left 
stirring for 2 hours at 40C and was then centrifuged at 1060g for 40 minutes. 
The supernatants of the aliquots were aspirated and the pellets redissolved 
individually in 2m1 PBS, pH 7.4. The extracts were then dialysed against 
PBS and were collected into universal tubes. The extracts were assayed for 
total protein using the Lowry method, and the total amount of TN and LM 
were determined using ELISA. The results of ELISA suggested that a 40% 
saturation of ammonium sulphate was most efficient for the precipitation of 
both two proteins. 
For the precipitation of spent medium proteins, ammonium sulphate (40% 
saturation) was slowly added to the pre-chilled conditioned media samples 
collected from TS and normal fibroblasts, which were slowly stirred to 
prevent frothing. The mixtures were incubated overnight at 4°C. The 
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precipitate from each mixture was collected by centrifugation at 17.989g for 
90 minutes and resuspended in 6ml of PBS, pH 7.4 containing 2mM PMSF, 
5mM EDTA. The ammonium sulphate was removed by dialysis against the 
same buffer, followed by passage of the redissolved pellets through 
Sephadex G-25 M desalting columns. The extracts of the spent media were 
ready to be applied to gelatin-agarose chromatography, for FN purification, 
and finally anion-exchange (Mono-Q-HR 5/5) column chromatography for 
LM and TN partial purification. 
2.3.4 Partial Purification of LM and TN by an Anion- 
Exchange (Mono Q-HR 5/5) Chromatography 
Partial purifications of laminin and tenascin from spent medium of fibroblasts 
(TS and normal) were the aims in early experiments of this work. After 
gelatin- agarose affinity chromatography ammonium sulphate precipitates of 
medium, concentrated and filtered samples were applied to a Mono Q-HR 
5/5 (Pharmacia) column in a FPLC system. The column was equilibrated 
with 20mM Tris-HCI, pH 7.9, supplemented with 1mM PMSF and 2mM 
EDTA (starting buffer) using the standard 15 minute "wash program". The 
column was washed with 10m1 of the same starting buffer (at a flow rate of 
lml/min) followed by 20m1 of the same buffer containing 1M NaCl (eluting 
buffer). Full equilibration and a stable base-line was obtained by washing 
with 5 column volumes of starting and eluting buffer. The anion-exchange 
column was re-equlibrated using 20-30ml of the starting buffer before 
application of the samples. All starting and elution buffers were prepared 
freshly and filtered through 0.22µm micropore filters prior to use. Filtered 
samples were injected (t =0 min) onto the column and allowed to equilibrate 
for 5 minutes in the presence of the starting buffer whilst allowing non- 
binding entities to be washed off. Following this, a 60ml linear gradient of 0 
to 1M NaCI was initiated and continued to completion in 60 minutes (at a 
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flow rate of i ml/I min). The column was then washed with an additional 5ml 
of 100% eluting buffer. Seventy lml fractions were collected. Elution of 
proteins was detected by continuous absorbance measurement at 280nm 
and the responses recorded on a chart recorder. 
2.3.5 Protein Desalting Methods 
a) Dialysis : Purified fibronectin from the Prosep-Gelatin column was 
dialysed against PBS with several changes in 2 cm visking tubing. Dialysed 
fibronectin was freeze dried and concentrated in 2.5 ml of 20mM CAPS 
buffer, pH 11, and finally desalted using PD-10 desalting columns. Prior to 
use, visking tubing was boiled for 1 hour in 10 mM sodium bicarbonate and 
1mM EDTA. The tubing was also boiled for 10 minutes in de-ionized water 
prior to use. 
b) Gel Filtration : Pre-packed PD-10 desalting columns containing 
Sephadex G-25 M (Pharmacia) were used for rapid desalting of protein 
samples. The column was equilibrated with 50 ml of nanopure water. 
Exactly 2.5 ml of sample (purified fibronectin from the Prosep-Gelatin or cell 
extracts) was applied to the PD-10 desalting column. Proteins were eluted 
with 3.5 ml of nanopure water. 
2.3.6 Protein Purity Check, Visualising and Transfer 
Methods 
2.3.6.1 Polyacrylamide Gel Electrophoresis (PAGE) 
Sodium dodecyl sulphate polyacrylamide-gel electrophoresis (SDS-PAGE) 
was performed according to the method of Laemmli (1970) with a Mighty 
Small II SE250 Vertical Slab Electrophoresis unit (Hoefer Scientific 
Instruments, USA). A discontinuous gel system was used in which two 
different compositions of gels were involved: an upper stacking gel which 
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concentrates the protein and a lower small-pore resolving gel separates the 
denatured proteins depending on molecular weight. 
Stock Solutions 
The gel recipes are summarised in Table 2.1. 
Resolving Gel Buffer: 1.5 M Tris-HCI, pH 8.8 (18.17 g of Tris and 
approximately 48 ml of IM HCl were mixed and brought to 100 ml final 
volume with distilled water). The solution was filtered through Whatman 
No. 1 paper and stored at 4°C. 
Stacking Gel Buffer: IM Tris-HCI, pH 6.8 (12.11 g of Tris was dissolved in 
40 ml of distilled water, titrated to pH 6.8 with HCl and finally brought up to 
a volume of 100 ml with distilled water). The solution was filtered through 
Whatman No. I paper and stored at 4°C. 
Reservoir (running) Bu r: 0.25 M Tris, 1.92 M glycine, 1% (w/v) SDS, pH 
8.3 (30.3 g of Tris, 144g of glycine and lOg of SDS were dissolved in 1 liter 
of distilled water) stored at 4 °C. 
Acrylamide-bisacrylamide solution (30: 0.8): Purchased from BDH 
Chemicals Ltd. 
Sample Application Buffer: 0.0625 M Tris-HCI, pH 6.8,2% (w/v) SDS, 5% 
(v/v) 2-mercaptoethanol, 10% (v/v) glycerol, 0.02% (w/v) bromophenol blue, 
pH 6.8. 
Sample preparation for SDS-PAGE: samples were prepared by mixing with 
an equal volume of sample application buffer and heating at 100°C for 5 
minutes. 
Reagents for Polymerisation: 1.5% ammonium sulphate (freshly prepared), 
and N, N, N', N'-tetramethylethylenediamine (TEMED) was purchased from 
BDH Chemicals Ltd. 
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5% resolving gel solutions were prepared using the recipe given in Table 2.1 
and pouring into the mini gel electrophoresis unit, then overlaying with 
water-saturated butanol. 
Table 2.1. Recipe for gel preparation 
Resolving Gel (5%) Stacking Gel 
volume/ml volume/ml 
30% Acrylamide-bisacrylamide 5 1.7 
Deionised water 16.9 6.8 
Resolving gel buffer 7.5 
---- 
Stacking gel bufer 
---- 
1.25 
10% (w/v) SDS 0.3 0.1 
10% (w/v) ammonium persulphate 0.3 0.1 
TEMED 0.03 0.01 
When the resolving gel had set, the butanol was removed by inversion and 
the gel rinsed with distilled water. Next, stacking gel solution was poured 
on top of the resolving gel and a comb was inserted in order to form the 
sample wells. When the stacking gel had set, the comb was removed, the 
cast was dismantled and two gels were then transferred to the running 
apparatus. Following this, reservoir buffer was added to the apparatus and 
the samples were applied into the wells. Finally electrophoresis was 
performed at a constant current of 40 mA (20mA/gel) at 40C for 3-4 hours 
until the dye-front had reached the bottom of the gel. After electrophoresis, 
one gel was stained with Coomassie fixing solution or silver staining, and the 
other Western blotted to nitrocellulose membranes as described in the 
following pages. 
In some cases, continuous gradients gels (30m1,1.5mm thick) were also 
prepared using a gradient caster. Typically, a mixture of 4-15% 
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polyacrylamide resolving gels were prepared using large glass plates. The 
gel was run at a current of 30mA (Vokam power pack) until the dye front 
reached the bottom (typically 4-6 hours). 
2.3.6.2 Coomassie and Silver Staining of Polyacrylamide Gels 
Proteins were visualised by either one of two methods: 
a) Coomassie staining of Gels : 
Polyacrylamide gels were stained with Coomassie blue fixing solution (5: 1: 5 
(v/v/v) methanol : acetic acid : water containing 0.1 % (w/v) Coomassie 
Brilliant Blue R-250) overnight at room temperature. Coomassie stained gels 
were destained in a solution A (50% (v/v) methanol and 10% (v/v) acetic 
acid) for 1 hour and then Solution B (10% v/v methanol, 5% v/v acetic acid) 
for several hours to visualise proteins. 
b) Silver Staining of Gels: 
The silver staining method is more sensitive than Coomassie staining for 
visualising proteins on polyacrylamide gels. Therefore, this method was used 
in some cases, where a higher detection sensitivity was required. 
Gels were washed in fixing solution (80% (v/v) ethanol, 20% (v/v) glacial 
acetic acid) from 30 minutes to overnight. Fixing solution was then replaced 
with an incubating solution (7% (w/v) sodium acetate 3H20,0.2% (w/v) 
sodium thiosulphate 5H20,0.13% (w/v) glutaraldehyde, 25% (v/v) ethanol) 
for 30 min. Gels were washed three times with distilled water (10 minutes 
each). The gels were incubated with silver solution (0.1 % (w/v) silver nitrate, 
0.02% (v/v) formaldehyde) for 40 minutes at room temperature with gentle 
shaking. After this period, AgNO3 solution was discarded and the gel briefly 
washed in a stream of distilled water for 20 seconds. Proteins were 
visualised by the addition of a development solution (2.5% (w/v) sodium 
carbonate, 0.01 % (v/v) formaldehyde) for several minutes until protein bands 
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became prominent. Finally, the reaction was stopped in 1.5% (w/v) EDTA. 
2H20 for 15 minutes and stored in distilled water. 
2.3.6.3 Transfer of Proteins onto Membrane Filters 
After proteins had been separated by SDS-PAGE, it was possible to transfer 
them to nitrocellulose (NC) or polyvinylidene difluoride (PVDF) membranes 
(Western blotting) for further analysis of proteins/glycoproteins such as 
antibody and lectin staining, and amino acid analysis or sequencing. To 
date, numerous companies have provided equipment for the electrophoretic 
transfer of proteins from acrylamide gels to solid matrices such as NC and 
PVDF. There are two basic types of electrophoretic transfer systems used in 
this research: the "tank" buffer apparatus and semi-dry blotting apparatus. 
a) The tank-buffer system: 
This system has been designed from the first reports (Towbin et al., 1979) 
which demonstrated the successful transfer of proteins to membranes and 
their subsequent detection by antibodies. This type of electrophoresis 
apparatus is fairly simple, in that an electrophoretic field is generated to 
transfer proteins from acrylamide to a more stable and permanent matrix such 
as NC or PVDF. Prior to blotting, both polyacrylamide gel and NC were 
soaked separately in transfer buffer for 10 minutes, and then prepared in a 
transfer sandwich consisting of filter papers soaked in buffer, the blotting 
membrane, and the gel, as shown in Figure 2.1. The transfer cassette was 
submerged in a "tank" of buffer for electrophoretic transfer of proteins. 
Transfer of proteins was achieved in a Biorad transblot apparatus using Tris- 
glycine-methanol transfer buffer (25mMTris HCl (pH 8.3) 192mM glycine, 
20% (v/v) methanol) at 100mA, at 40C overnight. 
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WHATMAN PAPERS 
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ANODE (+) 
Figure 2.1. Schematic diagram showing the assembly of the blotting sandwich. 
b) Protein Blotting Using Semi-Dry Electrophoretic Transfer Equipment 
In a semi-dry transfer, a stack of wetted Whatman No I filter papers in Tris- 
glycine buffer surrounding the gel and the blotting membrane was used as a 
buffer reservoir, instead of a tank buffer system as described above. The 
main advantages with semi-dry transfer were the ease of handling, the short 
time required (1 hour) for the transfer, and the low buffer consumption. A 
transfer sandwich without sponges was prepared as shown in Figure 2.1 
and placed between semi-dry equipment plates containing electrodes which 
were previously wetted with Tris-glycine buffer (25mM Tris HCl (pH 8.3) 
192mM glycine, 20% (v/v) methanol) or 10mM CAPS buffer. An apparatus 
of Hooffer Scientific Instruments USA, for semi-dry electrophoresis of 
proteins was used for an efficient transfer at 100mA for 1 hour in a cold room 
at 4°C. 
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2.3.7 Quantification Methods 
2.2.7.1 Lowry Microprotein Assay 
This assay, first described by Lowry et al. (1951), was used to determine the 
amount of protein present in cell and tissue extracts of tuberous sclerosis and 
normal skin samples. 
Required stock solutions 
Solution A: 2% (w/v) Sodium carbonate in 0.1M NaOH. 
Solution B: 2% (w/v) Sodium potassium tartrate + I% (w/v) copper sulphate 
in 0.1M NaOH. 
Solution C: 0.1 ml solution B+4.9m1 solution A 
Folin-Ciocalteu phenol reagent : dilution 1: 1 with distilled water 
Standard protein : Bovine serum albumin (BSA) 1 mg/ml in distilled water. 
Method 
The assay detects 0-20µg of protein. Duplicate determinations were 
performed on each sample fraction and the sample volume made up to 20µl. 
Standard calibration curves were constructed on the same microtitre plate 
using 5,10,15, and 20µg of BSA suspended in the same buffer as the samples. 
250µ1 of solution C was added to each well and mixed. The mixture was 
then left for 10 minutes. 30µl of Folin-Ciocalteu phenol reagent was 
subsequently applied and incubated for 30 minutes to allow colour 
development. The absorbances of samples were measured at 620nm using a 
plate reader (Dynatech MR5000). The BSA standards allowed the 
determination of a standard curve, which was used to estimate unknown 
protein concentrations. 
2.3.7.2 Enzyme-Linked Immunosorbent Assay (ELISA) 
The quantification of glycoproteins was made by enzyme-linked 
immunosorbent assay using a method described by Rennard et al. (1980). 
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96 well microtitre (Costar) plates were coated with fibronectin and laminin 
standards in the range 1 to 1 lOng/110 µl to give a standard curve. After 2 
hours at room temperature, the wells were emptied of samples and washed 
twice with PBS. Blocking buffer (200 µl) made of PBS, pH 7.4 with 0.5% 
(w/v) BSA and 0.05% (v/v) Tween-20 was then applied to each microtitre 
well and incubated for a further 2 hours at room temperature or left 
overnight at 4 OC. Following this, 100 µl of rabbit anti-FN, anti-LM or anti- 
TN diluted 1: 1000 (v/v) in blocking buffer was applied and incubated at 
room temperature for 2 hours. 
The antibody solutions were removed and the wells washed twice with PBS 
and twice again with 200 µl blocking buffer. 100 µl of the secondary 
antibody, containing peroxidase-conjugated swine anti-rabbit IgG (1/3000, 
(v/v) in the blocking buffer) was added and incubated for 1 hour at room 
temperature. 
Finally, 100 µl of enzyme substrate (0.01% (w/v) ABTS, 0-01% (v/v) H202 in 
0. IM citrate phosphate buffer, pH 4.2) was added to each well and the 
reaction allowed to progress. Peroxidase enzyme catalyses the reaction : 
ABTS + H2O2_--ý" ABTS-O (chromophore) as demonstrated in Figure 2.2. 
After 30 minutes incubation at room temperature, the enzyme reactions were 
stopped with 50 µl 4N H2SO4, and the amount of cromophore produced 
was measured at 405nm using a plate reader (Dynatech MR5000). 
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+ H1Q ABTS + H202 
Figure 2.2. Schematic representation of ELISA method. 
2.3.7.3 Flow Cytometry 
Flow cytometry is a highly sensitive method by which certain properties of 
cells are measured in a "flow system". Cells in a rapid stream of fluid are 
orientated in a single column as they pass through a precisely focused laser 
beam. The cells pass a source of light, usually an argon laser, giving a single 
wavelength of 488nm and the amount of forward scatter (FSC) and side 
scatter (SSC) can be measured (see Fig. 2.3). FSC (at 20 to 180) gives an 
indication of the size of the cells and SSC (at 90°) shows the structure of the 
61 
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cell, particularly its granularity. Every cell that passes through the laser is 
measured individually and the data stored. Fluorescent substances are 
excited by the 488 nm (blue) incident laser light and emit longer wavelength 
light. Through the use of appropriate dichroic reflectors and narrow band- 
pass filters, light of specific wavelengths can be directed to specific 
photomultiplier tubes, thus allowing the use of up to three different 
fluorescent markers. Fluorescent I (FL1) corresponds to a wavelength of 
510-530 nm (green), FL2 corresponds to 550-590 nm (red) and FL3 to > 600 
nm (red). Thus, cells can be differentiated by size and granularity as well as 
up to three fluorescent markers allowing detailed analysis of cell 
phenotypes. Moreover, a flow cytometer can be used quantitatively for 
measuring the fluorescence intensity of particles in a liquid stream in which 
cells are injected and measurements made. 
Flow cytometry is commonly used for the analysis of suspension cells, in 
particular blood cells (lymphocytes, monocytes and erythrocytes etc. ), to 
diffferentiate them. However, we have adapted a method for the 
quantitative analysis of major extracellular matrix glycoproteins expressed 
by skin fibroblasts attached to the cell culture plate. Therefore, a FACScan 
(Becton-Dickinson, CA, USA) was used for the quantitative analysis of TS 
and normal skin fibroblasts samples for the expression of fibronectin (FN), 
laminin (LM) and tenascin (TN) quantitatively. 2000 events were collected 
using Consort 30 program and standard fibroblasts settings. A logical 
fibroblasts gate was set before data analysis. FlowMATE (Dako) was used 
to analyse fluorescence intensity of the cells. 
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Figure 2.3. A simple schematic diagram of a flow cytometer. 
An adapted protocol for the preparation of cultured skin fibroblasts for flow 
cytometry was as follows; 
An Adapted Protocol for the Preparation of Cultured Skin Fibroblasts for 
Flow Cytometrv (Fluorescence-activated cell sorter, FACS) 
1) 
2) 
3) 
Spent medium was removed from culture dishes and cells washed 
twice in PBS. 
Cells were harvested at confluence using 5mM (or 0.1-0.2%) 
EDTA (as an alternative to trypsin) in PBS for 20min. at 370 C. 
Cells were transfered into a universal tube and centrifuged at 150g for 
7 minutes in a bench centrifuge (Sartories). 
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4) Supernatants were removed and cell pellets were gently disrupted by 
tapping the tube or vortexing. 
5) Cells were washed twice with 0.1 % bovine serum albumin (BSA) in 
PBS. 
6) Cells were resuspend in 3.8% formaldehyde in PBS (1 ml 
formaldehyde + 9m1 PBS) for 10 min. on ice. 
7) Cells were centrifuged at 150g for 7 minutes, supernatent was 
removed and the cell pellet was gently disrupted by tapping the 
tube or vortexing. 
8) Wash cells twice with 0.1% bovine serum albumin in PBS. 
9) Cells were resuspend in permeation solution in 70% ethanol (or 
I mg/mI glycine + 0.1 % Triton X-100) for 10 minutes on ice. 
10) Cells were centrifuged at 150g for 7 minutes, supernatent was 
removed and the cell pellet was gently disrupted by tapping the 
tube or vortexing. 
11) Cells were resuspended in 0.1% BSA in PBS. 
12) Cells were washed once by centrifugation in 1% BSA/PBS solution. 
13) Pellets were resuspended in BSA/PBS solution and cells counted, 
then made to 8x 105 cells per ml solution in I% BSA/PBS and 
transfered into eppendorf microfuge tubes as duplicates. The 
following incubations were performed. 
a) 125µl of 8x105 cells/ml solution (105 cells total): incubated with 
rabbit antibody to human fibronectin (1/50 dilution) for 1 hour on ice. 
b) 125µ1 of 8x105 cells/ml solution (105 cells total): incubated with 
rabbit antibody to tenascin (1/50 dilution) for 1 hour on ice. 
c) 1251AI of 8x105 cells/ml solution (105 cells total): incubated with 
rabbit antibody to laminin (1/50 dilution) for 1 hour on ice. 
d) 125µ1 of 8x105 cells/ml solution (105 cells total): incubated with 1% 
BSA/PBS solution for 1 hour on ice. 
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e) 125[d of 8x105 cells/ml solution (105 cells total): incubated with 1% 
BSA/PBS solution for 1 hour on ice. 
14) Cells were centrifuge for 4 seconds, supernatant was removed and 
cells washed twice with 1% BSA/PBS, supernatant was removed, and 
cell pellet was gently disrupted by tapping tube or vortexing 
eventually. 
15) The following; (a), (b), (c) and (d) were incubated with secondary 
fluorescein isothiocyanate-FITC conjugated antibody (FITC-swine 
anti-rabbit) in 1 %BSA/PBS at a dilution of 1/30 for 1 hour on ice. 
Tube (e) was incubated with 1%BSA/PBS only at a dilution of 1/30 
for l hour on ice. 
a) 125µl of 8x105 cells/ml solution (105 cells total): incubated with 
secondary antibody to fibronectin (1/50 dilution) for 1 hour on ice. 
b) 125µl of 8x105 cells/ml solution (105 cells total): incubated with 
secondary antibody to tenascin (1/50 dilution) for 1 hour on ice. 
c) 125µl of 8x105 cells/ml solution (105 cells total): incubated with 
secondary antibody to laminin (1/50 dilution) for 1 hour on ice. 
d) 125µ1 of 8x105 cells/ml solution (105 cells total): incubated with 
secondary antibody for 1 hour on ice (to check nonspecific binding). 
e) 125µ1 of 8x105 cells/ml solution (105 cells total): incubated only with 
1% BSA/PBS solution for 1 hour on ice (to check autofluorescence). 
16) Cells were centrifuged for 4 seconds, supernatant removed and cells 
washed twice with 1% BSA/PBS, removed supernatant and the cell 
pellet disrupted by tapping tube or vortexing. 
17) Cells were resuspended in 0.5 ml I% BSA/PBS solution. 
18) Flow cytometry was performed (FACScan, Becton Dickinson): a gate 
was set for fibroblasts and 2000 events were collected. a Consort 30 
software was used for acquisition of data. 
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2.3.8 Detection Methods 
2.3.8.1 Immunodetection of Glycoproteins on Nitrocellulose Membrane 
After Western blotting, the nitrocellulose was processed for antigen 
detection as follows. Non-specific protein binding sites were blocked using 
0.5% (w/v) bovine serum albumin, 0.05% (v/v) Tween-20 in PBS pH 7.4 for 
2 hours at room temperature, or overnight at 4°C. Primary antibodies (rabbit 
anti-human FN, anti-human TN, anti-human LM, and mouse anti-HNK-1) 
were diluted in blocking buffer to 1: 1000 (v/v) and applied to the 
nitrocellulose blot for 2 hours at room temperature. After this period, the 
nitrocellulose was washed three times (10 minutes each) with PBS, pH 7.4 
supplemented with 0.05 % (v/v) Tween-20. As the secondary antibody, 
peroxidase conjugated swine antirabbit immunoglobulin (diluted 1/3000, v/v, 
in blocking buffer) was applied onto nitrocellulose for FN, LM, and TN 
detection, and peroxidase conjugated anti mouse antibody was applied for 
HNK-1 carbohydrate detection for 1 hour each. The blot was washed three 
times (10 minutes each) with PBS containing Tween-20. 
Finally, the blot was developed using fresh 3,3' 
-diaminobenzidine (DAB) 
solution (12mg DAB in 18ml of Tris-HCI, pH 7.6,1 ml of 0.3% (w/v) NiC12). 
This solution was filtered through Whatman No. 1 filter paper and 20µl of 
H202 added to the filtered solution. The blot was applied to this solution 
and the reaction allowed to proceed until the brown bands were clearly 
visible (this usually took less than 5 minutes). The reaction was stopped by 
rinsing with PBS, and the membrane was then dried in air. 
In some experiments instead of using 3-3' diaminobenzidine, an enhanced 
chemilunescence kit was used. Luminol, in the presence of hydrogen 
peroxide was added to the blot and allowed to react for one minute. The 
excess detection reagent was drained off and the blot was wrapped in cling 
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film and exposed to HyperfilmT M MP (Amersham) for a period of 30 seconds 
to one minute. The film was then removed and developed. This sensitive 
detection system was used for detection of HNK-1 carbohydrate epitope and 
laminin B1 chain with monoclonal antibodies. 
2.3.8.2 Lectins and Glycan Differentiation On Nitrocellulose Membrane 
Lectins can be defined as proteins of non-immune origin that precipitate 
glycoconjugates and agglutinate cells. Lectins are able to bind to 
carbohydrate moieties of proteins. The specific binding of lectins to 
carbohydrate moieties allows the identification of sugar residues of proteins. 
Hence, lectins conjugated to digoxigenin (DIG) were used to label and 
detect specific sugars on a Western blot. A Boehringer Mannheim 
Biochemica Glycan Differentiation Kit (Cat. No. 1210238) was used for this 
purpose. The lectins applied were conjugated with the steroid hapten 
digoxigenin which enables immunological detection of the bound lectins 
following incubation with secondary alkaline phosphatase conjugated anti- 
digoxigenin antibodies. Brown colour development was performed in the 
presence of a suitable substrate (NBT and X-phosphate). 
Specificities of the lectins included in the kit: 
MAA (Maackia amurensis agglutinin): recognizes sialic acid linked a(2-3) 
to galactose. 
GNA (Galanthus nivalis agglutinin): recognizes terminal mannose, a(1-3), 
a(1-6) or a(1-2) linked to mannose. 
SNA (Sambucus nigra agglutinin): recognizes sialic acid linked a(2-6) to 
galactose. 
PNA (Peanut agglutinin): recognizes the core disaccharide galactose ß(1-3) 
N-acetyl gal actosami ne. 
DSA (Datura stramonium agglutinin): recognizes galactose ß(1-4) N- 
acetylglucosamine. 
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Required solutions for lectin staining 
TBS (Tris buffered saline): 0.05M Tris-HCI, 0.15M NaCI, pH 7.5. 
Bu er 1: 1 mM MgCI2, I mM CaCl2, I mM MnCI2 in TBS, pH 7.5. 
Buffer 2: 0.05M MgCI2,0.1 M NaCI in 0.1 M Tris-HCI, pH 9.5. 
Method 
1) The samples were first run on a polyacrylamide gel and then 
transferred onto a nitrocellulose membrane by the Western blot 
method. 
2) The dried nitrocellulose was incubated for at least 30 minutes in 20m1 
blocking buffer (0.25g blocking reagent in 50ml TBS). 
3) The blocking solution was removed and the nitrocellulose washed 
twice for 10 minutes each in 50ml TBS and then once with buffer 1. 
4) The nitrocellulose was exposed to lectins: 50µl of MAA or 10µl of 
GNA was added to 10ml of buffer 1 and incubated with the filter for 
1 hour in this solution. 
5) The lectin solution was removed by washing the blot three times 
with 50m1 TBS. 
6) 10µl of conjugate (alkaline phosphatase conjugated anti- 
digoxigenin) was added to 10ml TBS and nitrocellulose was 
incubated in this solution for 1 hour. 
7) The conjugate solution was removed by washing the nitrocellulose 
three times with 50m1 TBS. 
The glycoproteins on the nitrocellulose were stained using 10ml of buffer 2 
containing 50µl NBT (100mg 4-nitroblue tetrazolium chloride in 1.3 ml 
dimethylformamide) and 37.5µ1 X-phosphate (50 mg 5-bromo-4-chloro-3- 
indolyl-phosphate in lml dimethylformamide. The formation of brown 
colour was usually completed within a few minutes and the filter was rinsed 
with distilled water to stop the reaction. 
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2.3.8.3 Glycan Detection 
This method was used to detect glycoproteins on Western blots. A DIG 
Glycan Detection Kit from Boehringer Mannheim Biochemica was used. 
The principle of this method is described here; Sodium metaperiodate was 
added to the filter to oxidise vicinal hydroxyl groups, on the glycoprotein 
oligosaccharides, into aldehyde groups. Added digoxigenin (DIG) was then 
covalently attached to these aldehydes via a hydrazide group. A DIG- 
specific antibody conjugated with alkaline phosphatase was then used to 
detect the DIG labelled glycoproteins. 
Required solutions: 
Sodium acetate buffer. 0.1 mol/ 1. pH 5.5: 
Tris buffered saline (TBS). nH 7.5: 
Tris-HCI, 0.05 mol/I; NaCl, 0.15 mol/l 
Tris buffer. nH 9.5; 
Tris-HCI, 0.1 mol/1, pH 9.5; MgC12,0.05 mol/1; NaCI, 0.1 mol/1. 
PBS (phosphate buffered saline). pH 6.5 ; 
potassium phosphate K2P04,50 mmol/l; NaCl, 150 mmol/l. 
Method 
1) The filter was first washed twice in approximately 50 ml PBS, pH 6.5. 
2) The filter was incubated in approximately 10 ml of 10 mM sodium 
metaperiodate (dissolved in sodium acetate buffer) for 20 minutes at 
room temperature. 
3) The filter was washed 3 times for 10 minutes each with 
approximately 50 ml PBS. 
4) The filter was incubated with I µl DIG-succinyl-c-amidocaproic acid 
hydrazide dissolved in 5 ml sodium acetate buffer for 1 hour at room 
temperature. 
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5) The filter was washed 3 times (10 minutes each) with approximately 
50 ml TBS. 
6) The filter was incubated in the blocking solution (0.25g blocking 
reagent in 50 ml TBS, pH 7.5) for at least 30 minutes. 
7) The filter was washed 3 times (10 minutes each) with approximately 
50 ml TBS. 
8) The filter was incubated with 10 µl anti-DIG-alkaline phosphatase 
dissolved in 10 ml TBS for 1 hour. 
9) The filter was washed 3 times (10 minutes each) with approximately 
50 ml TBS. 
10) The filter was immersed without shaking in staining solution (10 ml 
TBS pH 9.5,37.5 µl X-phophate, 50 µl NBT) until colour developed. 
11) Finally, the filter was rinsed several times with distilled water to stop 
the reaction. 
2.3.9 Carbohydrate Analysis of Fibronectin: High-pH Anion 
Exchange Chromatography With Pulsed Amperometric 
Detection (PAD) 
The Dionex Corporation has developed a technique for the separation of 
carbohydrates. This has been commonly described in the literature as 
HPAEC-PAD (High performance, or High-pH, Anion Exchange 
Chromatography-Pulsed Amperometric Detection). 
2.3.9.1 Principles of the Method 
Carbohydrates are weak acids with pKa values of 12-14. In HPAEC, a 
strong alkaline solution, usually NaOH, is used as eluent. Under these 
conditions the hydroxyl groups of carbohydrates are transformed into 
oxyanions, thereby all carbohydrates are negatively charged from oxyanion 
formation; this is the basis for their retention on strong anion-exchange 
columns. The HPAEC-PAD system uses sodium hydroxide as the main 
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eluent to ionise the weakly-acidic hydroxyl groups of carbohydrates which 
are then separated by a high performance anion exchange column. The 
elution order of monosaccharides correlates well with their pKa values. For 
example, glucose and mannose have pKa values of 12.28 and 12.08 
respectively. Mannose elutes later than glucose. Carbohydrates can be 
detected with high sensitivity (in the low picomole range) by PAD (Hardy 
and Townsend, 1994). 
2.3.9.2 Reagents for HPAEC-PAD 
Sodium hydroxide: A 50% solution of NaOH (w/v) was purchased from 
BDH Chemicals Ltd, Poole. 8ml of 50% NaOH was added to I litre of helium 
degassed nanopure water to give 100 mM solution. It was important not to 
disturb the carbonate which precipitates to the bottom of this solution 
during the pipetting of the eluent. 
Acetate: Sodium acetate (HPLC grade) was obtained from BDH Chemicals. 
A 0.5 M solution in nanopure water was filtered using a 0.22 µm Millipore 
filter and sparged with helium for 1/2 hour, and used for sialic acid analysis. 
2.3.9.3 System Settings and Analysis of Carbohydrates by HPAEC-PAD 
Monosaccharides of fibronectin were analysed using a Dionex BioLC 
system consisting of a CarboPacPA-l anion exchange column of pellicular 
resin (4x250mm) with pulsed amperometric detection (PAD) equipped with a 
gold electrode. Hydrolysis with 2M trifluoroacetic acid (TFA) and heat was 
performed to release neutral and amino sugars from glycoproteins. Samples 
were dissolved in 100 µl with water, to which freshly prepared 4M TFA (100 
µl) was added. These samples were then heated at 100°C for 5 hours, and 
then dried under nitrogen gas at 30 oC. Dried samples were dissolved in 
nanopure water at a concentration of I µg/ 1 µd and injected onto the Dionex- 
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HPAEC-PAD. TFA, a strong, volatile acid, was handled in a fume hood to 
avoid skin contact and inhalation. 
A standard mixture of fucose (Fuc), galactosamine (GaIN), glucosamine 
(GIcN), galactose (Gal), glucose (Gic) and mannose (Man) at a concentration 
of 1 nM each was also prepared with 2M TFA and injected onto HPAEC- 
PAD with unknown monosaccharide samples. The retention times and 
integrals of the individual peaks of this standard mixture were used for the 
identification and quantification of monosaccharides present in fibronectin 
samples. 10-40 µl of monosaccharide samples obtained from fibronectin of 
TS and normal fibroblasts were loaded via a Spectra-Physics SP8880 
autoinjector and eluted with helium sparged eluants at a constant flow rate 
of lml/min at 30°C. Monosaccharides were separated by an isocratic 
solution of 17 mM NaOH from 0 to 15 min, followed by a 10 min wash step 
with 200 mM NaOH and the column was then re-equilibrated with 17 mM 
NaOH. Total run time was 37 minutes. Data were collected and stored using 
a RaChel (LabLogic, UK) software program with an Ahkter 386SX 
computer. The manipulation of data and calculation of integrals was 
performed with the RaChel program. 
For the sialic acid (N-acetyl-neuraminic acid, Neu5Ac) analysis, a hydrolysis 
of Neu5Ac derived from purified fibronectin and cell extracts was performed 
with 50 mM trifluoroacetic acid (TFA) in a heating block for lhr at 800C. A 
1 nM Neu5Ac standard was run as duplicate with unknown samples. A 
sodium acetate SA3-H gradient was required to elute the acidic sugars 
(Neu5Ac) from the CarboPac PA-1 anion exchange column. The elution of 
Neu5Ac was by 100 mM NaOH with a 50-500 mM sodium acetate 
concentration gradient. The gradient was as follows: 0-7.5 minutes 50- 
150mM sodium acetate, 7.5-15 minutes 150 mM sodium acetate, 15-20 
minutes 150-500mM sodium acetate, 20-25 minutes 500 mM sodium acetate 
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(wash step), 25-35 minutes 50 mM sodium acetate (equilibration step) with 
100mM NaOH. 
The PAD settings with gold electrode were as follows : EI=0.05 V, E2=0.8 V, 
E3=-0.15 V, pulse durations; T, =420 ms (range 2, position 4), T2=180 ms 
(position 3), T3=360 ms (position 6) with a response time of Is and at a 
range of 1000 nA. 
For the oligosaccharide analysis, aliquots of fibronectin samples purified from 
TS and control fibroblasts, plasma fibronectin, bovine fetuin and human 
transferrin as positive control standards were digested using N-glycanase 
(see section 4.3.1 for the details of the samples). The samples were dried 
using a speed Vac, dissolved in nanopure water and analysed directly by 
HPAEC. Oligosaccharides were seperated under OXALSA gradient of 100 
mM NaOH. 0-15 min. isocratic 15 mM sodium acetate (NaAc), 15-70 min. 
gradient from 15mM-255 mM NaAc, 70-80min. isocratic wash step 500 mM 
NaAc, 80.1 min. re-equilibrates 15 mM NaOAc. PAD settings: EI=0.05 V, 
E2=0.8 V, E3=-0.15 V, pulse durations; T1=420 ms., T2=180 ms., T3=360 ms. 
2.3.10 Comparative Immunocytochemical Studies of Skin 
Fibroblasts with Antibodies to Fibronectin, Tenascin and 
Laminin 
To investigate the expression and distribution of fibronectin, laminin and 
tenascin in skin fibroblasts derived from patients with TS and normal 
individuals, I carried out immunofluorescence studies on cultured fibroblast 
cells after 5-6 passages following primary cultures of skin tissues. For this 
purpose, TS fibroblasts and normal fibroblasts (control) were allowed to 
attach to glass coverslips in 6 well cell culture dishes in the presence of 
medium containing 10% foetal calf serum. The following second or third day 
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of cell culture, immunofluorescence staining of fibroblasts was undertaken as 
below; 
1) The medium was removed, and cell layers were washed three times 
with phosphate buffered saline (PBS), pH 7.4. 
2) Fibroblasts were fixed with 3.8% formaldehyde in PBS (1: 10) for cell 
surface staining of fibronectin, laminin, and tenascin. Cells were then 
permeabilised with a solution of 0.1 % (v/v) Triton-X- 100 and 1 mg/ml 
(w/v) glycine in PBS when cytoplasmic staining of these three 
glycoproteins was required. 
3) Fixed fibroblasts were washed with PBS three times, 3 minutes each. 
4) Cells were then blocked with I% (w/v) bovine serum albumin in PBS 
for Ihr at room temperature or overnight at 4°C. 
5) Fibroblasts were incubated with specific primary antibodies (rabbit 
polyclonal anti-human fibronectin, laminin or tenascin at 1: 50 
dilution and monoclonal mouse anti-human laminin at 1: 30 dilution 
in blocking buffer) for 1 hour at room temperature (RT). These 
primary polyclonal and monoclonal antibodies were omitted for the 
negative staining of fibroblasts as control. 
6) Cell layers were washed extensively with PBS three times, and 
incubated for 1 hour at RT with a fluoresceinated secondary swine 
anti-rabbit antibody for laminin, fibronectin, tenascin, and 
fluoresceinated secondary rabbit anti-mouse for laminin staining (at 
1: 30 dilution) in the dark. 
Finally cells were washed twice with PBS, and cover-slips were mounted in 
1: 1 (v/v) PBS/glycerol solution with 8 mg/ml (w/v) 1-4 diazabicyclo-2.2.2- 
octane (DABCO) to prevent photobleaching. Cover-slips were attached to 
slides using nail-varnish. Fluorescence was observed in a Nikon microscope 
(Labophot Y2A). Photographs were taken using Kodak EPD-200 film, with 
same exposure times 
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In some cases, the photographs of the cells were taken using a Bio-Rad 
DVC-250 Confocal laser scanning microscope in the Department of 
Obstetrics and Gynaecology with permission of Dr. Steven Fleming. 
2.3.11 Amino Acid Analysis of Fibronectin 
Standard plasma and cellular fibronectin, and purified fibronectin samples 
from the (collected medium of) fibroblasts of patients with tuberous sclerosis 
and from normal individuals were run on the 5% PAGE. Proteins of the gel 
were blotted onto a polyvinylidene difluoride (PVDF) membrane with semi- 
dry blotting equipment using 10mM CAPS buffer, 3-(cyclohexylamino-l- 
propanesulfonic acid], pH 11 for 1 hour. In this analysis, CAPS buffer was 
used to facilitate transfer of proteins (standard transfer buffer contains 
glycine which would complicate amino acid analysis) on to PVDF membrane 
(Millipore Ltd). Fibronectin bands were excised from the PVDF membrane 
after amido black staining as described in section 2.3.12, and then amino acid 
analysis were carried out using an Applied Biosystems model 420H 
automated amino acid analysis system. Hydrolysis with 6M hydrochloric 
acid at 2000C and subsequent pre-column derivatisation were carried out 
automatically. Amino acids were identified and quantified against known 
standards. This work was done in collaboration with Mr. K. Bailey in the 
Departmental Bio-polymer Synthesis and Analysis Unit (BSAU). 
2.3.12 Procedure for Amido Black Staining 
After semi-dry blotting of proteins, polyvinylidene difluoride (PVDF) 
membrane was stained with Amido Black just before amino acid analysis and 
sequencing of the fibronectin. 
1) Blotted PVDF membrane was removed from the blotting sandwich 
and rinsed with distilled water. 
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2) The membrane was then saturated with 100% methanol for a few 
seconds to wet it. 
3) Membrane was stained with 0.1 % (w/v) Amido Black in 40% (v/v) 
methanol and 1% (v/v) acetic acid to visualise the protein bands. 
4) Finally, the membrane was destained by rinsing extensively with 
distilled water. 
2.3.13 Digestion of Fibronectin with Chymotrypsin and 
Separation of Gelatin-binding Fragments 
600 µg Plasma fibronectin was digested by chymotrypsin (Calbiochem) in 
0.05 M Tris-HCI buffer pH 7.0 containing 0.15 M NaCl and 0.01 M CaCI2 at 
enzyme/substrate ratio of 1: 50 for 60 min at 23°C. The reaction was 
terminated by adding 2mM PMSF and soybean trypsin inhibitor. The 
digests were applied to a Prosep-gelatin column. The unbound fractions 
were pooled, dialysed and then concentrated. Bound fibronectin was eluted 
with phosphate-buffered saline PBS (pH 7.5) containing 4M urea, dialysed 
against water and lyophilised in a vacuumed freeze drier, and concentrated 
in PBS before its further analysis for protein sequencing as described below. 
2.3.14 Amino-terminal Protein Sequencing of Fibronectin 
Amino-terminal protein sequencing (Edman degradation) of plasma 
fibronectin was determined by K. Bailey (BSAU) using an Applied 
Biosystems model 473A automated protein sequencer. Data were collected 
and analysed using 610A data analysis software (Applied Biosystems, Foster 
City, California). Plasma fibronectin was run on the 5% PAGE and blotted 
onto the PVDF membrane with semi-dry blotting equipment using 10 mM 
CAPS buffer, pH 11. The fibronectin band was excised from the PVDF 
membrane after amido black staining, and sequenced directly. Sequencing 
of the excised fibronectin band showed that fibronectin was blocked due to 
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pyroglutamic acid from the N-terminal site and did not give any sequence of 
amino acids. 
In the second attempt of protein sequencing, fibronectin was proteolysed 
using chymotrypsin. The gelatin-binding domain of fibronectin was purified 
from its proteolytic fragments using Prosep-gelatin column chromatography. 
The purified domain of fibronectin was run on the 10% PAGE and blotted 
onto the PVDF membrane with semi-dry blotting equipment using 10mM 
CAPS buffer, pH 11. The excised gelatin-binding domain was not blocked 
and was sequenced successfully. 
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Chapter 3 
Chapter 3 
Purification of Fibronectin From Conditioned 
Medium of TS and Control Fibroblasts 
3.1. Introduction 
Fibronectins are extracellular matrix adhesive glycoproteins that are 
important in embryonic development, wound healing and tumorigenesis. 
Fibronectin molecules act as bridges between cell and extracellular materials. 
There are at least two major classes of fibronectins, namely plasma 
fibronectin and cellular fibronectin. In the blood, fibronectin is dimeric, but 
in tissues it forms disulphide crosslinked fibrils (Hynes, 1990,1986). Plasma 
and cellular fibronectins are very similar in amino acid and carbohydrate 
composition and in certain biological activities involving cell attachment to 
both collagen and plastic. However, the forms of fibronectin clearly differ in 
certain other biological activities that involve cell-cell interactions, cell 
morphology and hemaggiutination. They have also slightly different 
subunit polypeptide sizes, and major differences in solubility. Plasma 
fibronectin migrates on SDS-polyacrylamide gels under reducing conditions 
as a doublet, implying that at least two different (220-23OkDa) subunits 
exist. However, both cellular and amniotic fibronectins appear larger than 
plasma fibronectin and do not show a well-resolved doublet pattern (Hynes, 
1990). 
One of the main objectives of this thesis was to characterise the cellular 
fibronectin, in particular with respect to glycosylation, from the conditioned 
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medium synthesised by cultured skin fibroblasts derived from patients with 
tuberous sclerosis (TS) and normal individuals. In order to achieve this 
objective it was necessary to purify fibronectin in substantial quantities for 
carbohydrate analysis. In this chapter, the results of the isolation of cellular 
fibronectin from conditioned medium of cultured skin fibroblasts from 
patients with TS and normal individuals will be presented and discussed. 
This chapter also describes the partial purification of laminin and tenascin 
from conditioned medium to demonstrate their synthesis and secretion by 
fibroblasts into culture media as extracellular matrix glycoproteins. 
3.2 Use of Fibroblast Cultures as an Experimental System 
The macromolecules that constitute the extracellular matrix are mainly 
secreted locally by cells in the matrix. In most connective tissues these 
macromolecules are secreted by fibroblasts. Fibroblasts are principal cells of 
the dermis (Alberts et al., 1989), their cell culture systems having been used 
in many studies of disease and also in fibronectin research (Sly and Grubb, 
1979, and Hynes, 1990). There are several reasons for the popularity of 
fibroblasts systems, one of which is that they can be grown in culture from 
small amounts of tissue explants. 
Since TS appears to be a genetic disorder and that one of its major 
manifestations occurs in the skin of most patients, it would appear that 
cultured dermal fibroblasts derived from such individuals would provide a 
convenient and accessible system for the study of this disease which might, 
in turn, contribute to the elucidation of the possible molecular mechanisms of 
the disease process. 
In this work, fibroblasts were established from primary cultures of skin 
explants of patients with tuberous sclerosis (TS). In some cases this was 
from skin lesions and in other cases from unaffected skin. A cell culture 
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system has been employed to study the adhesive glycoproteins fibronectin, 
laminin and tenascin synthesised by these established TS fibroblasts. 
Control fibroblasts, for comparison, have been grown from explants of 
people who are not known to be suffering from TS nor any other disease or 
disorder (see Fig. 3.1). 
Established fibroblasts from TS and normal skin were grown at 370 C until 
they reached confluence. At confluence, the standard medium was replaced 
by fibronectin-depleted medium to avoid any plasma fibronectin 
contamination of the fibroblasts cellular fibronectin. After 2-3 days, the 
conditioned medium was harvested from the cell culture dishes in the 
presence of protease inhibitors, 2mM diaminoethanetetra-acetic acid (EDTA) 
and 2mM phenylmethylsulfonyl fluoride (PMSF). Harvested medium of TS 
and normal fibroblasts was stored at 
-800C until sufficient medium was 
available for fibronectin purification. 
3.3 Purification of Fibronectin by Gelatin affinity-Gel 
Chromatography 
As described in chapter 2 (section 2.2.2.1), cellular fibronectin was isolated 
by affinity chromatography on a Prosep-gelatin (Bioprocessing) column as a 
first step purification procedure, by a method established by Engvall and 
Ruoslahti (1977). 
Fibroblasts secrete much of the fibronectin they synthesise into the culture 
medium in preference to retaining it on the cell surface. 
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Figure 3.1. The figure shows the typical control fibroblasts established from normal 
human skin. These established fibroblasts were cultured to act as controls for 
fibroblasts established from the skin of the TS patients, 26x magnification. 
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Spent culture medium was therefore a logical source of fibronectin which 
could be purified by gelatin-affinity and gel filtration as well as anion- 
exchange chromatography techniques 
Foetal calf serum previously depleted of fibronectin was used in the 
preparation of the medium to ensure that the product is pure cellular 
fibronectin. Fibronectin-containing culture medium (500-1500m1) was 
collected from skin fibroblasts of different TS patients and normal skin 
fibroblasts, and stored at 
-800C until required. 
Typically, a 10ml Prosep-gelatin column (Bioprocessing Ltd. ) with 2mg/ml 
fibronectin binding capacity was equilibrated with phosphate-buffered 
saline (PBS) containing 2mM EDTA and 2mM PMSF, pH 7.5. Fibronectin- 
containing conditioned medium of fibroblasts was defrosted and filtered 
with Whatman (No. 50) filter paper, then passed through the Prosep-gelatin 
column at room temperature (5-12 hours). The Prosep-gelatin column was 
washed with 5 column volumes of PBS, then washed with 1M NaCl and IM 
urea in PBS, pH 7.5 to remove other contaminants. Bound fibronectin was 
eluted from Prosep-gelatin with 4M urea in 20 mM CAPS, pH 11, containing 
0.15M NaCl, 2mM PMFS, 2mM EDTA, and absorbances of collected 2ml 
fractions were measured at 280 nm spectrophotometrically as shown in 
Figure 3.2. 
Eluted fractions were assayed by ELISA, and fibronectin-positive fractions 
were dialysed, freeze-dried and concentrated in a vacuum dryer. The pellet 
was redissolved in 0.5 ml 20mM CAPS buffer, pH 11. To analyse the purified 
protein, samples were denatured and resolved by 4-15% gradient 
polyacrylamide gel electrophoresis. 
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Figure 3.2. Elution of protein from Prosep-gelatin. The figure shows the affinity 
chromatography of cellular fibronectin from culture medium on a column of Prosep- 
gelatin. 2ml fractions were collected. The arrow indicates the beginning of the 
elution of fibronectin with 4M urea. 
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Figure 3.3 shows a polyacrylamide gel of the partially purified cellular 
fibronectin from both TS and control skin fibroblasts from the Prosep-gelatin 
affinity column. Bands, of the correct molecular weight of fibronectins 
(approx. 230kDa) were clearly visible on the gel (see Fig. 3.3). 
The final yield of cellular fibronectin after the Prosep-gelatin column was 
typically 85% of that from conditioned medium applied to the column, as 
determined by ELISA (Table 3.1). 
* Amount of FN in 1000 ml conditioned medium : 0.408mg 
* Amount of FN after prosep-gelatin affinity 
chromatography : 0.346mg 
*% yield of FN : 85 
Table 3.1. The table shows an example of the recovery of fibronectin assayed by 
ELISA obtained from conditioned medium of TS skin fibroblasts before and after 
Prosep-gelatin affinity chromatography. 
It is worth noting that tenascin was found to be eluted by IM urea from the 
Prosep-gelatin column during the fibronectin purification (see Figure3.4). 
Tenascin was eluted by 1M urea wash from the column following washing 
with five column volume of PBS before the elution of fibronectin. Eluted 
tenascin from Prosep-gelatin was collected in 40-50 ml of 1M urea solution 
and dialysed overnight against PBS, pH 7,5, at 40 C. Dialysed sample was 
freeze dried and dissolved in 200µl PBS, pH 7.5, and mixed with equal 
amount of sample buffer containing mercaptoethanol for resolving by 5% 
SDS PAGE. Interestingly, tenascin purified in this way did not bind to a new 
Prosep-gelatin column. This suggests that tenascin binds or interacts with 
fibronectin on the Prosep gelatin column. 
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Figure 3.3. SDS 4%-15% gradient polyacrylamide gel electrophoresis pattern of 
partially purified fibronectin (16µg each) from the cell culture medium of (A) normal 
and (C) TS skin fibroblasts, using Prosep-gelatin beads. Also shown is (B) high 
molecular weight marker mixture, with the actual molecular weights indicated to the 
right. The gel was stained for protein using Coomassie Brilliant Blue. 
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Figure 3.4.1M urea wash of Prosep-gelatin elutes tenascin from the affinity 
column. The figure is a western blot of the SDS-PAGE (5%) stained using anti- 
tenascin as described in chapter 2 (section 2.3.8.1). Molecular weight of tenascin 
bands was determined by comparison with a standard mixture of proteins (not 
shown). This tenascin sample was prepared from conditioned medium of fibroblasts 
grown from the unaffected skin of a TS patient. 
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3.4 Final Purification of Fibronectin By Gel-filtration 
using a Fast Performance Liquid Chromatography (FPLC) 
System 
For the next purification step of the fibronectin, FPLC with a Superose 12 
gel filtration column was used. Partially-pure fibronectin from the Prosep- 
gelatin column was resolved on this sizing column. 
The Superose 12 column (24m1 bed volume) was first equilibrated with 5 bed 
volumes of 20mM CAPS buffer, pH 11. After obtaining a flat baseline on the 
chart recorder, 200µ1 of fibronectin solution was injected into the column 
and fractions were collected either manually or using a fraction collector, at 
constant flow rate (0.2m1/minute) (see Fig. 3.5). Proteins were detected by 
measuring the absorbance at 280nm. 
Thirty-two lml fractions were collected from the column. An ELISA assay 
was performed on these collected fractions to determine fibronectin positive 
fractions (see Fig. 3.6). ELISA positive fractions were selected and analysed 
by SDS-PAGE. 
Coomassie blue (See Fig. 3.7), silver (See Fig. 3.8), and antibody (See Fig. 
3.9) staining of the reduced purified fibronectin from TS and normal 
fibroblasts analysed by 5% SDS-PAGE showed a single broad band with 
approximate molecular weight of 230 000. The mobility of fibronectin 
isolated from fibroblasts grown from skin lesions of TS patients was identical 
to that from fibroblasts of unaffected skin. 
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Figure 3.5 Elution profile of fibronectin positive fractions (21-40) from Prosep- 
gelatin resolved on the Superose 12 gel filtration column. Eluted proteins were 
detected by measuring the absorbance at 280nm. 
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Figure 3.6. ELISA absorbances at 405nm of collected fractions from the Superose 
12 gel filtration column (figure 3.5) assayed using anti-fibronectin. Note the elution 
of fibronectin in the void volume of the column. 
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Figure 3.7. SDS-PAGE (5% gel) analysis of purified cellular fibronectin (8µg 
each) from (A) normal skin fibroblasts, (B) TS unaffected skin fibroblasts after the 
Superose 12 stage of purification. Purified fibronectin was detected by staining with 
Coomassie Brilliant Blue as described in chapter 2 (section 2.3.6.2-a). 
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Figure 3.8. SDS-PAGE (5% gel) analysis of purified cellular fibronectin (44g 
each) from the cell culture medium of (A) normal skin fibroblasts (B) TS unaffected 
skin fibroblasts after the Superose 12 stage of purification. Purified fibronectin was 
detected by the silver staining method as described in chapter 2 (section 2.3.6.2-b). 
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Figure 3.9. Western blotting (5% SDS-PAGE) analysis of purified cellular 
fibronectin from the cell culture medium of (A) TS unaffected skin fibroblasts (B) 
normal skin fibroblasts after the Superose 12 stage of the purification. Purified 
fibronectin (lane A=12µg, lane B=5µg fibronectin) was detected by staining with 
polyclonal anti-fibronectin as described in chapter 2 (section 2.3.8.1). 
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Typically, the final yield of fibronectin from the Superose-12 column was 
70% of that applied, as shown in Table 3.2. However, the overall recovery 
of fibronectin following Prosep-gelatin and Superose-12 columns was 
-60% 
of that in the conditioned medium used. 
* Amount of FN after Prosep-gelatin affinity 
chromatography : 0.346mg 
* Amount of FN after gel filtration (Superose- 12) 
column chromatography : 0.242mg 
*% yield of FN : 70 
Table 3.2. The table shows an example of the final recovery of fibronectin obtained 
from conditioned medium of TS skin fibroblasts after the Superose- 12 gel filtration 
column. 
The purified fibronectin from conditioned medium of both TS and control 
cell lines was then ready for further carbohydrate and amino acid analysis. 
3.5 Partial Purification of LM and TN from Conditioned 
Cell Culture Medium by Anion-Exchange (Mono Q-HR 5/5) 
Chromatography 
a) Ammonium Sulphate Precipitation of the Conditioned medium 
The major extracellular matrix (ECM) glycoproteins secreted by fibroblasts 
were investigated by a series of purification procedures using the spent 
medium of cultured fibroblasts. Ammonium sulphate precipitation was 
carried out to achieve a partial fractionation of the two ECM glycoproteins, 
laminin (LM) and tenascin (TN) from conditioned medium as a first stage of 
the purification procedure. The first strategy was to attempt to optimise the 
ammonium sulphate concentration for precipitation of LM and TN. 
Successive 20,30,40,50,60,70 and 80% saturation of ammonium sulphate 
was used to precipitate medium obtained from TS fibroblasts (TSFM) (see 
section 2.3.3). After centrifugation, the pellets were resuspended in 0.5ml 
PBS and dialysed. 
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Figure 3.10. Ammonium sulphate precipitation of conditioned medium of TS 
fibroblasts and absorbances of precipitates for (A) LM and (B) TN measured by 
ELISA. 
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Dialysed samples were assayed for LM and TN by the ELISA method as 
described earlier. Figure 3.10 shows that 40% saturation gave the highest 
absorbance at 405nm by the ELISA method for LM and TN, although 
appreciable quantities of both LM and TN were precipitated at all 
concentrations of ammonium sulphate. 
After optimising the precipitation procedure, the required amount of 
ammonium sulphate to reach 40% saturation was added slowly by mixing to 
each sample of conditioned medium, followed by incubation at 40 C 
overnight. After centrifugation, the pellets were redissolved in 6m1 of PBS 
with 10mM sodium citrate, 2mM PMSF, pH 7.4. The samples were desalted 
using Sephadex G-25M columns (Pharmacia), giving final volumes of 15m1 
for each sample. The total protein of the precipitates from the conditioned 
medium from two different TS patients abbreviated as TSFM (520 ml), TSFC 
(496 ml), and normal fibroblasts (NSFS, 389 ml) samples was determined by 
the Lowry method to be 20.4,54.6 and 25.5mg respectively. 
To use the samples efficiently, first of all, each collected medium was 
subjected to the gelatin-agarose (Sigma) affinity chromatography for the 
partial purification of fibronectin as described before (see section 2.3.2.1). 
The fractions eluted by 4M urea were pooled together and dialysed. 
Samples were then freeze-dried and resuspended in 2ml of PBS containing 
2mM PMSF, pH 7.5 and kept at 
-200 C until required. 
Laminin and tenascin were then isolated by anion exchange 
chromatography from the remaining sample of the gelatin-agarose column. 
b) Anion-Exchange (Mono Q-HR 5/5) Chromatography 
Remaining medium and the first 19 (2m1) fractions of the 1M NaCl and 1M 
urea wash from the gelatin-agarose affinity column were pooled and 
desalted by dialysis against distilled water at 40 C. Following freeze-drying, 
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samples were resuspended in 20 ml Tris-HCI, pH 7.9 containing 1mM PMSF 
(chromatography buffer) and filtered using 0.22µm filters. Following this, 
samples were loaded onto a Mono Q HR 5/5 high performance anion- 
exchange (FPLC) column pre-equilibrated with 20mM Tris-HCI, pH 7.9 
containing protease inhibitors. The column was washed with 5ml buffer at a 
flow rate of lml/min and then eluted using a linear gradient of 0 to 1M NaCl 
(1 hour). Collected Iml fractions were assessed by ELISA for tenascin and 
laminin (see Figures. 3.11 and 3.12 respectively). The salt gradient eluted 2 
main peaks of immunoreactivity for anti-tenascin in fractions 35-42 and 48- 
52, at just greater than 0.45M NaCl. The main anti-laminin immunoreactivity 
occured as a broad peak in fractions 55-65, eluted at just over 0.80 M NaCl. 
In early experiments of these purification studies, the degree of any possible 
cross-reactivity of fibronectin with anti-tenascin and anti-laminin was 
determined using ELISA and dot-blot methods. No evidence of cross- 
immunoreactivity was seen (results not shown). Moreover, there was also 
no cross-reactivity of laminin with anti tenascin and anti-fibronectin. 
The combined LM fractions from the mono-Q column were negative when 
tested with the ELISA method for FN and TN. The combined TN fractions 
from this column were also negative when tested with the ELISA method for 
FN but showed the presence of a traces of LM. Both fractions of LM and 
TN also contained some other proteins and as could be described as only 
partially purified. 
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Figure 3.11. Elution profile of fractions containing tenascin determined by ELISA 
following Mono-Q anion exchange chromatography of conditioned medium from 
normal fibroblasts. The main anti-tenascin immunoreactivity occured fractions 35-42 
and 48-52, corresponding to elution conditions of 0.45 M NaCl or higher. 
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Figure 3.12. Elution profile of fractions containing laminin determined by ELISA 
following Mono-Q anion exchange chromatography of conditioned medium from TS 
fibroblasts. The main anti-laminin immunoreactivity occured as a broad peak in 
fractions 55-65, corresponding to elution conditions of 0.80 M NaCl or higher. 
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The eluted 1 ml fractions with the highest absorbances at 405 nm were 
selected for further examination. Typically, the strongly positive fractions 
for LM (57-62 fractions) were pooled together and mixed with equal 
amount of sample buffer containing mercaptoethanol. The TN fractions (49- 
51) were also combined in a similar way. These fractions were then 
subjected to analysis by SDS-PAGE followed by western blotting. Figure 
3.13 (D) and 3.14 show the western-blots probed with anti-laminin and anti- 
tenascin respectively. 
ABC0 
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Figure 3.13. Western blotting analysis of (D) a sample of combined fractions 57-62 
from the mono-Q column, (B) concentrated conditioned medium, (C) extracts of TS 
fibroblasts, and (A) standard laminin. The samples were separated on 5% SDS- 
polyacrylamide gel electrophoresis, the gel blotted on nitrocellulose and laminin bands 
were detected with anti-laminin. as described in chapter 2 (section 2.3.8.1). For the 
extraction; fibroblasts were washed with PBS and treated with sample application 
buffer described in section 2.3.6.1. 
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Figure 3.14. Western blotting analysis of duplicate samples of combined fractions 
48-52 from the mono-Q column. The samples were separated on 5% SDS- 
polyacrylamide gel electrophoresis, the gel blotted on nitrocellulose and tenascin 
bands were detected with anti-tenascin as described in chapter 2 (section 2.3.8.1). 
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Western blot analysis of standard laminin (from Telios) showed the two 
bands expected at 400 and 200 kDa (Fig. 3.13-A). The anti-laminin 
antibody also showed specific labelling of these two bands in fibroblasts, 
and in culture medium, as seen in Figure 3.13 (C and B) respectively. 
The western blot analysis of the tenascin fractions eluted from mono Q 
column showed two major tenascin bands (28OkDa and 190kDa, 
respectively) in fibroblasts from affected skin (ungual fibroma) of a TS 
patient, as seen in Figure 3.14. 
Here, the western blot analysis of tenascin and laminin (ELISA positive 
fractions from the Mono Q column) again demonstrated the presence of 
these two extracellular matrix glycoproteins, in addition to fibronectin, in 
conditioned medium of cultured TS and control fibroblasts. 
3.6 Discussion 
In summary, ammonium sulphate precipitation, Prosep-gelatin affinity 
chromatography, gel filtration (superose-12) and mono-Q anion exchange 
chromatography were used for the isolation of the adhesive glycoproteins 
fibronectin, laminin and tenascin. 
Foetal calf serum previously depleted of fibronectin was used in preparation 
of the cell culture medium to ensure that the product is pure cellular 
fibronectin. The purification of cellular fibronectin was achieved from 
conditioned medium of established TS and control fibroblasts using Prosep- 
gelatin affinity chromatography and gel filtration chromatography 
techniques. The use of gelatin columns for purification of fibronectin was 
initially developed by Engvall and Ruoslahti (1977). However, purified 
fibronectin by this method was only partially pure (see Fig. 3.3). Therefore, 
fibronectin was purified further by gel filtration chromatography to give 
pure protein for carbohydrate analysis. 
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The affinity of fibronectin for gelatin allowed the isolation of relatively pure 
fibronectin in the first step of purification. The washing steps of the Prosep- 
gelatin affinity column with IM NaCl and IM urea in PBS were useful to 
remove some other minor contaminants such as tenascin. 4M urea was 
sufficient to elute fibronectin from the Prosep-gelatin affinity column. 
Interestingly, tenascin was found to contaminate and interact with 
fibronectin bound to Prosep-gelatin and was detected during the 1M urea 
wash of Prosep-gelatin affinity column. Although the binding of tenascin to 
fibronectin has been described before (Yamada, K. M, 1991) this 
phenomenon has also been recognised in the purification of these 
compounds. It is possible that this interaction between tenascin and 
fibronectin might be important in the assembly of the extracellular matrix, 
and in the functions of these two glycoproteins. 
Fibronectin was further purified by gel filtration chromatography which 
separates molecules according to size. Fibronectin was eluted in the void 
volume (5-7 ml fractions) of a Superose 12 size column because of high (440 
kDa) native molecular weight. The purified fibronectin from conditioned 
medium of both TS and control cell lines showed a single broad band with 
approximate molecular weight of 230 000 (denatured) on SDS PAGE as 
seen in Figures 3.7,3.8, and 3.9. The purified fibronectin from TS and 
control fibroblasts was then ready for further carbohydrate and amino acid 
analysis. 
Generally speaking, the purification of cellular fibronectin from conditioned 
medium requires intricate and extensive cell culture work because of the 
lower expression of this protein than of plasma fibronectin. Storage of 
fibronectin can sometimes be a problem because of its insolubility at neutral 
pH after purification, particularly during the lyophilisation procedure, and 
sensitivity of fibronectin to proteolysis. The dissolution of fibronectin was 
achieved by using cyclohexylaminopropanesulfonic (CAPS) buffer, pH 11, 
and protection from proteolysis using PMSF and EDTA. The solution was 
stored at 
-800 C in plastic vials for further analysis. 
In this thesis, the expression of laminin and tenascin in addition to 
fibronectin by TS and control skin fibroblasts was investigated by ELISA, 
immunofluorescence, and flow cytometry techniques, these results are 
discussed later. This chapter has demonstrated the synthesis and secretion 
of tenascin and laminin into cell culture medium in addition to fibronectin by 
TS and control skin fibroblasts. Seperation of these proteins was achieved 
by ammonium sulphate precipitation, gelatin-agarose affinity 
chromatography and Mono-Q anion exchange chromatography techniques. 
Expression of laminin by fibroblasts was particularly important for this 
research as there are contrary indications in previous published scientific 
papers about its expression by fibroblasts (Timpi et al., 1982, Woodley et al., 
1988, and Cooper et al., 1993). 
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Chapter 4 
Chapter 4 
Carbohydrate and Amino Acid Analysis of 
Purified Fibronectin From Conditioned Medium of 
TS and Control Fibroblasts 
4.1 Introduction 
The fibronectins are large, multifunctional glycoproteins found in the plasma 
and extracellular matrix. Fibronectin variants isolated from plasma, cultured 
cells, or tissues have been reported to differ from each other with respect to 
their carbohydrate content. Fibronectin contains 4-9% carbohydrate, 
depending on the tissue or cell origin (Petersen et al., 1989). The fibronectin 
from adult human skin fibroblasts has a low carbohydrate content, whereas 
fibronectin derived from tumor cells has a higher content (Ruoslahti, 1988). 
Fibroblast-derived fibronectin contains fucose linked to the innermost N- 
acetylglucosamine, and its sialic acid is linked a2-3 to galactose, whereas 
plasma fibronectin lacks fucose and its sialic acid is a2-6 linked (Fukuda et 
al., 1982). Human amniotic fluid fibronectin has a higher carbohydrate 
content (6-10%) than plasma or fibroblasts fibronectins from various species 
including human (Ruoslahti et al., 1981). Fibronectin glycosylation mainly 
consists of complex type oligosaccharides linked to asparaginyl residues. 
This chapter focuses on the carbohydrate analysis and characterisation of 
peptides of purified cellular fibronectin from conditioned medium of cultured 
fibroblasts derived from patients with tuberous sclerosis (TS) and normal 
individuals. 
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4.2 Monosaccharide Analysis of Purified Fibronectin 
Samples 
4.2.1 Preparation of Samples for Monosaccharide Analysis 
As described and demonstrated in chapter 3, fibronectin was purified from 
conditioned medium of established fibroblasts from patients with TS and 
normal human skin explants. The purity of each fibronectin sample was 
established by SDS-PAGE as demonstrated in Figures 3.6,3.7, and 3.8 of 
chapter 3. Glycosylation of the purified fibronectin was confirmed using a 
Dig-Glycan detection kit (Boehringer) on blotted membranes (see Fig. 4.1). 
The pure fibronectin samples were de-salted using Sephadex G-25m columns 
(PD-10-Pharmacia) and concentrated in a freeze dryer prior to carbohydrate 
analysis. Lyophilised samples were dissolved in nanopure water (100-200µl) 
and the amounts of fibronectin present were measured by ELISA. Aliquots 
(25-100µg) of the purified fibronectin were subjected to acid hydrolysis in 
2M trifluoroacetic acid (TFA) at 1000 C for 5 hours to release the neutral 
sugars, and 50mM TFA at 800 C for 1 hour to release sialic acid (N- 
acetylneuraminic acid, Neu5Ac). Monosaccharides were separated by high 
pH anion-exchange chromatography (HPAEC) using a Carbopac PA 100 
column eluted with a 50-150 mM sodium acetate gradient in 100 mM NaOH 
for sialic acid (Neu5Ac), and 17 mM isocratic NaOH for neutral sugars as 
described previously (section 2.3.9.3). Separated monosaccharides were 
detected by a pulsed amperometric detector (PAD). 
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Figure 4.1. The figure shows glycan detection of purified fibronectin from 
conditioned medium of TSFL-fibroblasts established from neck fibroma of a TS 
patient. 12µg of fibronectin sample mixed with sample buffer containing SDS and 
mercaptoethanol was separated by 5% SDS-PAGE, the gel was blotted onto 
nitrocellulose, and the fibronectin was detected with a DIG-Glycan Detection Kit 
(Boehringer). 
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4.2.2 Analysis of Monosaccharides of Fibronectin by HPAEC-PAD 
Neutral monosaccharides of fibronectin were analysed according to the 
method described (see section 2.3.9.3). A standard mixture of 
monosaccharides containing fucose, galactosamine, glucosamine, galactose, 
glucose and mannose was used with each at a concentration of lnanomole. 
The retention times and integrals of the individual peaks of the standard 
monosaccharide mixture were used for identification and quantitation of 
monosaccharides in the unknowns. Glucose is a common contaminant of 
the samples and is therefore not included in the analyses. Typical elution 
profiles and retention times of standard plasma fibronectin monosaccharides 
(2M trifluoroacetic acid (TFA) hydrolysate), and a standard mixture of 
monosaccharides are given in Figures 4.2-a and 4.2-b respectively. 
Monosaccharide analysis of 2M TFA hydrolysate of purified cellular 
fibronectin from conditioned medium of TS fibroblasts, and standard mixture 
of monosaccharides with their typical retention times are shown in Figures 
4.3-a and 4.3-b. 
The monosaccharides eluted from each sample were identified by comparing 
their retention times with the mixture of standards, containing lnmole each 
of fucose (Fuc), galactosamine (Ga1N), glucosamine (G1cN), galactose (Gal), 
glucose (Glc), and mannose (Man). The standards used for such 
comparisons were treated in the same way as the unknowns during the 
sample preparation. 
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Figure 4.2. Elution profiles from HPAEC-PAD monosaccharide analysis. 
(A) Monosaccharide analysis of TFA hydrolysate of 30µg human plasma 
fibronectin. (B) A standard solution containing lnanomole each of fucose, 
galactosamine, glucosamine, galactose, glucose, and mannose. Peaks with similar 
retention times to standard monosaccharide are annotated. 
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Figure 4.3. Elution profiles from HPAEC-PAD monosaccharide analysis of cellular 
fibronectin. (A) Purified fibronectin from conditioned medium of cultured skin 
fibroblasts established from neck fibroma of a TS patient. (B) A standard solution 
containing inmol each of fucose, galactosamine, glucosamine, galactose, glucose, 
and mannose. Peaks with similar retention times to standard monosaccharide are 
annotated. 
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4.2.3 Sialic Acid (N-Acetylneuraminic Acid) Analysis of purified 
fibronectin 
The sialic acids, which are often the terminal monosaccharides of animal 
oligosaccharides, are a family of 9-carbon carboxylated sugars (Varki, 1992). 
There are many different types of sialic acids occurring in nature. In 
fibronectin, the most common form is called N-acetylneuraminic acid 
(Neu5Ac). 
Purified fibronectin samples from conditioned medium of both established 
fibroblasts from patients with TS and normal human skin explants were 
prepared for sialic acid analysis as described in section 4.2.1. Sialic acids, 
principally Neu5Ac, were analysed using HPAEC-PAD with a sodium 
acetate gradient elution system. In this system standard N- 
glycolylneuraminic acid has a retention time of 15 minutes compared with 
that of 8 minutes for Neu5Ac. 
Typical elution profiles and retention times for standard plasma fibronectin, 
and standard Neu5Ac are given in Figure 4.4-A and 4.4-B respectively. 
Neu5Ac analysis of 50mM trifluoroacetic acid (TFA) hydrolysate of purified 
cellular fibronectin from conditioned medium of TS fibroblasts, and standard 
Neu5Ac with their typical retention times are also shown in Figures 4.5-A 
and 4.5-B. N-Acetylneuraminic acid in the cellular fibronectin samples was 
identified by its retention time compared to that of the standard Neu5Ac. 
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Figure 4.4. Elution profiles from HPAEC-PAD N-Acetylneuraminic acid (Neu5Ac) 
analysis. A) Monosaccharide analysis of a 50mM TFA hydrolysate of 25µg human 
plasma fibronectin and B) a standard solution containing 250ng Neu5Ac run on the 
SA3-H gradient described in chapter 2 (section 2.3.9.3). Retention times of the 
Neu5Ac peaks were A) 7.58, B) 8.00 minutes. The peak with similar retention time 
to standard Neu5Ac is annotated. 
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Figure 4.5. Elution profiles from HPAEC-PAD N-Acetylneuraminic acid (Neu5Ac) 
analysis. A) Purified fibronectin from conditioned medium of cultured skin 
fibroblasts established from a neck fibroma of a TS patient. and B) a standard 
solution containing lnanomole of Neu5Ac run on the SA3-H gradient described in 
chapter 2 (section 2.3.9.3). Retention times of the NeuSAc peaks were A) 8.37, B) 
8.41 minutes. The peak with a similar retention time to standard Neu5Ac is 
annotated. 
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In summary, Figures 4.2,4.3,4.4 and 4.5 show that the carbohydrate 
portion of the fibronectin molecule is made up of galactose, mannose, 
glucosamine, galactosamine, sialic acid, and fucose. As noted earlier, 
fibroblast-derived fibronectin contains fucose linked to the innermost N- 
acetylglucosamine, and its sialic acid is linked a2-3 to galactose, whereas 
plasma fibronectin lacks fucose as seen in Figure 4.2, and its sialic acid is a2- 
6 linked. 
Monosaccharide (neutral and amino sugars) composition was determined by 
HPAEC-PAD after 2M trifluoroacetic acid (TFA) hydrolysis of purified 
cellular fibronectin from conditioned medium of TS and control skin 
fibroblasts. Two different purifications of fibronectin from conditioned 
medium of normal (Jpa), and three established fibroblast lines (TSFL, TSHS, 
and TSAH) from the skin of three different TS patients were analysed and 
the results are presented in Table 4.1. The three established TS fibroblast 
lines were derived from neck fibroma (TSFL), ungual fibroma (TSHS), and 
unaffected skin (TSAH) of different patients (see section 2.3.1.1 for details of 
these fibroblasts). The carbohydrate composition of plasma fibronectin was 
also analysed in duplicate and presented in Table 4.1. 
In another analysis, sialic acid (Neu5Ac) was released from purified 
fibronectin samples in 50mM TFA for l hour at 800C and separated by 
HPAEC-PAD using a Carbopac PA100 column. The results of the sialic acid 
analysis from two independent purifications of fibronectin from conditioned 
medium of three different TS (TSFL, TSHS, and TSAH) and control 
fibroblasts (JPa) are presented in Table 4.1. 
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Figure 4.6. The figure shows comparison of the percentage glycosylation of 
purified fibronectins from conditioned medium of fibroblasts grown from normal skin 
(JPa) and fibroblasts grown from ungual fibroma (TSHS), from neck fibroma 
(TSFL) and from unaffacted skin (TSAH) of TS patients. Separately obtained sialic 
acid data were added to neutral and amino sugars to give total glycosylation. 
Variations of the % glycosylation between two independent purifications (A and B) of 
each sample were less than 5%. 
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The results presented in Table 4.1 and in Figure 4.6 establish that there are 
substantial differences between monosaccharide compositions of 
fibronectins purified from conditioned medium of fibroblasts grown from 
normal skin and fibroblasts from skin lesions, but not unaffected skin, of TS 
patients. In general, total glycosylation of purified fibronectins from skin 
lesions (ungual and neck fibromas) of TS patients was increased more than 
two-fold in comparison to control fibroblasts from normal skin. Furthermore, 
the increased concentration of sugars was general, being observed in sialic 
acid, galactosamine, glucosamine, galactose mannose and fucose of 
fibronectin purified from fibroblasts of neck and ungual fibromas of patients 
with TS. The ratios of these sugars were two to three fold (depending on the 
sugar) increased in TS lesion-derived fibronectin samples. However, 
glycosylation of fibronectin purified from the fibroblasts of unaffected skin 
of TS patient did not change in comparison to skin lesions of TS patients and 
was at similar levels to control fibroblasts from normal skin. 
Interestingly, little N-acetylgalactosamine was detected in plasma fibronectin, 
with that being three-fold less than cellular fibronectin. However, it was 
increased one or one and half fold in fibronectins from fibroblasts of ungual 
and neck fibromas of TS patients respectively in comparison to control 
fibronectin. N-acetylgalactosamine was also detected in plasma and 
amniotic fluid fibronectins by other researchers (Pande et al., 1981, Ruoslahti 
et al., 1981). Skorstengaard et al., (1986-b) detected O-linked side chains in 
fibronectin. In addition, O-linked oligosaccharide units have also been 
identified on amniotic fluid fibronectin (Krusius et al., 1985). The presence 
of N-acetylgalactosamine could be the result of 0-glycosylation in 
fibronectin. 
It was previously reported that fucose is present in hamster cellular 
fibronectin but not in plasma fibronectin. The presence and absence of 
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fucose was one of the pieces of evidence for chemical diversity between 
cellular and plasma fibronectin (Fukuda et at., 1982). Here, the results 
presented in table 4.1 indicate that fucose (0.19%) is present in cellular 
fibronectin produced by human skin fibroblasts (JPa) in contrast to plasma 
fibronectin. In addition, the presence of fucose (0.18%) was also observed 
in another control fibroblasts line (DAKO) from normal skin (data not 
shown). 
Overall, monosaccharide analysis of cellular fibronectin purified from two 
different control human skin fibroblasts (JPa and DAKO) by HPAEC-PAD 
revealed that the main components of the glycan portion were mannose, 
galactose, glucosamine, galactosamine, fucose and sialic acid with less than 
3% total glycosylation. Plasma fibronectin was found to be 3.88% 
glycosylated in this investigation. Vuento et al., (1977) have previously 
reported that human plasma and cellular fibronectin contains 
-4.5% 
carbohydrate. Different methodology, incomplete TFA hydrolysis or even 
monosaccharide decomposition under acidic conditions are possible 
explanations for the lower value found in this investigation. 
Plasma fibronectin contains more sialic acid than cellular fibronectin 
produced by fibroblasts (JPa) as seen in Table 4.1. The relatively low sialic 
acid content of the latter suggests the existence of incomplete branches on 
the side chains of human cellular fibronectin. Such incomplete branches 
with terminal galactose residues are observed in the cellular fibronectin 
produced by human fibroblasts (Ledger et al., 1983) and in hamster cellular 
fibronectin (Fukuda and Hakomori, 1979). 
4.3 N-Glycanase Released Oligosaccharide Analysis of 
Fibronectin by HPAEC 
High-pH anion-exchange chromatography (HPAEC) has been used 
succesfully to analyse covalently linked carbohydrates from natural and 
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recombinant glycoproteins. HPAEC is a useful 'oligosaccharide mapping' 
method since because it gives sufficient chromatographic resolution for all 
classes of oligosaccharides found on glycoproteins, there is a high 
probability that each peak represents a single oligosaccharide structure 
(Hardy and Townsend, 1994). 
In addition to the monosaccharide analysis of fibronectin, oligosaccharide 
mapping of the cellular FN purified from TS and control fibroblasts using 
HPAEC was highly desirable. 
4.3.1 Preparation of N-linked oligosaccharides using N-Glycanase 
N-Glycanase digestion of FN to release N-linked oligosaccharides was 
carried out according to the recent method of Hardy and Townsend (1994). 
Briefly, purified FN samples (70µg/70µ1 each) from conditioned medium of 
fibroblasts grown from normal skin (Rica) and fibroblasts grown from ungual 
fibroma (TSFC) and from unaffacted skin (TSAH) of TS patients were 
concentrated using a 'Speed Vac' and dissolved in 48µl of nanopure water 
and 2µl of 5% (w/v) SDS. 150µg/ 150µl of plasma FN, 480µg/480µ1 of 
bovine fetuin and human transferrin (positive controls) were also 
concentrated and dissolved in 48µl of nanopure water and 2µl of 5% (w/v) 
SDS. All samples were denatured at 100 oC for 3 minutes and allowed to 
cool to room temperature. Then, 2.5µl of 10% (v/v) Nonidet P40 (non-ionic 
detergent), 24µl of 5x concentrated incubation buffer (phosphate; EDTA pH 
pH 7.5-8) purchased from Oxford GlycoSystems, 38.5µl nanopure water and 
5µl (7 unit/ml) N-Glycanase (Oxford GlycoSystems) were added. The total 
volume (120µl) of all samples was incubated at 37 OC for 20 hours. 
Approximately 30% of the released oligosaccharides are in an unstable 
glycosylamine form resulting in 2 peaks during HPAEC. Hence, 10 . tl of 
174mM acetic acid was added and left for 2 hours at RT; this lowers the pH 
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and converts the glycosylamine to its single reducing form (Hardy and 
Townsend, 1994). Finally, all samples (130µl) were dried using a'Speed Vac' 
and dissolved in 55µl of nanopure water. 
4.3.2 Analysis of N-Linked Oligosaccharides of Fibronectin by 
HPAEC-PAD 
Although FN from two cultures of normal cells (JPa and Rica) from three 
cultures of TS affected tissues TSFC, TSFL and TSHS and from one culture 
from TS unaffected tissue TSAH was purified there generally was insufficient 
for this analysis. In fact there was an sufficient for a preliminary experiment 
with TSFC only. Aliquots (-45µg/35µl) prepared from the fibronectins of 
TS and control fibroblasts, and a 95.5µg/35µl aliquot of plasma fibronectin 
were analysed directly by HPAEC. In addition, 305µg/35µ1 aliquots of 
fetuin and transferrin was also analysed by HPAEC. Both bovine fetuin 
with 18% glycosylation and human transferrin with 6% glycosylation are N- 
linked glycoproteins which were used as positive controls in the analyses. 
The oligosaccharide map from N-glycanase treated bovine fetuin was 
identical to the hydrazinolysis released standard from Oxford GlycoSystems 
(see Fig. 4.7). N-linked oligosaccharide finger print patterns of the plasma 
fibronectin, transferrin and disialylated biantenary standard were 
demonstrated by HPAEC as shown in Figure 4.8. HPAEC chromatograms 
of N-glycanase released oligosaccharides from TS and plasma fibronectins 
are presented in Figures 4.9-A and 4.9-B respectively. In general, the 
analyses of purified fibronectin samples from conditioned medium of 
fibroblasts grown from normal skin (Rica) and fibroblasts grown from 
unaffected skin (TSAH), and from ungual fibroma (TSFC) of TS patients was 
unsuccessful; in summary, only TSFC purified fibronectin chromatograms of 
these samples were obtained by HPAEC-PAD, and only using a high 
sensitivity scale of the program in the computer. 
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Figure 4.7. Sialyloligosaccharides from bovine fetuin analysed by HPAEC. 
Commercial preparation released by hydrazinolysis (17.5µg sugar) from Oxford 
GlycoSystems (A), and PNGase treated fetuin-350µg (B). The assignment of the 
groups of the peaks in A is based on information supplied by Oxford GlycoSystem 
accompanying the sample obtained from them. This assignment is indicated at the 
bottom of the diagram. For simplicity each group has been given a number to aid 
identification of peaks in traces from other samples. Samples were run on the 
OXALSA gradient described in chapter 2 (section 2.3.9.3). 
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Figure 4.8. A typical HPAEC-PAD chromatogram of PNGase-released 
oligosaccharides obtained from (C) human transferrin, (D) plasma fibronectin, and 
(E) disialylated biantennary standard from oxford G1ycoSystem. The numbers 
alongside peaks are explained in the legend to figure 4.7. Peak 2 indicates the 
presumed position of asialoglycan. Samples were run on the OXALSA gradient 
described in chapter 2 (section 2.3.9.3). 
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Figure 4.9. The figures show the typical HPAEC-PAD chromatograms of N- 
glycanase released oligosaccharides from purified fibronectin of TSFC-fibroblasts 
derived from ungual fibroma of a TS patient (A), and plasma fibronectin (B). The 
numbers alongside peaks are explained in the legends of figures 4.7 and 4.8. 
Samples were run on the OXALSA gradient described in chapter 2 (section 2.3.9.3). 
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Figure 4.10. Comparison of the carbohydrate structures of plasma and purified 
cellular fibronectin with two digoxigenin-labelled lectins: from Sambucus nigra 
agglutinin (SNA) and Maackia amurensis agglutinin (MAA). 7µg of the plasma 
fibronectin in lanes 1, and 5µg of purified cellular fibronectin from conditioned 
medium of normal fibroblasts (JPa) in lanes 2 were used. Fibronectin samples were 
mixed with sample buffer containing SDS and mercaptoethanol and separated by 5% 
SDS-PAGE, the gel blotted on to nitrocellulose and the fibronectins were detected 
with the Glycan Differentiation Kit (Boehringer). SNA recognizes sialic acid linked 
a(2-6) to galactose. MAA recognizes sialic acid linked a(2-3) to galactose. 
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Figure 4.11. Structural assignment of oligosaccharide peaks appearing in figures 
4.8 and 4.9. Major peak 4 represents di-sialylated oligosaccharides in which X1 and 
X2 would be sialic acid residues. Major peak 3 represents mono-sialylated 
oligosaccharides in which X1 or X2 would be sialic acid residue. Major peak 2 
represents asialylated oligosaccharides in which no sialic acid residues occur in the 
positions of X1 and X2. 
PNGase treatment of plasma and TSFC purified fibronectin and other 
glycoproteins resulted in the successful release of N-glycosides. These were 
visualised as peaks on the HPAEC chromatograms as seen in Figures 4.7, 
4.8 and 4.9. The oligosaccharide map from PNGase treated bovine fetuin 
was identical to hydrazinolysis released standard (see Figure 4.7). 
Oligosaccharides from human plasma fibronectin eluted as 3 sharp peaks. 
The main one (see peak D4 with retention time -42min) coincided with the 
biantenary, disialylated complex-type oligosaccharides from transferrin (C4) 
and fetuin (A4; B4) as well as the standard from Oxford GlycoSystems (E4) 
which represents these structures as demonstrated in Figure 4.11. 
Therefore, X1 and X2 in Figure 4.11 would be sialic acid residues in plasma 
fibronectin and purified cellular fibronectin from TSFC fibroblasts. Peak D3 
eluted in the same position as C3, B3, and A3 which in the latter case was 
identified as monosialylated glycan with the monosialylated derivative of 
peak 4. Peak D2 is assumed to be the asialooligosaccharide derivatives, as 
peaks Al and B1 represents free sialic acid. Oligosaccharides of plasma 
fibronectin and TSFC purified fibronectin appeared basically as mono and 
disialylated biantenary structures (see Fig. 4.9). 
Figure 4.10 showed that sialic acid linked to galactose with a linkage a(2-6) 
in plasma, and a(2-3) in cellular fibronectins. However, monosialylated 
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oligosaccharides in TSFC purified cellular fibronectin appeared more 
prominent than in plasma fibronectin. As described before, the presence of 
fucose in purified cellular fibronectins of TS and normal fibroblasts is also 
another difference from plasma fibronectin carbohydrate structure. 
4.4 Cellular Fibronectin Purified from TS Skin Fibroblasts 
Does Not Express HNK-1 Carbohydrate Epitope 
The L2 and HNK-1 (anti-Leu-7) monoclonal antibodies recognise an unusual 
carbohydrate structure which is expressed on glycolipids, glycoproteins and 
proteoglycans in the peripheral and central nervous system. It has been 
reported that a sulphated, glucuronic acid-containing carbohydrate structure 
is a marker for neural cell adhesion molecules involved in cell-cell and cell- 
substrate interactions during neural development (Kruse et al., 1984,1985; 
Gowda et al., 1989: Chou et al., 1986; Schachner, 1989). Expression of the 
HNK-1 carbohydrate epitope in tumors of neuroectodermal origin has been 
reported by Harper et al., (1990). These workers showed that a human 
neuroectoderm-derived cell line secretes fibronectin that shares the HNK-1 
carbohydrate epitope with neural cell adhesion molecules. Preliminary 
experiments in our laboratory (Ellis private communication) suggested 
fibronectin from TS patients may also carry this epitope. For these reasons 
the expression of this epitope on fibronectin produced by cells grown from 
skin and skin lesions of TS patients was also investigated. Fibronectin was 
purified from the conditioned medium of TS and normal cells by affinity 
chromatography on Prosep-gelatin, and gel filtration chromatography 
techniques. Fibronectin samples mixed with sample buffer containing 
mercaptoethanol and SDS were resolved by 5% SDS-PAGE and western 
blotted. The blot was probed with mouse monoclonal HNK-I (anti-Leu 7) 
antibody for antigen detection as described in 2.2.8.1. An extract of normal 
human brain tissue was also subjected to 5% SDS-PAGE and western- 
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blotting. Although anti-Leu 7 was positive on the brain extracts, we did not 
observe any reactivity on the blot even when the most sensitive methods 
such as enhanced chemiluminescence (ECL) were used for the detection of 
this antigen. The expression of this epitope was also checked on several TS 
and control fibroblasts by immunofluorescence staining with 1/25 dilution of 
mouse monoclonal anti-Leu 7 antibody. There was no staining of these cell 
lines (data not shown). These negative results suggest that the HNK-1 
carbohydrate epitope is not expressed by TS and normal skin fibroblasts and 
their product fibronectin. 
4.5 Amino Acid Analysis of Purified Fibronectin 
4.5.1 Analysis of Amino Acids by Amino Acid Analyser 
As described before (section 2.3.11), standard plasma and cellular fibronectin, 
and purified fibronectin samples from the collected medium of fibroblasts 
from patient with TS and normal individuals were resolved by 5% SDS- 
PAGE. Proteins on the gel were blotted onto polyvinylidene difluoride 
(PVDF) membrane (millipore) with a semi-dry blotting apparatus using 10mM 
CAPS buffer, 3-[cyclohexylamino-l-propanesulfonic acid] pH 11 for 1 hour. 
In this analysis, CAPS buffer was used to facilitate transfer of proteins 
(standard transfer buffer contains glycine which would complicate amino 
acid analysis) on to PVDF. Fibronectin bands were excised from the PVDF 
membrane after amido black staining as described in section 2.3.12, and then 
amino acid analysis of fibronectin was carried out using an Applied 
Biosystems model 420H automated amino acid analysis system. Hydrolysis 
with 6M hydrochloric acid at 200 oC and subsequent pre-column 
derivatisation were carried out automatically. Amino acids were idendified 
and quantitated against known standards. The results obtained from the 
amino acid analysis are shown in Table 4.2. 
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Cell FN Pl. FN TSJH- TSFL- TSAH- JPa- St. Cell. 
- 
Vuento Vuento St. P1. 
- Amino FN FN FN FN FN et. al. et. al. FN 
acid p*** p** p** p** c*** (1977) (1977) c*** 
E--Glu 11.77 14.47 16.25 15.58 12.51 11.63 11.78 13.57 
G--Gly 12.41 9.12 12.01 11.81 10.20 8.85 8.27 10.02 
ID--Asp 
10.5 9.65 10.95 10.45 10.49 9.52 10.08 9.18 
S--Ser 7.89 8.19 8.99 9.79 9.14 8.33 8.55 6.80 
T--Thr 8.23 10.75 8.52 8.44 10.00 8.42 10.42 8.55 
V--Val 6.49 8.34 6.53 6.45 7.44 6.16 6.01 10.19 
R--Arg 6.09 5.24 6.42 5.95 6.11 4.51 4.48 5.48 
P--Pro 8.92 8.32 5.39 5.63 6.35 8.46 7.01 6.62 
A--Ala 5.49 5.17 5.25 5.37 4.96 4.93 5.10 5.55 
L--Leu 5.4 6.12 4.88 5.43 5.68 5.52 6.17 6.97 
{--Lys 3.46 2.25 3.66 3.40 3.79 5.13 4.35 3.39 
(--Tyr 3.94 3.80 3.36 3.17 3.94 4.21 4.34 3.71 
--Ile 3.2 4.16 3.07 3.33 3.64 3.56 3.12 4.61 
--Phe 2.32 2.00 1.59 1.79 2.15 2.54 2.56 2.13 
1--Met 2.00 0.90 1.34 1.67 1.53 0.86 1.09 1.45 
[--His 1.89 1.55 1.82 1.77 2.07 1.96 1.80 1.78 
Table 4.2. Amino acid compositions (mol %) of human cellular fibronectins purified (p) 
from conditioned medium of fibroblasts (JPa) grown from normal skin, and fibroblasts 
grown from the skin (TSJH: forehead plaque (lesion), TSFL: neck fibroma, and TSAH: 
unaffected skin) of different TS patients. Commercial (c) plasma and cellular fibronectins 
purchased from Gibco were analysed as controls. Values for composition are given as the 
mean of determinations from three (***) or two (**) independent samples, and expressed 
as mole percentage. Variations within these independently prepared samples were usually 
within ± 10%. 
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In general, the amino acid composition of the purified fibronectin from 
normal fibroblasts (JPa) was very similar to that of purified fibronectins from 
TS fibroblasts as well as standard plasma (pFN) and cellular fibronectin (cFN) 
(Table 4.2). However, small consistent differences (between TS affected 
tissue and normal or unaffected tissue) were observed in serine and proline 
but significance of these changes is not clear. In addition, the amino acid 
composition of fibronectin showed close agreement between our results and 
Vuento et al., (1977) as expected. 
4.6 Amino Acid Sequence of Fibronectin 
In the first attempt, unsuccesful sequencing of excised fibronectin bands 
from PVDF membrane showed that fibronectin was N-terminally blocked. In 
the literature, it has been indicated that the amino terminus of the plasma 
protein from different sources is blocked by pyroglutamic acid (Furie and 
Rifkin, 1980), thus preventing direct sequence determination. Therefore, it 
was necessary to cleave the fibronectin into fragments to make available an 
internal sequence. The original plan was to develop the proteolytic 
digestion procedure on human plasma fibronectin since more of this was 
available. As can be seen from the following this worked well. 
Unfortunately there was never sufficient purified fibronectin from cultured 
cells to complete this aspect of work. 
Plasma fibronectin was digested with chymotrypsin as described in section 
2.3.13 (see Fig. 4.12-a and 
-b), and the digest were applied to Prosep-gelatin 
to purify the gelatin-binding domain of fibronectin (Fig. 4.13). Amino- 
terminal protein sequencing (Edman degradation) of the purified gelatin- 
binding domain of fibronectin was determined using an Applied Biosystems 
model 473A automated protein sequencer. Data was collected and analysed 
using 610A data analysis software (Applied Biosystems, Foster City, 
California). 
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Figure 4.12. SDS-PAGE analysis of plasma fibronectin chymotryptic fragments. 
Lane I: reduced plasma fibronectin before chymotrypsin digestion, Lanes 2-5 
fibronectin proteolytic fragments (In lane 2, fibronectin was digested with 
chymotrypsin in 0.05 M Tris, 0.15 M NaCl, and 0.01M CaC12, in lanes 3-5, 
fibronectin was digested with chymotrypsin in 0.05 M Tris, 0.15 M NaCl, and 
0.02M MgC12). Lane 6: pre-stained molecular weight standards (125 kDa, 94 kDa, 
71.5 kDa, 51 kDa and 4lkDa) A) Coomassie staining of 7.5% SDS-PAGE,. B) 
Antibody staining (Anti-FN) as for A. 
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Figure 4.13. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of purified 
plasma fibronectin chymotryptic gelatin-binding fragments. Coomassie staining of 
the 10% SDS-PAGE: Lane 1: 45 kDa standard gelatin-binding domain (Gibco), lane 
2 purified chymotryptic gelatin-binding fragments using Prosep-gelatin column, lane 
3: pre-stained molecular weight standards (125 kDa, 94 kDa, 71.5 kDa, 51 kDa and 
4lkDa). A similar gel to above was blotted, and the major band in the middle of the 
lane 2 was excised from PVDF membrane after amido black staining, then sequenced 
for five amino acid residue using an Applied Biosystems model 473A automated 
protein sequencer. 
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Figure 4.14. N-terminal amino acid sequencing of human plasma fibronectin 
gelatin-binding chymotryptic fragment. 
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As indicated before, the gelatin-binding domain of plasma fibronectin was 
not blocked and was sequenced successfully following the process shown 
in Table 4.14. Plasma fibronectin was digested with chymotrypsin as shown 
in Figure 4.12-a and 
-b, and the digest was applied to Prosep-gelatin to 
purify gelatin-binding domain of fibronectin as seen the result in Figure 
4.13. Amino-terminal protein sequencing (Edman degradation) of purified 
gelatin-binding domain of fibronectin was determined. The results of 
sequence analysis showed the N-terminal sequence glutamine-proline- 
glutamine-proline-histidine (Q-P-Q-P-H) in the 45 kDa collagen-binding 
domain. These five residues were compared to the sequence of plasma 
fibronectin reported by Petersen et al., (1989), and found to be equivalent to 
amino acid residues 264-268. 
It was also demonstrated that the purified gelatin-binding domain (Figure 
4.13) carries many but not all of the carbohydrate side chains of the 
fibronectin as judged by using digoxigenin-labelled lectins in the Glycan 
Differentiation Kit-Boehringer (results not shown). 
4.7 Effects of Plasma and Purified Cellular Fibronectins on 
Cell Morphology and Spreading 
Cells can attach, spread, and migrate on a variety of extracellular 
glycoproteins including fibronectin. These interactions occur through 
specific cell surface receptors. Cell adhesion receptors belong to a large 
superfamily of related cell surface complexes called the integrins (for reviews 
see Ruoslahti and Pierschbacher, 1987; Hynes, 1987, Buck and Horwitz, 
1987; Hay, 1991; Bosman, 1993). Many of the adhesive glycoproteins 
contain a common tripeptide sequence (RGD) which is recognised by the 
cell surface integrins and helps bind cells to the extracellular matrix (ECM). 
The ECM plays an important role in the proliferation, differentiation and 
attachment of many cells including fibroblasts. 
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To investigate the effects of cellular fibronectins purified from conditioned 
medium of TS and control fibroblasts, and plasma fibronectin (Gibco) on 
fibroblasts, cell culture plates were coated with different concentrations of 
purified cellular and plasma fibronectins. A procedure according to 
Freshney (1992) to coat tissue culture plastic with fibronectin was used; 
i) Different concentrations of plasma and purified cellular fibronectins 
(1.5µg/cm2,3µg/cm2 and 6µg/cm2 in distilled water) were transferred into 
tissue culture multi-well plates with covers (Flow Laboratories) and were left 
to air-dry at 40 °C for 10 days. 
ii) When the fibronectin solution was dried completely in each well, all wells 
were rinsed extensively with sterile distilled water and again air dried. 
iii) Equal number (0.15x104) of normal fibroblasts (DAKO) in 3ml fresh 
medium (DMEM) containing fibronectin depleted 10% foetal calf serum and 
2mM L-glutamine were transferred to each group of wells coated with the 
plasma and cellular fibronectins from TS and normal fibroblasts. 
iv) Cells were incubated at 37 OC in a humidified incubator with 5% C02 in 
air for 48 hours. 
After 48 hours, fibroblasts were examined under the light microscope. 
Photographs of the fibroblasts were taken using a Nikon camera connected 
to the light microscope. Examples of these photographs are shown in 
Figures 4.15 and 4.16. 
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Figure 4.15. Morphological effects on normal skin fibroblasts of the purified 
fibronectins from (A) conditioned medium of normal skin fibroblasts, and (B) 
conditioned medium of TSFC-fibroblasts derived from skin lesion of a TS patient. 
Photographs were taken at 26x magnification on 3gg/cm2 fibronectin-coated plates. 
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Figure 4.16. Morphological effects on normal skin fibroblasts of the purified 
cellular fibronectin from conditioned medium of normal skin fibroblasts (A), and 
plasma fibronectin purchased from Gibco (B). Photographs were taken at 26x 
magnification on 6gg/cm2 fibronectin-coated plates. 
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134 
In the presence of plasma and cellular fibronectins, increased attachment and 
flattening of cells are both likely to be consequences of the increased 
adhesivity of the cells observed in early stages of the cell culture. In general, 
cell adhesion and spreading was promoted in all fibronectin coated cell 
culture plates after 48 hours. 
Interestingly, altered morphology and less confluence were observed in 
normal fibroblasts cultured on the purified fibronectin (3µg/cm2 and 
6µg/cm2) from conditioned medium of fibroblasts derived from skin lesion of 
a TS patient. The appearance of the normal fibroblasts was often changed 
and cells became larger and expanded on the TS derived cellular fibronectin 
(Fig. 4.15-B). Altered morphology and reduced proliferation of fibroblasts 
grown on the TS derived cellular fibronectin may be the result of the 
increased glycosylation of fibronectin derived from fibroblasts of TS skin 
lesions. The morphology of the cells was normal, well established, and the 
cell culture plates were nearly confluent on the cultured normal cellular 
fibronectin purified from conditioned medium of normal skin fibroblasts 
(Figures 4.15-a and 4.16-a). In plasma fibronectin coated cell culture plates 
at all concentrations, the morphology of the cells was normal, however, 
plates were more confluent than TS-derived fibronectin coated plates, but 
were less confluent than normal cellular fibronectin coated plates (Figure 
4.16-B). Moreover, plasma and cellular fibronectins at all concentrations 
(1.5µg/cm2,3µg/cm2 and 6µg/cm2) were equally active in promoting cell 
attachment. However, cellular fibronectin from normal fibroblasts appeared 
more active in promoting the spreading of fibroblasts than plasma 
fibronectin, and this is consistent with the literature (Yamada and Olden, 
1978). Overall, these results suggest that all fibronectins (plasma and 
cellular) were equally active in promoting cell attachment. However, these 
fibronectins, especially the TS derived cellular fibronectin, were not equally 
active in promotion of the normal cell morphology and confluency. 
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4.8 Discussion 
In summary, the results of the carbohydrate analysis and characterisation of 
peptides of purified fibronectin from conditioned medium of TS and normal 
fibroblasts are presented in this chapter. 
Analysis of purified fibronectin samples by high pH anion-exchange 
chromatography (HPAEC-PAD) revealed that the carbohydrate portion of 
the fibronectin molecule was made up of galactose, mannose, glucosamine, 
galactosamine, sialic acid and fucose. Oligosaccharides of TSFC-purified 
fibronectin from fibroblasts of TS skin lesion and plasma fibronectin 
appeared basically as mono and disialyted biantenary structures respectively 
(Fig. 4.9). The major type of side chain in fibronectin glycosylation is of the 
biantennary complex asparagine-linked type (Fig. 4.11). As expected, 
fucose was not detected in human plasma fibronectin. Fucose was also not 
detected in hamster plasma fibronectin by other researchers (Fukuda et at., 
1982). In human plasma and fibroblasts derived cellular fibronectin, the most 
common form of sialic acid was found to be N-acetyl neuraminic acid. 
Nevertheless, the sialic is N-glycolyl neuraminic acid in hamster plasma 
fibronectin according to Fukuda and colleagues (1982). 
Moreover, there was altered monosaccharide composition of fibronectin 
purified from conditioned medium of fibroblasts grown from skin lesions of 
different TS patients in comparison to carbohydrates of fibronectin derived 
from normal fibroblasts. An increased concentration of sugars was observed 
in sialic acid, galactosamine, glucosamine, galactose and mannose of purified 
fibronectin from neck and ungual fibromas of patients with TS. The total 
increase of carbohydrates of TS fibroblasts fibronectin was more than two 
fold in comparison to normal fibroblasts-derived fibronectin. 
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Interestingly, more galactosamine was detected in cellular fibronectin of TS 
and normal fibroblasts than in human plasma fibronectin. This suggests the 
occurence of the 0-glycosylation in fibronectin, as it was also detected by 
Skorstengaard et al., (1986-b). Carter and Hakomori (1979) and Fukuda and 
Hakomori (1979) have also reported the presence of some galactosamine 
associated with hamster cellular fibronectin. 
In this thesis, the results of the purified cellular fibronectin glycosylation 
represent a more detailed study than preliminary observations in this 
laboratory. Earlier, Ellis and Hemming (1990) reported the increased 
glycosylation of the fibronectin on the metabolically labelled (glucosamine 
and mannose incorporation) cultured fibroblast derived glycoproteins using 
SDS-PAGE. In the more extensive study presented in this thesis, only 
fibroblasts from skin lesions but not unaffected skin of TS patients showed 
an increased glycosylation of purified cellular fibronectin in comparison to 
normal skin fibroblasts. 
Several oligosaccharide-dependent functional alterations of fibronectin have 
previously been described. It was shown that glycosylation can modulate 
the interaction of fibronectin with collagen and with the cell membrane. 
Jones et al. (1986) compared glycosylated and non-glycosylated human 
skin fibroblast fibronectins and found that the deglycosylated form had an 
increased affinity for gelatin and enhanced adhesion-promoting properties. 
An important function of the carbohydrate moieties of the fibronectin is also 
protection of the protein from proteolytic attack. Bernard and colleagues 
demonstrated that the heavily glycosylated collagen-binding domain of 
chick embryo fibroblast fibronectin was selectively resistant to a broad 
variety of proteases (Bernard et al., 1982). 
Harper et al., (1990) previously reported that human tumors of 
neuroectodermal origin secrete fibronectin that contains the cell-adhesion- 
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related HIN-1 epitope. In this study, the glycoproteins including fibronectin 
derived from TS skin fibroblasts and normal fibroblasts were found not to 
express the HNK-1 carbohydrate epitope. This result is not surprising, 
because the epitope was reported to be a marker for neural cell adhesion 
molecules involved in cell-cell and and cell substrate interactions during 
neural development. 
Since fibronectin glycosylation is involved in promotion of fibroblasts 
adhesion and spreading, and playing significant roles in the extracellular 
matrix (ECM), the abnormal glycosylation of fibronectin found in skin 
lesions of TS patients may effect the cell-cell adhesion and cell-ECM 
interaction during the early and later embryonic development. 
In general, the amino acid composition of the purified fibronectin from 
normal fibroblasts (JPa) was very similar to that of purified fibronectins from 
TS fibroblasts as well as standard plasma (pFN) and cellular fibronectin (cFN) 
puchased from Gibco and Telios, USA, respectively (Table 4.2). Amino acid 
composition of these fibronectins was also consistent with the scientific 
literature. This suggests, as expected, no major differences in the primary 
structure of the fibronectin in TS. 
Amino acid sequencing of fibronectin purified from TS and normal 
fibroblasts was not satisfactorily completed because of the N-terminal 
blocking and low expression of these fibroblast derived cellular fibronectin. 
However, N-terminal amino acid sequencing (Edman degradation) was 
demonstrated on the purified gelatin-binding domain of chymotrypsin 
digested human plasma fibronectin. The results of sequence analysis 
showed the N-terminal sequence glutamine-proline-glutamine-proline- 
histidine (Q-P-Q-P-H) in the 45 kDa collagen-binding domain. It was also 
found that the purified gelatin-binding domain carries many but not all of the 
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carbohydrate side chains of the fibronectin as judged by using digoxigenin- 
labelled lectins in the Glycan Differentiation Kit (Boehringer). 
To investigate the effects of cellular fibronectins purified from conditioned 
medium of TS and control fibroblasts, and plasma fibronectin (Gibco) on 
fibroblasts, cell culture plates were coated with different concentrations of 
purified cellular and plasma fibronectins. Adhesion of fibroblasts was 
promoted in all concentrations of plasma and TS derived cellular fibronectin 
coated cell culture plates. 
Interestingly, altered morphology and less confluence were observed in the 
culture plates coated with cellular fibronectin derived from TS skin lesions. 
This altered morphology may be the consequence of the effects of altered 
(increased) glycosylation of the fibronectin as a ECM macromolecule. The 
appearance of the fibroblasts was very similar (and normal) on the cultured 
plates coated with plasma, and normal cellular fibronectin derived from 
normal skin. However, cellular fibronectin coated fibroblast cultures were 
more confluent than plasma fibronectin coated culture plates. This indicated 
that cellular fibronectin is more active than plasma fibronectin in the 
promotion of the cell spreading, proliferation and morphology. 
In general, these results suggest that such changes in ECM composition and 
organisation may have profound effects on cell spreading, adhesion, 
proliferation, cell shape and behaviour during the early embryonic 
development. However, the possible consequences of these effects in 
relation to TS will be discussed in detail in chapter 6. 
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Chapter 5 
Chapter 5 
Expression of Adhesive Glycoproteins 
Fibronectin, Tenascin and Laminin by Cultures of 
Skin Fibroblasts From Patients With 
Tuberous Sclerosis 
5.1 Introduction 
Cells in connective tissues are embedded in an intricate extracellular matrix 
that not only binds cells and tissues together but also influences the 
development, polarity, and behavior of the cells it contacts (Alberts et al., 
1994). Fibronectin, laminin, and tenascin are examples of large adhesive 
glycoproteins in the matrix. By means of their multiple binding domains, 
such proteins help cells adhere to and become organised by the ECM. 
Many of these adhesive glycoproteins contain a common tripeptide 
sequence (RGD), which is recognised by cell surface receptors, called 
integrins. Through these links, cells influence the nature of the matrix and 
the matrix affects the physiology of the cells. Moreover, proportions and 
arrangements of these matrix components play vital roles in the construction 
and functions of the matrix. Therefore, expression of the major matrix 
glycoproteins fibronectin, laminin, and tenascin by fibroblasts may be 
important in hardening of affected tissue, particularly in most common skin 
lesions of tuberous sclerosis (TS) patients. The interrelations between cells 
and the surrounding extracellular matrix (ECM) is an important parameter in 
the degree of hardening. The macromolecules that constitute the 
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extracellular matrix are mainly secreted locally by cells in the matrix. In most 
connective tissues these macromolecules are secreted by fibroblasts which 
are the principal cells of the dermis. 
The general procedure of investigating the expression and distribution of 
extracellular matrix glycoproteins fibronectin, laminin and tenascin was as 
follows: 
I) Immunocytochemical studies on established skin fibroblasts from TS 
patients and normal individuals were carried out to determine the 
expression and localisation of the glycoproteins of both cell lines. 
II) Quantitative analysis of the three ECM glycoproteins was 
determined on TS and normal skin fibroblasts using flow cytometry 
and enzyme-linked immunosorbant assay (ELISA). 
5.2 Expression and Distribution of Fibronectin by Skin 
Fibroblasts from Patients with TS and Normal Individuals 
5.2.1 Immunofluorescence Microscopic Localisation of Fibronectin 
As described in more detail in section 2.3.10, TS and normal fibroblasts were 
cultured on glass coverslips in 24 well cell culture dishes. On the second or 
third day of cell culture, immunofluorescence (indirect) staining of fibroblasts 
was undertaken. Cells were fixed with 3.8% formaldehyde in PBS (v/v), 
1: 10 dilution, for cell surface staining. Fibronectin visualised in such cells 
was primarily extracellular. To detect intracellular fibronectin, the cells were 
fixed with 3.8% formaldehyde and made permeable with Triton X-100 (0.1 % 
in PBS). Cells were rinsed three times with PBS, pH 7.4, after each of these 
steps. Then, cells were blocked with 1% bovine serum albumin in PBS (w/v) 
overnight at 4 °C. 
Next day, fibroblasts were incubated with the polyclonal antibody (rabbit 
anti-human fibronectin at 1: 50 dilution in blocking buffer) for 1 hour at 
room temperature. This primary antibody was omitted for the negative 
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control staining of fibroblasts. Cell layers were washed with PBS three 
times, and incubated for 1 hour with a fluoresceinated secondary swine anti- 
rabbit IgG antibody (at 1: 30 dilution) at room temperature in the dark. 
Finally cells were washed twice with PBS, and cover slips were mounted in 
1: 1 (v/v) PBS/glycerol solution with 8 mg/ml (w/v) 1-4 diazabicyclo-2.2.2- 
octane (DABCO) to prevent photobleaching. Cover slips were attached to 
slides using nail-varnish. Cells were examined on a Nikon microscope 
(Labophot Y2A). Photographs using Kodak EPD-200 film were taken at 
20X or 40X magnification, all with the same exposure times. 
In this study, skin samples were obtained from patients undergoing surgery. 
The following fibroblast cell lines, established from primary cultures of skin 
samples, were used for our immunocytochemical studies : 
TSFL : Skin tissue was obtained from a neck fibroma of a 13 year old male 
TS patient. 
TSAH : Unaffacted skin was obtained from the lumbo-sacral area of a 65 
year old male TS patient. 
TSFM : Skin tissue was derived from an ungual fibroma of the second 
phalanx of a 10 year old male. 
TSJH : Skin tissue was obtained from a forehead plaque (lesion) of a 14 year 
old female TS patient. 
DAKO and JPA normal skin fibroblasts derived from skin explants of 12 year 
old female and 8 year old male respectively were used as control. 
By means of immunofluorescence, we have analysed the distribution of 
cellular fibronectin in the above TS and control fibroblast cell lines. Figures 
5.1,5.2, and 5.3 show the results of indirect immunofluorescence studies of 
these cell cultures. 
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Figure 5.1. Indirect immunofluorescence localisation of cell-surface fibronectin. 
Normal JPa-skin fibroblasts (a), and ungual fibroma-derived TSFM-fibroblasts (b) 
were fixed with formaldehyde for cell-surface staining. Photographs were taken at 
40X magnification. 
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Figure 5.2. Indirect immunofluorescence localisation of intracellular fibronectin. 
Normal JPa-skin fibroblasts (a), and ungual fibroma-derived TSFM-fibroblasts (b) 
were fixed with formaldehyde and made permeable with Triton X-100. Photographs 
were taken at 40X magnification. 
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Figure 5.3. The figure shows the indirect irnmunofluorescence localisation of 
intracellular fibronectin on a large ungual fibroma-derived TSFM-fibroblast (a), and 
the fibrillar matrix of fibronectin on cultured normal JPa-fibroblasts (b). This sort of 
dense matrix (fibril network) is typical of confluent cultures of fibroblasts. 
Fibroblasts were fixed in formaldehyde and made permeable with Triton X-100 to 
visualize both fibrillar surface-associated and intracellular fibronectins. Photographs 
were taken at 40X (a), and 20X magnification (b). Note the increased fibril formation 
around the large cell derived from the skin lesion (ungual fibroma) of a TS patient (a). 
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Indirect immunofluorescence studies revealed that the distribution and 
expression of fibronectin compared to controls was only altered in TSFM 
ungual fibroma-derived skin fibroblasts of the 10 year old male TS patient. 
However, the distribution and expression of fibronectin was not changed in 
other fibroblasts derived from a forehead plaque lesion and neck fibroma of a 
14 year old female and 10 year old male TS patient respectively in 
comparison to control fibroblasts. Unaffected skin fibroblasts (TSAH) 
derived from the skin of the lumbosacral area of a TS patient also showed 
similar distribution and fluorescence intensity for fibronectin in comparison 
to normal (control) skin fibroblasts (data not shown). 
The immunofluorescence staining results in Figures 5.1,5.2, and 5.3 show 
the altered distribution of fibronectin in TSFM-fibroblasts derived from 
ungual fibroma of a TS patient in comparison to normal Ra-fibroblasts. Cell 
surface staining of ungual fibroma derived TSFM-fibroblasts with anti- 
fibronectin was markedly different than normal (control) skin fibroblasts. 
Moreover, the cell surface distribution of fibronectin was uneven and 
appeared more dense on the TSFM-fibroblasts derived from ungual fibroma 
of a TS patient, while it is evenly distrubuted on control Ra-fibroblasts (Fig. 
5.1). 
The intensity of the fluorescence of intracellular fibronectin was increased in 
the TSFM-fibroblasts derived from ungual fibroma of a TS patient in 
comparison to normal Ra-fibroblasts. Cells from an ungual fibroma of a TS 
patient appeared larger than normal fibroblasts in size. In addition, the 
fluorescence intensity was diffuse and predominantly perinuclear in both TS 
and normal skin fibroblasts (Fig. 5.2). However, the intracellular 
fluorescence was patchy and also predominantly perinuclear in large cells 
(called N-cells by others) of TS fibroblasts (Fig. 5.3). 
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In agreement with the literature (Yamada and Olden 1978; Hynes 1990), a 
fibrillar matrix of fibronectin was also observed in our normal human skin 
fibroblasts (Fig. 5.3-b). These striking fibrillar arrays were better established 
around the large TS cells derived from ungual fibroma than normal skin 
fibroblasts (compare Figures. 5.3-a and 5.2-a). The fibrillary matrix of 
fibronectin was also observed in formaldehyde-fixed confluent TS and 
normal fibroblasts (data not shown). This suggests that the fibrillary matrix 
of fibronectin is mainly cell surface associated. 
As a negative control, primary antibody (anti-fibronectin) staining was 
omitted, and fibroblasts were incubated with a fluoresceinated secondary 
swine anti-rabbit antibody (at 1: 30 dilution). There was no staining of 
secondary antibody in these negative control fibroblasts as expected (Fig. 
5.4). 
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Figure 5.4. Negative control staining of fibroblasts with only fluoresceinated 
secondary swine anti-rabbit antibody (1: 30 dilution). 
5.2.2 Quantitative Analysis of Fibronectin Expressed by TS 
and Normal Skin Fibroblasts 
5.2.2.1 Flow Cytometric Analysis of Fibronectin 
A flow cytometer can be used quantitatively to compare the fluorescence 
intensity of particles (Givan, 1992). In addition to immunofluorescence 
studies, quantitative analysis of fibronectin expression was performed using 
a Becton Dickinson FACScan in the Department of Immunology. 2000 
events were collected using the consort 30 program and standard fibroblasts 
settings. A logical fibroblasts gate was set before data analysis. F1owMATE 
(Dako) and Consort 30 (Becton Dickinson) programs as PC and FACScan 
software respectively were used to analyse the mean fluorescence intensity 
of dual labelled cells for fibronectin. 
In this thesis, the fluorescent intensity of TS and normal skin fibroblasts was 
measured and compared. In the example shown in Figure 5.5 (A) forward 
(FSC) versus side scatter (SSC) light measurements (cytogram), and (B) the 
fluorescence of fibroblasts, is displayed on the gated histogram. Using 
specific gating procedures in the computer program, a box was drawn 
around the fibroblast populations. This gate or window is used by the 
computer to select cells for accumulation of events into the fluorescence 
histogram. 
TSFL (neck fibroma), TSFM (ungual fibroma) and JPa (normal skin) 
fibroblasts were subjected to the flow cytometric analysis of fibronectin. An 
adapted flow cytometry protocol was described in detail in section 2.3.7.3. 
Figure 5.6 shows a typical photograph of the trypsinised rounded TSFM 
fibroblasts which were stained with primary (anti-fibronectin) and FITC- 
conjugated secondary antibodies, and suspended in 0.5 ml of 1% BSA/PBS 
solution just before flow cytometric analysis. 
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Figure 5.5. The figure shows the typical cytograms and histograms of flow 
cytometric analysis of fibronectin (FN). Panel A shows the forward (FSC) versus 
side scatter (SSC) cytograms (dotplots of fibronectin expression) of TS and normal 
skin fibroblasts. Panel B shows the fluorescence histograms of TS (TSFM) and 
normal skin fibroblasts (JPa). A box is drawn around the fibroblast cluster and used 
as a gate so that the fluorescence intensity of only the cells falling within this gate are 
displayed in the immunofluorescence profile shown in Panel B. For comparison, see 
panel B-1 and B-3 which represents fluorescence intensity of fibronectin of JPa and 
TSFM fibroblasts respectively. Panel B-2 represents only FITC-conjugated 
secondary (anti-rabbit) antibody staining of fibroblasts (omitting primary anti-FN) as 
negative control staining. 
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Figure 5.6. Trypsinised. fixed and permeabiliscd (A) TSFM (ungual fibroma), and 
(B) JPa (normal skin) rounded fibroblasts were stained with rabbit anti-fibronectin, 
and labelled with FITC-conjugated secondary (anti-rabbit) antibody, then suspended 
in 0.5 ml 1% BSA/PBS solution for flow cytometric analysis (see details in section 
2.3.7.3. ). Cells in suspension were cytospun and mounted in 1: 1 (v/v) PBS/glycerol 
solution with 8 mg/ml (w/v) 1-4 diazabicyclo-2.2.2-octane (DABCO) to prevent 
photobleaching. The photographs of the cells were taken at 60X magnification using 
a Bio-Rad DVC-250 Confocal laser scanning microscope in Obstetrics and 
Gynaecology Department. For comparison, note the size and fluorescence intensity 
of TSFM fibroblasts (A) and normal JPa-fibroblasts (B). 
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Quantitatively, the fluorescence intensity of 2000 TS (TSFM and TSFL) and 
normal skin fibroblast (JPa) populations for fibronectin was measured as 
mean using a Becton Dickinson FACScan in the Department of 
Immunology. Figure 5.5 shows that TSFM fibroblasts derived from an 
ungual fibroma have more dense staining of fibronectin than normal JPa skin 
fibroblasts. Figure 5.6 confirm this observation and suggested that the large 
cells of TSFM fibroblasts posses the more dense fibronectin staining than 
normal JPa skin-fibroblasts. As discussed earlier, the distribution of 
intracellular fibronectin was patchy and predominantly perinuclear in the 
large TS fibroblasts (Fig. 5.3). 
Previous indirect immunofluorescence studies have shown that the 
distribution and expression of fibronectin was only altered in TSFM ungual 
fibroma-derived skin fibroblasts of a 10 year old male TS patient. However, 
the distribution and expression of fibronectin was not changed in other 
fibroblasts derived from a forehead plaque lesion and neck fibroma of a 14 
year old female and 10 year old male TS patient respectively, in comparison 
to control fibroblasts. Here, flow cytometry results confirmed and 
strengthened these earlier observations quantitatively. 
The flow cytometric data of fibroblasts collected in Consort 30 program was 
gated using the F1owMATE program, and the mean (fluorescein intensity) 
was obtained quantitatively. An average mean of four analysis was used in 
Figure 5.7. In Figure 5.7 we can observe that TSFM ungual fibroma- 
derived skin fibroblasts have a higher fluorescence intensity (mean) for 
fibronectin than TSFL neck fibroma-derived and JPa normal skin fibroblasts. 
Increased expression of fibronectin was observed in both cytoplasm 
(permeabilised) and cell surface (not-permeabilised) of TSFM ungual 
fibroma-derived skin fibroblasts in contrast to TSFL and JPa fibroblasts (see 
Fig. 5.7). 
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Figure 5.7. Quantitative analysis of fibronectin expressed by normal skin (JPa), 
and TS fibroblasts (TSFM, ungual fibroma; TSFL, neck fibroma) by flow cytometry. 
Cells were trypsinised, fixed and permeabilised for cytoplasmic staining or not- 
permeabilised for cell surface staining of fibronectin as described in detail in section 
2.3.7.3. JPa, TSFM and TSFL fibroblasts were stained using primary polyclonal 
rabbit anti human fibronectin antibody and FITC-conjugated secondary (anti-rabbit) 
antibody. In control (cont. ) normal skin fibroblasts primary anti-fibronectin was 
omitted, and cells were stained only with FITC-conjugated secondary (swine anti- 
rabbit) antibody as a negative control. 2000 events from each fibroblast line were 
analysed by flow cytometry. An average mean (fluorescence intensity) of four 
different flow cytometric analysis samples was plotted in this bar graph. Variations in 
mean within four different analysis of fibronectin were within ± 4%. 
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5.2.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) for Fibroblasts 
Fibronectin Production 
ELISAs were performed to quantitate the amount of fibronectin secreted 
into the cell culture medium by TS and normal skin fibroblasts. Briefly, near 
confluent fibroblasts cultures were set up by placing lX 105 freshly 
trypsinised fibroblasts in 1 ml of Dulbecco's Modification Eagle's Medium 
(DMEM) containing 10% foetal calf serum (FCS) into 24 well microculture 
plates (2 cm2 surface area, Linbro; Flow laboratories). TS and normal skin 
fibroblasts were incubated for 24 hours at 37 °C in a humidified incubator 
with 5% C02. Medium was then removed and replaced with Imi fresh 
DMEM with 10% FCS and incubated for 72 hours. For ELISA assay of 
fibronectin, supernatant medium was removed from 24 well microculture 
plates, and 100 µl of conditioned medium and 10 µl PBS were added per well 
to 96 well microtitre plates (Costar). The cells which had secreted the 
fibronectin into the supernatant medium were harvested with trypsin and 
counted using a hemocytometer. Fibronectin standard, diluted in the range 
10 to 1lOng/110 
.d in increasing concentrations to give a standard curve, 
was also added to the first two lines of the 96 well microtitre plates. Control 
culture medium (DMEM with 10% FCS) which had been preincubated for 3 
days along with the cells were used as the control. After 4 hours at room 
temperature, the 96 wells were emptied of samples and washed twice with 
PBS, and then blocking buffer (200 µl) made of PBS, pH 7.4 with 0.5% (w/v) 
BSA and 0.05% (v/v) Tween-20 was then applied to each microtitre well 
and left overnight at 4 oC. The following day, the ELISA method was 
performed exactly as described previously in section 2.3.7.2. 
ELISA results of the fibronectin production into the cell culture medium by 
three TS (TSFL, TSFM and TSJH), and two normal skin fibroblasts (JPa and 
DAKO) is presented in Table 5.1. 
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Fibroblasts Passage Secreted Fibronectin* 
by 1X 105 cell 
ng/1OOµl medium t SD 
TSFL 12-15 15.21 ± 0.64 
TSFM 12-15 45.40 ± 0.85 
JPa 12-15 10.26 ± 0.26 
TSJH 12-15 13.01 ± 0.08 
DAKO 12-15 10.44: t 0.13 
Table 5.1. Quantitative determination of fibronectin of TS (TSFL, neck fibroma, 
TSFM, ungual fibroma and TSJH, forehead plaque) and normal skin fibroblasts (JPa 
and DAKO) detected by ELISA. *Fibronectin production was assessed by measuring 
the quantity of fibronectin in fibroblast culture medium using ELISA and is expressed 
as ng/l00µ1 medium of 0.25X105 cells t standard deviation (SD) of triplicate 
determinations. 
ELISA assay of fibronectin suggested the increased production of 
fibronectin in TSFM fibroblasts derived from ungual fibroma of a TS patient 
in comparison to normal skin fibroblasts (JPa and DAKO) and other two 
TSFL and TSJH fibroblasts derived from neck fibroma and forehead plaque 
lesions of TS patients respectively. This more than 4 fold increase of 
fibronectin in TSFM fibroblasts also confirms previous findings of 
immunofluorescence and flow cytometry experiments of fibronectin. 
Production of fibronectin in TSFL and TSJH fibroblast cultures was also 
higher nearly 50% and 30% respectively in comparison to normal JPa and 
DAKO skin fibroblasts. 
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5.3 Expression and Distribution of Tenascin by Skin 
Fibroblasts from Patients with Tuberous Sclerosis and 
Normal Individuals 
5.3.1 Immunoflourescence Microscopic Localisation of Tenascin 
In this thesis, the expression of another extracellular matrix glycoprotein, 
tenascin, was studied in two normal human skin fibroblast cell lines (DAKO, 
JPa), and in four TS skin fibroblast cell lines (TSFL, TSFM, TSJH and TSAH) 
established from tissue explants as detailed in section 2.3.1.1. 
By means of immunofluorescence, the distribution of tenascin was examined 
in the TS and normal fibroblast cell lines using polyclonal anti-tenascin. 
Figures 5.8,5.9, and 5.10 show the results of the indirect 
immunofluorescence studies of these established cell lines. The method used 
was as before, described in section 2.3.10. 
Immunofluorescence experiments showed that tenascin was visible both at 
the cell surface and in intracellular granular structures. The cell surface 
distribution of tenascin in TSFM-fibroblast derived from ungual fibroma of a 
TS patient was uneven, and appeared more dense than in normal JPa- 
fibroblasts (Fig. 5.8). The fluorescence intensity of the intracellular tenascin 
staining was uneven and perinuclear in both TS and normal skin fibroblasts 
(Fig. 5.9). 
The presence of most of the tenascin was observed mainly in the 
extracellular matrix of both TS and normal skin fibroblasts, rather than at cell 
surface or within the cells. In confluent cultures from normal and TS skin 
fibroblasts, tenascin forms a meshwork of fibrils. These meshwork occurred 
in large (diffuse) patches in TSFM-fibroblast derived from ungual fibroma of 
a TS patient, while they were more ordered (linear) fibrillar structures in 
normal JPa-fibroblasts (Fig. 5.10). 
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Figure 5.8. Indirect inununotluorescence localisation of cell-surtäce tenascin on 
TSFM-fibroblast derived from ungual fibroma of a TS patient (a), and JPa-fibroblasts 
derived from normal skin (b). Fibroblasts were fixed in formaldehyde and stained 
with a polyclonal rabbit anti-human tenascin antibody followed by a secondary 
antibody coupled to FITC. Photographs were taken at 40X magnification. 
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Figure 5.9. Indirect immunofluorescence localisation of intracellular tenascin on 
TSFM-fibroblasts derived from an ungual fibroma of a TS patient (a), and JPa- 
fibroblasts derived from normal skin (b). Both cell lines were fixed in formaldehyde 
and made permeable with Triton X-100, then stained with a polyclonal rabbit anti- 
human tenascin antibody followed by a secondary antibody (swine anti-rabbit) 
coupled to FITC. Photographs were taken at 20X magnification. 
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Figure 5.10. Indirect immunofluorescence localisation of tenascin in TSFM- 
fibroblast derived from ungual fibroma of a TS patient (a), and JPa-fibroblasts 
derived from normal skin (b). This sort of fibril network is typical of confluent 
cultures of fibroblasts. Both cell lines were fixed in formaldehyde, and stained with a 
polyclonal rabbit anti-human tenascin antibody followed by a secondary antibody 
coupled to FITC. Photographs were taken at 20X magnification. 
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Interestingly, as for fibronectin immunofluorescence studies showed that the 
distribution of tenascin was only changed in TSFM ungual fibroma-derived 
skin fibroblasts of a 10 year old male TS patient, as presented here. However, 
the distribution of tenascin was not changed in other fibroblasts (TSJH and 
TSFL) derived from a forehead plaque lesion, and a neck fibroma, of a 14 
year old female and 13 year old male respectively in comparison to control 
fibroblasts. Unaffected skin fibroblasts (TSAR) derived from skin of the 
lumbosacral area of a TS patient also showed similar distribution and 
fluorescence intensity for tenascin in comparison to normal (control) skin 
fibroblasts (data not shown). 
As a negative control, primary antibody (anti-tenascin) staining was omitted, 
and fibroblasts were incubated with a fluoresceinated secondary swine anti- 
rabbit antibody (at 1: 30 dilution). There was no staining of secondary 
antibody in these negative control fibroblasts as expected (see Fig. 5.4). 
5.3.2 Quantitative Analysis of Tenascin Expressed by TS and Normal 
Skin Fibroblasts 
5.3.2.1 Flow Cytometric Analysis of Tenascin 
In addition to immunofluorescence studies of tenascin, quantitative analysis 
of tenascin expression was performed using a Becton Dickinson FACScan in 
the Department of Immunology. 2000 events were collected using consort 
30 program and standard fibroblasts settings. A logical fibroblasts gate was 
set before data analysis. F1owMATE (Dako) and Consort 30 (Becton 
Dickinson) programs as PC and FACScan software respectively were used 
to analyse the mean fluorescence intensity of dual labelled cells for tenascin. 
The fluorescent intensity of tenascin was measured and compared on TS and 
normal skin fibroblasts as for fibronectin. In the example shown in Figure 
5.11 (A) forward (FSC) versus side scatter (SSC) light measurements 
(cytogram), and (B) the fluorescence of fibroblasts, is displayed on the gated 
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histogram. Using specific gating procedures in the computer program, a box 
was drawn around the fibroblast populations. This gate or window is used 
by the computer to select cells for accumulation of events into the 
fluorescence histogram. 
TSFL (neck fibroma), TSFM (ungual fibroma) and JPa (normal skin) 
fibroblasts were subjected to the flow cytometric analysis of tenascin. An 
adapted flow cytometry protocol was described in detail in section 2.3.7.3. 
Quantitatively, the mean fluorescence intensity of 2000 TS (TSFM and 
TSFL) and normal skin fibroblast (JPa) populations for tenascin was 
measured using a Becton Dickinson FACScan. 
The flow cytometric data of fibroblasts collected in Consort 30 program was 
gated using F1owMATE program (Fig. 5.11), and the mean (fluorescein 
intensity) was obtained quantitatively. An average mean of four analysis 
was used and shown graphically in Figure 5.12. 
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Figure 5.11. The figure shows the typical cytograms and histograms of flow 
cytometric analysis of tenascin (TN). Panel A shows the forward (FSC) versus side 
scatter (SSC) cytograms (dotplots of tenascin expression) of TS and normal skin 
fibroblasts. Panel B shows the fluorescence histograms of TS (TSFM) and normal 
skin fibroblasts (JPa). A box is drawn around the fibroblast cluster and used as a 
gate so that the fluorescence intensity of only the cells falling within this gate are 
displayed in the immunofluorescence profile shown in Panel B. For comparison, see 
panel B-1 and B-3 which represents fluorescence intensity of tenascin of JPa and 
TSFM fibroblasts respectively. Panel B-2 represents only FITC-conjugated 
secondary (anti-rabbit) antibody staining of normal JPa-fibroblasts (omitting primary 
anti-TN) as negative control staining. 
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Figure 5.12. Quantitative analysis of tenascin expressed by normal skin (Ra), and 
TS fibroblasts (TSFM, ungual fibroma; TSFL, neck fibroma) by flow cytometry. 
Cells were trypsinised, fixed, and permeabilised for cytoplasmic staining or left intact 
for cell surface staining of tenascin as described in detail in section 2.3.7.3. JPa, 
TSFM and TSFL fibroblasts were stained using primary polyclonal rabbit anti-human 
tenascin antibody and FITC-conjugated secondary (anti-rabbit) antibody. In control 
(cont. ) normal skin fibroblasts primary antibody was omitted, and cellls were stained 
only with FITC-conjugated secondary (swine anti-rabbit) antibody as a negative 
control. 2000 events from each fibroblast line were analysed by flow cytometry. An 
average mean (fluorescence intensity) of four different flow cytometric analysis 
samples was plotted in this bar graph. Variations in mean within four different 
analyses of tenascin were always within ± 5%. 
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Interestingly, similar to fibronectin expression, Figure 5.12 show that TSFM 
ungual fibroma-derived skin fibroblasts have a higher fluorescence intensity 
(mean) for tenascin than TSFL neck fibroma-derived and JPa normal skin 
fibroblasts. Increased expression of tenascin was observed in both the 
cytoplasm (permeabilised) and cell surface (not-permeabilised) of TSFM 
ungual fibroma-derived skin fibroblasts in contrast to TSFL and JPa 
fibroblasts. Earlier, immunofluorescence studies showed that the distribution 
and expression of tenascin was altered only in TSFM ungual fibroma- 
derived skin fibroblasts of 10 year old male TS patient. The distribution and 
expression of tenascin was not changed in other fibroblasts derived from a 
forehead plaque lesion and neck fibroma of a 14 year old female and 10 year 
old male TS patients respectively in comparison to control fibroblasts. Here, 
flow cytometry results confirmed quantitatively, and strengthened these 
earlier findings of immunofluorescence studies of tenascin. 
5.3.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) for Fibroblasts 
Tenascin Production 
Because of difficulties in obtaining standard tenascin commercially, ELISAs 
were performed to measure the absorbance of the tenascin secreted into the 
cell culture medium by TS and normal skin fibroblasts. As the amount of 
chromophore produced in ELISA is directly proportional to the original 
quantity of protein, absorbances of tenascin detected in conditioned medium 
would allow comparison of tenascin expression in both TS and normal skin 
fibroblasts. ELISA procedure for tenascin production was performed using 
anti-tenascin exactly as for fibronectin apart from using standard dose- 
response curves, (described in 5.2.2.2). ELISA absorbances at 405 nm were 
used to compare production of tenascin in TSFL, TSJH, TSFM and normal 
JPa and DAKO skin fibroblasts. 
ELISA absorbances of tenascin produced into the cell culture medium by 
three IS, and two normal skin fibroblasts is presented in Table 5.2. 
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Fibroblasts Passage Secreted Tenascin* 
by IX 105 cell 
absorbances/200µI medium 
± SD 
TSFL 12-15 1.194. ±: 0.014 
TSFM 12-15 1.429 ± 0.026 
TSJH 12-15 1.169 ± 0.015 
JPa 12-15 0.972 ± 0.020 
DAKO 12-15 0.931 t 0.040 
Table 5.2. Absorbances of tenascin produced into cell culture medium by TS 
(TSFL, neck fibroma, TSFM, ungual fibroma and TSJH, forehead plaque) and 
normal skin fibroblasts (JPa and DAKO) detected by ELISA. *Tenascin production 
was assessed by measuring the absorbance of tenascin in fibroblast culture medium 
using ELISA and is expressed as absorbance/200µl medium of 1X105 cells t 
standard deviation (SD) of triplicate determinations. Absorbances of control culture 
medium (DMEM with 10% FCS) which had been preincubated for 3 days along with 
the cells were subtracted from the data. 
The most significant increased absorbances of tenascin production were 
seen in TSFM fibroblasts derived from ungual fibroma of a TS patient in 
comparison to normal skin fibroblasts (JPa and DAKO) and TSFL and TSJH 
fibroblasts derived from neck fibroma and forehead plaque lesions of TS 
patients respectively. As the amount of chromophore produced in ELISA is 
directly proportional to the original quantity of protein, these increased 
absorbances of tenascin (in TSFM fibroblasts reflect the elevated production 
of tenascin in TSFM fibroblasts. This increased tenascin production into cell 
cuture medium by TSFM fibroblasts (-50% of controls) also agrees with 
previous findings of immunofluorescence and flow cytometry experiments 
on tenascin. TSFL and TSJH fibroblast cultures was also showed higher 
absorbances (-23% of controls) in comparison to normal JPa and DAKO 
skin fibroblasts. 
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5.4 Expression and Distribution of Laminin by Skin 
Fibroblasts from Patients with Tuberous Sclerosis and 
Normal Individuals 
5.4.1 Immunofluorescence Microscopic Localisation of Laminin 
In this thesis, the expression of laminin was also investigated in TS and 
normal skin fibroblasts by immunofluorescence as well as ELISA and flow 
cytometry techniques. As indicated earlier, the expression of laminin by 
fibroblasts was particularly important for this research, since there are 
contrary indications in previous published scientific papers about its 
expression by fibroblasts (Timpl et al., 1982, Woodley et al., 1988, and 
Cooper et al., 1993). In chapter 3, the synthesis and secretion of laminin by 
skin fibroblasts was shown by western blotting. 
Two normal human skin fibroblast cell lines (DAKO, JPa), and four TS skin 
fibroblast cell lines (TSFL, TSFM, TSJH and TSAH) established from tissue 
explants (see details of these cell lines in section 2.3.1.1) were used to 
analyse the distribution of laminin by means of immunofluorescence. The 
immunofluorescence method was performed using monoclonal (mouse) and 
polyclonal (rabbit) anti-human laminin antibodies followed by a secondary 
antibody coupled to FITC (see section 2.3.10). 
The results of the indirect immunofluorescence localisation of laminin are 
presented in Figures 5.13 (cell surface staining), 5.14,5.15, and 5.16 
(cytoplasmic staining) on TS and normal cell lines. 
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Figure 5.13. In, iim, t inýrýun, ýi, uýýrý"ýýn: ý lUkaliyatiom OI' ! aInInin. Acnnial J1'&" 
skin fibroblasts (a), and neck fibroma-derived TSFL-fibroblasts (b) were fixed with 
formaldehyde, and stained for cell-surface laminin with a polyclonal rabbit anti-human 
laminin antibody followed by a secondary antibody (swine anti-rabbit) coupled to 
FITC. Photographs were taken at 4OX magnification. 
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A 
E 
Figure 5.14. Indirect immunofluorescence localisation of intracellular laminin. 
Normal JPa-skin fibroblasts (a), and neck fibroma-derived TSFL-fibroblasts (b) were 
fixed with formaldehyde and made permeable with Triton X-100, and stained with a 
polyclonal rabbit anti-human laminin antibody followed by a secondary antibody 
(swine anti-rabbit) coupled to FITC. Photographs were taken at 40X magnification. 
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A 
B 
Figure 5.15. Indirect immunofluorescence localisation of intracellular larninin using 
monoclonal anti-laminin: (a) neck fibroma-derived TSFL-fibroblasts were fixed with 
formaldehyde and made permeable with Triton X-100, then stained with a monoclonal 
anti-human laminin (mouse) antibody followed by a secondary antibody (rabbit anti- 
mouse) coupled to FITC. (b) Negative control, ungual fibroma-derived TSFL- 
fibroblasts were fixed with formaldehyde and made permeable with Triton X- 100, 
and stained only with a secondary antibody (rabbit anti-mouse) coupled to FITC. 
Photographs were taken at 40X magnification. 
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A 
B 
Figure 5.16. Indirect imrnunotlu&)reScencc localisation of intracellular laminin. 
Normal skin JPa-fibroblasts (a) and normal skin DAKO-fibroblasts (b) were fixed 
with formaldehyde and made permeable with Triton X-100 then stained with a 
polyclonal rabbit anti-human laminin antibody followed by a secondary antibody 
(swine anti-rabbit) coupled to FITC. Photographs were taken at 20X magnification. 
169 
Anti-laminin staining seen suggested that laminin is synthesed in detectable 
amounts by human skin fibroblasts. In Figures 5.13 and 5.14, laminin 
staining of TS fibroblasts derived from a neck fibroma is compared with that 
of normal skin fibroblasts. The increase in the former is apparent. In normal 
JPa skin fibroblasts, cell surface staining of laminin is not uniform, and 
laminin is hardly detectable in comparison to TSFL neck fibroma derived 
fibroblasts. In TSFL fibroblasts in particular, the laminin staining appears to 
be concentrated to produce intense patches. Intracellular laminin staining is 
bright, and diffuse in the cytoplasm of large cells derived from a neck fibroma 
of a TS patient, but this was usually seen around nuclei only in normal skin 
fibroblasts (Fig. 5J6). 
Figure 5.15 confirmed more specifically the laminin synthesis by TS 
fibroblasts using monoclonal mouse anti-laminin as no staining occurred in 
control staining. Immunofluorescence stainings of two different normal 
fibroblasts (JPa and DAKO) derived from skin tissue of 8 year old male and 
12 year old female showed similar perinuclear stainings of laminin (Fig. 
5.16). 
Interestingly, altered distribution of laminin was observed at the cell surface 
and in the cytoplasm of, particularly in large cells, TSFL-derived fibroblasts 
from neck fibroma of a 13 year old male. However, changes of fibronectin 
and tenascin staining were observed in TSFM-fibroblasts derived from an 
ungual fibroma of a 10 year old male TS patient, while TSFL-fibroblasts 
showed normal fibronectin and tenascin distribution. This suggested a 
different nature of extracellular matrix appears in neck and ungual fibromas 
of TS patients 
. 
The other TSFM, TSJH, and TSAH fibroblasts derived from 
an ungual fibroma, a forehead plaque and unaffacted skin of TS patients 
respectively showed normal and similar distribution of laminin in contrast to 
TSFL-fibroblasts. As a negative control, primary antibody (anti-tenascin) 
staining was omitted, and fibroblasts were incubated with a fluoresceinated 
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secondary swine anti-rabbit antibody (at 1: 30 dilution). There was no 
staining of secondary antibody in these negative control fibroblasts as 
expected (see Fig. 5.4). 
5.4.2 Quantitative Analysis of Laminin Expressed by TS and Normal 
Skin Fibroblasts 
5.4.2.1 Flow Cytometric Analysis of Laminin 
In addition to immunofluorescence studies of laminin, quantitative analysis 
of laminin expression was also performed using a Becton Dickinson 
FACScan as described in section 5.2.2.1 for fibronectin analyses. 
The fluorescent intensity of laminin on the cytoplasma and cell surface of TS 
and normal skin fibroblasts was measured and compared as for fibronectin 
and tenascin. In the example shown in Figure 5.17 (A) forward (FSC) 
versus side scatter (SSC) light measurements (cytogram), and (B) the 
fluorescence of fibroblasts is displayed on the gated histogram. Using 
specific gating procedures in the computer program, a box was drawn 
around the fibroblast populations. This gate or window is used by the 
computer to select cells for accumulation of events into the fluorescence 
histogram. 
TSFL (neck fibroma), TSFM (ungual fibroma) and JPa (normal skin) 
fibroblasts were subjected to the flow cytometric analysis of laminin. An 
adapted flow cytometry protocol was described in detail in section 2.3.7.3. 
Quantitatively, the fluorescence intensity of 2000 TS (TSFM and TSFL) and 
normal skin fibroblast (JPa) populations for laminin was measured as a mean 
using a Becton Dickinson FACScan in the Department of Immunology. The 
flow cytometric data of fibroblasts collected in Consort 30 program was 
gated using FIowMATE program (Fig. 5.17), and the mean (fluorescein 
intensity) was obtained quantitatively. An average mean of four analysis 
was used and shown graphically in Figure 5.18. 
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Figure 5.17. The figure shows the typical cytograms and histograms of flow 
cytometric analysis of laminin. Panel A shows the forward (FSC) versus side 
scatter (SSC) cytograms (dotplots of laminin expression) of TS and normal skin 
fibroblasts. Panel B shows the fluorescence histograms of TS (TSFL) and normal 
skin fibroblasts (JPa). A box is drawn around the fibroblast cluster and used as a 
gate so that the fluorescence intensity of only the cells falling within this gate are 
displayed in the immunofluorescence profile shown in Panel B. For comparison, see 
panel B-1 and B-3 which represents the fluorescence intensity of laminin of JPa and 
TSFL fibroblasts respectively. Panel B-2 represents only FITC-conjugated 
secondary (anti-rabbit) antibody staining of normal JPa-fibroblasts (omitting primary 
anti-LM) as negative control staining. 
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Figure 5.18. Quantitative analysis of laminin expressed by normal skin (JPa), and 
TS fibroblasts (TSFM, ungual fibroma; TSFL neck fibroma) by flow cytometry. 
Cells were trypsinised, fixed and permeabilised for cytoplasmic staining or not 
permeabilised for cell surface staining of fibronectin as described in detail in section 
2.3.7.3. JPa, TSFM. and TSFL fibroblats were stained using primary polyclonal 
rabbit anti human laminin antibody and F1'TC-conjugated secondary (anti-rabbit) 
antibody. In control (cont. ) normal skin fibroblats primary antibody, anti-laminin 
were omitted, and stained only with FITC-conjugated secondary (swine anti-rabbit) 
antibody as negative control. 2000 events from each fibroblast line were analysed by 
flow cytometry. An average mean (fluorescence intensity) of four different flow 
cytometric analysis samples was plotted in this bar graph. Variations in mean within 
four different analysis of laminin were always within ± 5%. 
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Cont. JPa TSFL TSFM 
In contrast to fibronectin and tenascin expression, Figure 5.18 showed that 
TSFL neck fibroma-derived skin fibroblasts have a higher fluorescence 
intensity (mean) for laminin than TSFM ungual fibroma-derived and JPa 
normal skin fibroblasts. Increased expression of laminin was observed in 
both cytoplasm (permeabilised) and cell surface (not-permeabilised) of TSFL 
neck fibroma-derived fibroblasts in contrast to TSFM and normal JPa skin 
fibroblasts. Earlier, immunofluorescence studies have shown that the 
distribution and expression of laminin was only changed in TSFL neck 
fibroma-derived skin fibroblasts of 13 year old male TS patient. However, 
the distribution and expression of laminin was not changed in other 
fibroblasts derived from a forehead plaque lesion and ungual fibroma of a 14 
year old female and 10 year old male TS patient respectively in comparison 
to control fibroblasts. 
Overall, these results suggest that the nature of the extracellular matrix 
(ECM) in the neck fibroma derived fibroblasts in terms of increased 
expression of laminin is different than ungual fibroma derived fibroblasts 
which posses the increased expression of fibronectin and tenascin. 
5.4.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) for Fibroblasts 
Laminin Production 
As for fibronectin, ELISAs were performed to quantitate the amount of 
Iaminin secreted into the cell culture medium by TS and normal skin 
fibroblasts. ELISA assay for laminin production was performed as described 
previously in 5.2.2.2. 
ELISA assay results of laminin production into the cell culture medium by 
three TS (TSFL, TSFM and TSJH), and two normal skin fibroblasts (JPa and 
DAKO) is presented in Table 5.3. 
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Fibroblasts Passage Secreted Laminin* 
by IX 105 cell 
ng/2O0µ1 medium ± SD 
TSFL 12-15 13.58 ± 0.20 
TSFM 12-15 3.16 ± 0.07 
JPa 
TSJH 
12-15 3.46 ± 0.29 
12-15 4.27 ± 0.05 
DAKO 12-15 3.78 ± 0.28 
Table 5.3. Production of laminin by TS (TSFL, neck fibroma, TSFM, ungual 
fibroma and TSJH, forehead plaque) and normal skin fibroblasts (JPa and DAKO) 
detected quantitatively by ELISA. *Laminin production was assessed by measuring 
the quantity of laminin in fibroblast culture medium using ELISA and is expressed as 
ng/2O01il medium of 1X105 cells ± standard deviation (SD) of triplicate 
determinations. 
ELISA assay results of laminin in cell culture medium presented in Table 5.3 
showed the four fold increased production of laminin in TSFL fibroblasts 
derived from neck fibroma of a TS patient in comparison to normal skin 
fibroblasts (JPa and DAKO) and other two TSFM and TSJH fibroblasts 
derived from ungual fibroma and forehead plaque lesions of TS patients 
respectively. This increased production of laminin by TSFL fibroblast was 
also in agreement with the previous results of flow cytometry and 
immunofluorescence experiments. Laminin levels were not changed 
consistently in other two TS (TSFM and TSJH) and normal (JPa and DAKO ) 
skin fibroblasts. 
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5.5 Discussion 
In this chapter 5, expression and distribution of fibronectin, tenascin and 
laminin by established TS and normal skin fibroblasts using 
immunofluorescence, ELISA, and flow cytometry techniques were analysed 
and presented qualitative and quantitatively. 
Indirect immunofluorescence studies revealed that the distribution of 
fibronectin compared to controls was only altered in TSFM ungual fibroma- 
derived skin fibroblasts of the 10 year old male TS patient. However, the 
distribution of fibronectin was not changed in other fibroblasts derived from 
a forehead plaque lesion and neck fibroma of a 14 year old female and 10 
year old male TS patient respectively in comparison to control normal skin 
fibroblasts. 
The intensity of the fluorescence of cell surface fibronectin was increased 
and showed uneven distribution in the TSFM-fibroblasts derived from 
ungual fibroma of a TS patient in comparison to normal Ra-fibroblasts. 
Intracellular staining of ungual fibroma derived TSFM-fibroblasts with anti- 
fibronectin was also elevated in comparison to normal (control) skin 
fibroblasts. In addition, the fluorescence intensity was evenly distributed 
and predominantly perinuclear in both TS and normal skin fibroblasts. 
However, the intracellular fluorescence was patchy and also predominantly 
perinuclear in large cells (N-cells) of TS fibroblasts. 
In agreement with the literature (Hynes 1990), a cell surface associated 
fibrillar matrix of fibronectin was also observed in normal skin fibroblasts. 
However, the fibrillar arrays were better established in the ungual fibroma 
derived TSFM fibroblasts. 
ELISA and flow cytometric analyses of fibronectin also showed increased 
quantities and increased fluorescence intensity (mean) respectively of 
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fibronectin in the TSFM-fibroblasts derived from an ungual fibroma of a TS 
patient in comparison to normal skin fibroblasts. Therefore, quantitative 
analysis of both TS and normal fibroblasts determined by flow cytometry 
and ELISA assays were confirmed and strengthened the increased 
expression of fibronectin in the TSFM-fibroblasts derived from ungual 
fibroma of a TS patient in comparison to normal skin fibroblasts, following 
earlier findings of immunofluorescence studies. 
Similar to fibronectin, a meshwork of fibrils of tenascin occurred in large 
(diffuse) patches in TSFM-fibroblast derived from ungual fibroma of a TS 
patient, while they were more ordered fibrillar structures in normal JPa- 
fi broblasts. 
Increased expression of tenascin was observed in both cytoplasmic and cell 
surface immunofluorescence staining of TSFM ungual fibroma-derived skin 
fibroblasts in contrast to other TS and normal skin fibroblasts. Flow 
cytometry and ELISA results confirmed quantitatively and strenghened 
these earlier findings of immunofluorescence studies of tenascin. 
Interestingly, increased expression of tenascin was observed in a similar 
direction with fibronectin in TSFM fibroblasts derived from an ungual 
fibroma of a TS patient. This increase in TSFM fibroblasts may be the 
response of functions (adhesive and antiadhesive effects) of these two 
extracellular matrix glycoproteins to control the cell adhesion and spreading 
in ungual fibromas of TS patients, since it has been reported that tenascin 
inhibits cell adhesion to fibronectin (Chiquet-Ehrismann et al., 1988). 
Immunofluorescence studies showed that the distribution of laminin was 
altered in TSFL neck fibroma-derived fibroblasts, but not in ungual fibroma 
(TSFM), forehead plaque lesion (TSJH) or unaffacted skin (TSAH) derived 
fibroblasts of TS patients in comparison to control fibroblasts. Particularly. 
large cells of neck fibroma-derived TSFL fibroblasts populations showed 
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bright and diffuse staining of laminin in the cytoplasm, however laminin 
staining was usually observed around the nucleus (perinuclear) in normal 
(control) skin fibroblasts. 
In contrast to increased expression of fibronectin and tenascin in ungual 
fibroma derived TSFM fibroblasts, quantitative analyses of laminin by flow 
cytometry and ELISA assay showed the increased expression of laminin 
only in neck fibroma-derived TSFL fibroblasts. Laminin expression was not 
changed in ungual fibroma-derived TSFM fibroblasts and remained at similar 
levels to normal skin fibroblasts. These results suggested the presence of 
altered composition of extracellular matrix in neck and ungual fibromas as 
well as forehead plaque lesions of TS patients. 
Moreover, detection of laminin using monoclonal and polyclonal antibodies 
in immunofluorescence and flow cytometry studies of cells and in ELISA of 
cell culture medium also demonstrated once more the synthesis and secretion 
of this protein by human skin fibroblasts. However, laminin synthesis and 
secretion into cell culture medium by TS and normal skin fibroblast appeared 
to be less (three fold) than fibronectin synthesis as a general tendency. 
So far, there have been few studies that examine the sythesis of laminin by 
human dermal fibroblasts. Since there are contrary indications in these 
previous published papers about laminin expression by dermal fibroblasts 
(Timpl et al., 1982; Woodley et al, 1988; Cooper et al., 1993), these results 
reported in this thesis may also be important in elucidating the question of 
whether or not human dermal fibroblasts synthesise laminin as well as in 
understanding the pathogenesis of TS tissues. 
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Chapter 6 
Chapter 6 
General Discussion and Conclusions 
In this project, studies were carried out 
i) to characterise the amino acid composition and compare the 
glycosylation of purified cellular fibronectin from the conditioned 
medium of cultured skin fibroblasts derived from patients with 
tuberous sclerosis (TS) and from normal individuals, and 
ii) to establish the expression, distribution, and localisation of 
extracellular matrix (ECM) glvcoproteins fibronectin, laminin and 
tenascin in cultures of skin fibroblasts derived from patients with 
TS and normal individuals. 
6.1 Studies on purification, carbohydrate and peptide analysis of 
fibronectin from the conditioned medium of fibroblast cultures 
established from skin explants of patients with TS and normal 
individuals 
The macromolecules that constitute the extracellular matrix (ECM) are mainly 
secreted locally by cells in the matrix. In most connective tissues these 
macromolecules are secreted by fibroblasts. Fibroblasts are the principal cells 
of the dermis and responsible for the production and maintenance of the 
connective tissue matrix. Therefore, cultured fibroblasts were used in this 
research of skin lesions of TS patients to study the production of the 
adhesive glycoproteins of the ECM. 
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Fibroblasts were established from primary cultures of skin explants of 
patients with tuberous sclerosis. In some cases this was from skin lesions 
and in other cases from unaffected skin. Control fibroblasts, for comparison, 
have been grown from explants of people who are not known to be 
suffering from TS nor any other disease or disorder 
Fibroblasts secrete much of the fibronectin they synthesise into the culture 
medium in preference to retaining it on the cell surface. Therefore, cellular 
fibronectin was purified from conditioned medium of confluent fibroblasts 
by affinity chromatography on a Prosep-gelatin (Bioprocessing) column as a 
first step purification procedure, by a method established by Engvall and 
Ruoslahti (1977). However, purified fibronectin by this method was only 
partially pure. Therefore, final purification of cellular fibronectin was 
achieved from conditioned medium of established TS and control fibroblasts 
using gel filtration chromatography for carbohydrate analysis. Foetal calf 
serum previously depleted of fibronectin was used in the preparation of the 
medium of cell cultures to ensure that the purified product is pure cellular 
fibronectin. 
In the final purification step of the fibronectin, partially-pure fibronectin from 
the Prosep-gelatin column was applied on to Superose 12 gel filtration 
column (sizing column) connected with FPLC. Coomassie blue, silver and 
antibody staining of the reduced purified cellular fibronectin from TS and 
normal fibroblasts analysed by 5% SDS-PAGE showed a single broad band 
with approximate molecular weight of 230 000. The mobility of fibronectin 
isolated from fibroblasts grown from skin lesions of TS patients was identical 
to that from fibroblasts of unaffected skin. Typically, the final yield of 
fibronectin from the Superose-12 column was 70% of that applied from 
Prosep-gelatin. 
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Solubility of fibronectin was sometimes a problem at neutral pH after 
purification. Fibronectin was also sensitive to proteolysis. The dissolution 
of fibronectin was achieved by using cyclohexylaminopropane sulfonic 
(CAPS) buffer, pH 11, and protection from proteolysis using PMSF and 
EDTA. The solution was stored at 
-800 C in plastic vials for further analysis. 
The majority of studies of fibronectin in the scientific literature were carried 
out with plasma fibronectin rather than cellular fibronectin of fibroblast 
origin. This is because of the higher cost and complexity of cell culture and 
purification of cellular fibronectin. 
Analysis of purified fibronectin samples by high pH anion-exchange 
chromatography (HPAEC-PAD) revealed that the carbohydrate portion of 
the fibronectin molecule was made up of galactose, mannose, glucosamine, 
galactosamine, sialic acid and fucose. Oligosaccharides of TSFC-purified 
fibronectin from fibroblasts of TS skin lesion and plasma fibronectin 
appeared basically as mono and disialylated biantenary structures 
respectively. The major type of side chain in fibronectin glycosylation is of 
the biantennary complex asparagine-linked type. As expected, fucose was 
not detected in human plasma fibronectin. In human plasma and fibroblasts 
derived cellular fibronectin, the most common form of sialic acid was found 
to be N-acetyl neuraminic acid. Moreover, there was altered monosaccharide 
composition of fibronectin purified from conditioned medium of fibroblasts 
grown from skin lesions of different TS patients in comparison to 
carbohydrates of fibronectin derived from normal fibroblasts. An increased 
concentration of sugars was observed in sialic acid, galactosamine, 
glucosamine, galactose and mannose of purified fibronectin from neck and 
ungual fibromas of patients with IS. The total increase of carbohydrates of 
TS fibroblasts fibronectin was more than two fold in comparison to normal 
fibroblasts-derived fibronectin. 
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Several oligosaccharide-dependent functional alterations of fibronectin have 
previously been described. It was shown that glycosylation can modulate 
the interaction of fibronectin with collagen and with the cell membrane. 
Jones et al. (1986) compared glycosylated and non-glycosylated human 
skin fibroblast fibronectins and found that the deglycosylated form had an 
increased affinity for gelatin and enhanced adhesion-promoting properties. 
An important function of the carbohydrate moieties of the fibronectin is also 
protection of the protein from proteolytic attack. Bernard and colleagues 
demonstrated that the heavily glycosylated collagen-binding domain of 
chick embryo fibroblast fibronectin was selectively resistant to a broad 
variety of proteases (Bernard et al., 1982). 
Harper et al., (1990) previously demonstrated that human tumors of 
neuroectodermal origin secrete fibronectin that contains the cell-adhesion- 
related HNK-1 epitope. In this study, the glycoproteins including fibronectin 
derived from TS skin fibroblasts and normal fibroblasts were found not to 
express the HNK-1 carbohydrate epitope. This result is not surprising, 
because the epitope was reported to be a marker for neural cell adhesion 
molecules involved in cell-cell and and cell substrate interactions during 
neural development. 
Since fibronectin glycosylation is involved in promotion of fibroblasts 
adhesion and spreading, and playing significant roles in the ECM, the 
abnormal glycosylation of fibronectin found in skin lesions of TS patients 
may effect the cell-cell adhesion and cell-ECM interaction during the early 
and later embryonic development. 
In general, the amino acid composition of the purified fibronectin from 
normal fibroblasts (JPa) was very similar to that of purified fibronectins from 
TS fibroblasts as well as standard plasma (pFN) and commercial cellular 
fibronectin (cFN). Amino acid composition of these fibronectins was also 
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consistent with the scientific literature. This suggests, as expected, no major 
differences in the primary structure of the fibronectin in IS. 
Amino acid sequencing of fibronectin purified from TS and normal 
fibroblasts was not satisfactorily completed because of the N-terminal 
blocking and low expression of these fibroblast derived cellular fibronectin. 
However, N-terminal amino acid sequencing (Edman degradation) was 
demonstrated on the purified gelatin-binding domain of chymotrypsin 
digested human plasma fibronectin. The results of sequence analysis 
showed the N-terminal sequence glutamine-proline-glutamine-proline- 
histidine (Q-P-Q-P-H) in the chymotryptic 45 kDa collagen-binding domain 
in agreement with earlier reports by other workers (Zhu et al., 1984). 
To investigate the effects of cellular fibronectins purified from conditioned 
medium of TS and control fibroblasts, and plasma fibronectin on fibroblasts, 
cell culture plates were coated with different concentrations of purified 
cellular and plasma fibronectins. Adhesion of fibroblasts was promoted in all 
concentrations of fibronectins coated cell culture plates. Altered 
morphology and less confluence were observed in the culture plates coated 
with cellular fibronectin derived from TS skin lesions. This altered 
morphology may be the consequence of the effects of altered (increased) 
glycosylation of the fibronectin as a ECM macromolecule. The appearance 
of the fibroblasts was very similar (and normal) on the cultured plates coated 
with plasma, and normal cellular fibronectin derived from normal skin. 
However, cellular fibronectin coated fibroblast cultures were more confluent 
than plasma fibronectin coated culture plates. This indicated that cellular 
fibronectin is more active than plasma fibronectin in the promotion of the cell 
spreading, proliferation and morphology. 
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6.2 Expression, distribution, and localisation of ECM glycoproteins 
fibronectin, laminin and tenascin in cultures of skin fibroblasts derived 
from patients with TS and normal individuals. 
There have been few studies that examine the synthesis of laminin by human 
dermal fibroblasts. There were contrary indications in these previous 
published scientific papers about its expression by fibroblasts (Timpl et al., 
1982, Woodley et al., 1988, and Cooper et al., 1993). In this study, the 
synthesis and secretion of tenascin and laminin into cell culture medium in 
addition to fibronectin by TS and control skin fibroblasts were demonstrated 
by western blotting. Partial purification of laminin and tenascin were 
achieved by ammonium sulphate precipitation and Mono-Q anion exchange 
chromatography techniques. 
Expression and distribution of fibronectin, tenascin and laminin by 
established TS and normal skin fibroblasts using immunofluorescence, 
ELISA, and flow cytometry techniques were analysed and presented 
qualitative and quantitatively. 
Indirect immunofluorescence studies revealed that the distribution and 
expression of fibronectin compared to controls was only altered in TSFM 
ungual fibroma-derived skin fibroblasts of the 10 year old male TS patient. 
However, the distribution and expression of fibronectin was not changed in 
other fibroblasts derived from a forehead plaque lesion and neck fibroma of a 
14 year old female and 10 year old male TS patient respectively in 
comparison to control fibroblasts. Unaffected skin fibroblasts (TSAH) 
derived from the skin of the lumbosacral area of a TS patient also showed 
similar distribution and fluorescence intensity for fibronectin in comparison 
to normal (control) skin fibroblasts. Cell surface staining of ungual fibroma 
derived TSFM-fibroblasts with anti-fibronectin was found to be different 
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than normal (control) skin fibroblasts. Moreover, the cell surface distribution 
of fibronectin was uneven and appeared more dense on the TSFM- 
fibroblasts derived from ungual fibroma of a TS patient, while it is evenly 
distributed on control Ra-fibroblasts. The intensity of the fluorescence of 
intracellular fibronectin was increased in the TSFM-fibroblasts derived from 
ungual fibroma of a TS patient in comparison to normal Pa-fibroblasts. Cells 
from an ungual fibroma of a TS patient appeared larger than normal 
fibroblasts in size. In addition, the fluorescence intensity for fibronectin was 
evenly distributed and predominantly perinuclear in both TS and normal skin 
fibroblasts. However, the intracellular staining of fibronectin was patchy 
and also predominantly perinuclear in large cells (called N-cells by others) of 
TS fibroblasts. In general, fibrillar matrix of fibronectin were better 
established around the large TS cells derived from ungual fibroma than 
normal skin fibroblasts. 
Similar to fibronectin, immunofluorescence studies showed that the 
distribution and expression of tenascin was only altered in TSFM ungual 
fibroma-derived skin fibroblasts of 10 year old male TS patient. However, 
the distribution and expression of tenascin was not changed in other 
fibroblasts derived from a forehead plaque lesion and neck fibroma of a 14 
year old female and 10 year old male TS patients respectively in comparison 
to control fibroblasts. Increased expression of tenascin was observed in 
both cytoplasm and cell surface of TSFM ungual fibroma-derived skin 
fibroblasts compared to neck fibroma derived TSFL fibroblasts and normal 
skin JPa fibroblasts. 
Immunofluorescence studies with mono and polyclonal antibodies on both 
TS and normal fibroblasts also showed laminin synthesis by dermal skin 
fibroblasts. Interestingly, altered distribution of laminin was observed at the 
cell surface and in the cytoplasm of, particularly in large cells, TSFL-derived 
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fibroblasts from neck fibroma of a 13 year old male. However, changes in the 
immunofluorescent staining of fibronectin and tenascin were observed in 
TSFM-fibroblasts derived from an ungual fibroma of a 10 year old male TS 
patient. In normal JPa skin fibroblasts, cell surface staining of laminin was 
hardly detectable compared to TSFL neck fibroma derived fibroblasts. 
Intracellular laminin staining is bright, and diffuse in the cytoplasm of large 
cells derived from a neck fibroma of a TS patient, but this was usually seen 
around nuclei only in normal skin fibroblasts. 
Increased expression of laminin in neck fibroma-derived TSFL fibroblasts 
was also confirmed by ELISA and flow cytometry quantitatively 
. 
In 
contrast to TSFL fibroblasts, ELISA and flow cytometry results confirmed 
quantitatively and strenghened the earlier findings of immunofluorescent 
studies of fibronectin and tenascin in TSFM fibroblasts derived from an 
ungual fibroma. Flow cytometry and ELISA results showed quantitatively 
that laminin exression was increased in cytoplasm, cell surface and in the 
conditioned medium of TSFL fibroblasts derived from neck fibroma. These 
two quantitative experiments also proved that fibronectin and tenascin were 
increased in cytoplasm, cell surface and in the conditioned medium of TSFM 
fibroblasts. 
Cell-matrix interactions via ECM macromolecules play many critical roles in 
embryonic development and disease processes. Lallier (1991) proposed a 
model for tuberous sclerosis mutation effects on neural crest cell migration 
(see Fig. 1.2). According to Lallier "normal neural crest cells may migrate 
through a series of extracellular matrix molecules, causing them to 
differentiate into a specific cell type. Tuberous sclerosis mutant cells may 
lack the ability to properly interact with the matrix molecules they 
encounter, leading to misplaced cells or cells that differentiate into abnormal 
cell types. " 
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Altered expression and distribution of fibronectin and laminin were well 
observed particularly in large cells of ungual fibroma and neck fibroma of TS 
patients respectively. All these results suggest the abnormal assembly of 
ECM in different TS skin lesions. It is also clear that there are some 
differences between TS fibroblasts from different sources. This may be 
important in understanding the nature of the skin lesions which occur in 
various locations of TS patients bodies. 
Therefore, altered expression and arrangements of fibronectin, laminin and 
tenascin on ungual fibroma and neck fibroma derived fibroblasts reported in 
this thesis may effect the interactions of ECM with cells during embryonic 
development, and therefore that may result with misplaced cells or cells that 
differentiate into abnormal cell types (for example large, N-cells observed in 
this research) in different TS lesions. Moreover, functional distruption 
between ECM macromolecules and the cells may result in disease states, 
hardness of tissues and alterations in the behavior and shape of the cells in 
TS tissues during development. As reported earlier in chapter 4 (see Figs. 
4.15 and 4.16), altered morphology and less confluence were observed in 
the culture plates coated with cellular fibronectin derived from TS skin 
lesions. This altered morphology of fibroblasts may be the consequence of 
the effects of increased glycosylation of the fibronectin as a ECM 
macromolecule, since fibronectin glycosylation modulates fibroblast 
adhesion and spreading according to Jones and his colleagues (1986). 
Overall, these results suggest that abnormal assembly of the ECM 
demonstrates defects in the biosynthesis or deposition of fibronectin, laminin 
and tenascin which might result in hardened tissues of TS. These findings of 
this thesis may be a good evidence to support the idea that changes in ECM 
composition and organisation may have profound effects on cell spreading, 
adhesion, proliferation, cell shape and behaviour during the development of 
187 
hardened TS tissues. Studies of these changes in the ECM components may 
contribute to the understanding of the mechanisms involved in the aetiology 
of hardened tissues of TS. 
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